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1. Introduction 
1.1. Fundamental features of the immune system 
We spend our lives surrounded by potentially pathogenic microorganisms, nevertheless we 
only rarely become ill. This is due to the highly effective immune system that has evolved in 
vertebrates. Corresponding to the immense number of pathogens and various ways of 
infection, the immune system is composed of a great variety of cells as well as messenger and 
effector molecules. In principle, two systems of defense are distinguished: the innate and the 
adaptive immune system. The innate immune system represents a first line of defense, and 
protects the organism against many common bacterial infections at an early time point with its 
rather unspecific mechanisms and invariant receptors, recognizing common features of 
pathogens such as bacterial cell wall components or double-stranded RNA. This system is so 
effective that we often do not notice infections by pathogens of low virulence. But the innate 
immune system can not always eliminate infectious organisms, and there are also many 
pathogens which can evade the mechanisms of the innate immune system. The cellular 
members of the adaptive immune system act much more specific. They possess diverse 
surface receptors and can recognize and target pathogenic microorganisms or cells infected by 
them. In addition, they mediate – sometimes lifelong – protection against re-infection by the 
same pathogen due to an immunological memory. The synergistic action of both the innate 
and the adaptive immune system is the basis for a rapid, highly specific and protective 
immune response against potentially pathogenic microorganisms. This allows survival in a 
principally hostile microbial environment. 
 
1.2. The adaptive immune system 
The two cellular mediators of adaptive immunity, the T and the B lymphocytes, express on 
their surface highly diverse receptors capable of recognizing a wide diversity of antigens, i.e. 
molecules or structures, that induce an immune response. Each individual lymphocyte clone 
bears receptors of a single antigen specificity only. 
The T lymphocytes, also named T cells, are responsible for cellular immunity. T cells, like 
other blood cells, are known to be derived from hematopoietic stem cells. T cell progenitors 
migrate from the fetal liver (FL) or after birth from the bone marrow (BM) to the thymus, 
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where they mature (Kruisbeek, 1999). After maturation, they leave the thymus and recirculate 
through the secondary lymphatic organs, e.g. spleen, lymph nodes and Peyer’s patches. 
T lymphocytes express the T-cell receptor (TCR) as antigen-binding structure on their 
surface. For the majority of T cells the TCR is a heterodimer consisting of an α and a β chain 
(α:β T cells). Such T cells are not able to recognize native antigen, but only a peptide 
fragment bound to a molecule of the major histocompatibility complex (MHC). Two classes 
of the MHC molecules exist: MHC class I molecules, that mainly present peptides of the 
cytosolic compartment, and MHC class II molecules, which primarily present peptides of 
proteins that are taken up via endocytic vesicles (Watts and Powis, 1999). 
Based on cell surface markers and functional properties the α:β T cells can be subdivided into 
at least two subsets. First, into the cytotoxic T cells that display the surface antigen CD8 and 
second, into T-helper cells, characterized by the surface antigen CD4. The CD8+ cytotoxic T 
cells can recognize, for instance, virus infected cells via antigens presented by MHC class I 
and then kill these cells by induction of apoptosis, thus stopping further spreading of the 
virus. The CD4+ T-helper cells recognize peptide fragments presented by MHC class II 
molecules and are specialized activators for other cells. As TH1 cells they activate 
macrophages to kill pathogens (Paulnock, 1992), and as TH2 cells they activate B 
lymphocytes to differentiate and to produce antibodies (Parker, 1993). 
Some T cells bear an alternative form of the TCR with γ and δ chains (γ:δ T cells). The 
function of these γ:δ T cells are at present still unknown, likewise their ligands. Interestingly, 
it has been shown that the γ:δ receptor is sometimes able to recognize antigen directly (Born 
et al., 1999). 
B lymphocytes (or B cells) are the cells responsible for the humoral immunity. On their 
surface, they express immunoglobulins (Ig) as antigen receptors (B-cell receptor, BCR), 
which can recognize native antigen. After antigen contact and further activation, B cells can 
differentiate into plasma cells and secrete the immunoglobulins as antibodies. These 
antibodies participate in three different ways in the combat against an infection. First, they 
bind bacterial toxins and viruses and thereby block their access to cells that they may infect or 
destroy (neutralization). Second, antibodies coat pathogens and foreign particles 
(opsonization), providing a signal for their elimination by phagocytic cells of the innate 
immune system (like macrophages or neutrophils). The third function upon antigen-binding is 
the activation of a system of plasma proteins known as complement, leading to the destruction 
and removal of the pathogen. 
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Like T lymphocytes and other blood cells, B lymphocytes are derived from hematopoietic 
stem cells. In mammals B cells both develop and mature in fetal liver or after birth in bone 
marrow (Akashi et al., 2000a; Busslinger et al., 2000). In birds they require the bursa of 
Fabricius for final maturation, which was the reason to originally name these cells B 
lymphocytes. 
Based on cell surface markers, anatomical localization and function, mature B cells are 
classified into at least two subsets, B1 and B2. The B1 cells dominate the body cavities, like 
pleural cavity and peritoneum, while they can be found relatively rarely in the peripheral 
lymphoid organs, like spleen and lymph nodes. B1 cells often produce poly-reactive 
antibodies against bacterial polysaccharides, which are probably important for an early 
immune response against bacterial pathogens (Boes et al., 1998). The B2 cells, also called 
conventional B cells, play an essential role in the adaptive immune response with their 
monospecific antibodies. B2 cells represent the predominating B-cell population in the 
peripheral lymphoid organs, like spleen and lymph nodes, but they can also be found in body 
cavities. 
The major difference between the two populations is that B2 cells are not generated before 
birth. Without antigen contact they have only a limited life span and are continuously 
replaced by newly formed B cells from the bone marrow. This is in contrast to the B1 cells, 
which possess the capacity of self-renewal, and it has been suggested that their generation is 
completed shortly after birth. Presumably, they originate mainly in the fetal liver and neonatal 
bone marrow (Herzenberg, 2000; Hayakawa and Hardy, 2000). 
 
1.3. Structure of an antibody molecule 
The effector molecules secreted by activated B cells are the antibodies. Antibodies are Y-
shaped molecules composed of two identical heavy (H) and two identical light (L) 
polypeptide chains normally linked by disulfide bonds (Fig. 1-1). Each chain consists of a 
variable and a constant region. The variable (V) region at the amino-terminal end displays 
three regions with particular variability, the so called hypervariable or complementarity-
determining regions (CDR), surrounded by four regions which are relatively invariant, named 
framework regions (FWR). While the FWRs are important for the structure of the antibody 
molecule, the CDRs of both the heavy and the light chain together form the antigen-binding 
site of the antibody. 
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The constant (C) carboxy-terminal part of the heavy chain determines the class or isotype of 
the antibody. There are five main heavy-chain classes: IgM, IgD, IgG, IgE and IgA, where the 
IgG-isotype in mice is subdivided into the subclasses IgG1, IgG2a, IgG2b and IgG3. The 
corresponding heavy chains are denoted by Greek letters: µ, δ, γ, ε and α, and γ1, γ2a, γ2b and 
γ3 respectively. The class of an antibody molecule determines its functional activity. IgG 
antibodies activate phagocytic cells, while IgE antibodies stimulate mast cells to release 
histamine. 
 
 
Fig. 1-1: Structure of an antibody molecule. Shown are the functional domains, intrachain and 
interchain disulfide bonds and the hypervariable regions of both the heavy and the light chains of an 
IgG1 molecule. 
 
Two different types of light chains exist: kappa (κ) and lambda (λ). No functional difference 
has been found between antibodies bearing κ or λ light chains, only the ratio of the two types 
is characteristic for a species. In humans the κ to λ ratio is about 2 : 1, in mice 10 : 1. 
Each antibody molecule is expressed either in a membrane-bound form or as secreted 
molecule, except IgD, which exists only in the membrane-bound form. The membrane-bound 
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antibody molecule is anchored by a hydrophobic transmembrane domain in the membrane of 
B lymphocytes and is called BCR. The BCR normally contains only a small cytoplasmic 
domain, thus can not transduce signals by itself. It is therefore complexed with the signal 
transducing molecules Igα and Igβ (Reth et al., 2000). 
In the secreted form, a secretory tail replaces the transmembrane domain and the cytoplasmic 
component. Membrane-bound antibodies like IgG and IgE molecules exist only as monomers, 
while secreted IgM and IgA antibodies are usually synthesized as multimers. IgA forms 
dimers, whereas IgM forms pentamers or hexamers (Johansen et al., 2000). In these 
multimers the single monomeric subunits are joined by disulfide bonds and an additional 
polypeptide chain, the J (joining) chain (summarized in Frazer and Capra, 1999). 
 
1.4. Generation of the primary antibody repertoire 
An organism must be able to recognize each potential antigen or to develop a specific 
antibody against each particular antigen. The multitude of potential antibodies is formed from 
a very limited number of genes that encode them. The great diversity of the antibodies is only 
realized by the fact that genes encoding the variable regions of the antibody molecules are 
composed of several gene segments, which are separated in the germline but combined in 
developing B lymphocytes in a process called somatic recombination or rearrangement. A 
similar process takes place during receptor formation in developing T lymphocytes. 
Each genetic locus encoding a particular immunoglobulin chain is special concerning 
organization and arrangement of the gene segments (summarized in Tonegawa, 1983; Max, 
1999). Moreover, they are also localized on different chromosomes. The heavy chain locus of 
the mouse is on chromosome 12, while the κ and the λ light chain loci are on chromosome 6 
and 16, respectively.  
 
1.4.1. The heavy chain locus 
The heavy chain variable regions are encoded in three gene segments: VH, DH and JH. The 
region containing these gene segments is very complex and comprises hundred or more VH 
(variable) gene segments, the exact number of them is not yet known. By means of sequence 
homology, different VH gene segments could be classified into 14 VH gene families. A 
considerable number of these VH gene segments are not able to rearrange or lead to non-
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functional polypeptide chains due to mutations. They are therefore called pseudo-genes. 
Downstream of the VH gene segments a cluster of 16 functional DH (diversity) segments can 
be found (Fig. 1-2). Localized further 3’ are four functional JH (joining) segments. 
The particular gene segments are flanked by so called recombination signal sequences (RSS), 
which are essential for the site-directed recombination process. A RSS contains a highly 
conserved palindromic heptamer and a moderately well conserved A/T rich nonamer 
sequence, which are separated by either 12 or 23 base pairs (bp) of non-conserved spacer 
DNA (Fig. 1-3). While the VH and JH gene segments are flanked by RSS with a 23 bp spacer, 
the DH segments are flanked at both sides by RSS with 12 bp spacers. Recombination can 
combine only a gene segment flanked by a 12mer-spaced RSS with one displaying a 23mer-
spaced RSS (the 12/23 rule, summarized in Tonegawa, 1983; Gellert, 1997). By this means, it 
is guaranteed that a VH gene segment is always joined to a JH gene segment via an 
intermediate DH gene segment. 
The immunoglobulin CH region gene segments form a large cluster 3’ of the JH gene 
segments. Each CH region gene coding for the constant region of the different antibody 
classes and subclasses is split into separate exons corresponding to the domains of an 
antibody molecule. 
 
Fig. 1-2: The murine heavy chain locus. The gene segments are displayed in germline configuration 
(not to scale). Each VH gene segment is flanked by a leader (L) region, coding for a leader peptide 
important for the intracellular transport into the endoplasmatic reticulum. After the transport the leader 
peptide is cleaved off. Shown are the intron (Eµ) and the 3’ enhancer (3’Eµ). Arrows indicate 
promoters. Only for Cµ the four exons in addition to the two short exons coding for the transmembrane 
and cytoplasmic part are shown. S: switch region. 
L1 LnVH1 VHn
D gene segments 
(n=16)
H 
J gene 
segments
H 
DQ52 S
S S S S S S 3’EH
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Fig. 1-3: Flanking recombination signal sequences of heavy and light chains. Shown are the 
conserved heptamer and nonamer sequences as well as the spacer length of the particular gene 
segments. 
 
After maturation and exit from the bone marrow, B lymphocytes that had not encountered 
antigen yet display two immunoglobulin isotypes with identical V regions at their surface, 
IgM and IgD. Mechanistically, these cells produce a long primary transcript including both 
the Cµ and the Cδ gene segment, that resides downstream of Cµ. Alternative processing leads 
to two different mRNA molecules and consequently to the co-expression of IgM or IgD. A 
similar mRNA modification takes place after antigen stimulation, when the antibody is 
expressed in its secreted form instead of the membrane-bound form. 
After antigen contact B cells are also able to express other antibody classes. In a reaction 
called class switch recombination (CSR), the original CH gene segment is replaced by another 
downstream segment changing the antibody class and effector function. The antigen 
specificity remains the same during these events. 
 
1.4.2. The κ light chain locus 
The variable regions of light chains are encoded by V and J gene segments only. For the κ 
locus so far 140 Vκ gene segments are localized and sequenced. 75 of them are functional, 
GTGTCAC
CACTGTGGGTTTTTGT
GTGACACCCAAAAACA
CACAGTG ACAAAAACC
TGTTTTTGG23
12 23
VH 23 23
12
JH
12 12DH
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while 44 are pseudo-genes and 21 are only potentially functional. The latter bear mutations in 
promoters, splice-sites, RSS or exons, but nevertheless a cDNA could be found in the 
database (Roschenthaler et al., 2000). A unique characteristic of the κ locus is, that the Vκ 
gene segments are located in both transcriptional orientations relative to the C region. 
 
 
Fig. 1-4: The murine κ light chain locus. The gene segments are displayed in germline configuration 
(not to scale). Both possible transcriptional orientations of the Vκ segments are indicated by the 
position of the leader regions. Shown are the intron (iEκ) and the 3’ enhancer (3’Eκ). Promoters are 
indicated by arrows, pseudo-genes by the Greek letter Ψ. RS: recombining sequence. 
 
Downstream of the Vκ gene segments is a cluster of five Jκ genes (Fig. 1-4). One of them 
(Jκ3) was found to be non-functional. The single segments are flanked 5’ with 23mer-spaced 
RSS whereas consequently the Vκ gene segments are 3’ flanked by 12mer-spaced RSS. 
Separated by a 2.5 kb intron from the Jκ gene segments, a single Cκ segment could be found 
(Max et al., 1981). 
Similar to the VH gene segments it is also possible to subdivide the Vκ gene segments into 18 
different families by means of sequence homology. The biggest family Vκ04/05 contains 33 
Vκ gene segments whereas other families like Vκ22, Vκdv, Vκ38c and VκRF consist only of a 
single member. The Vκ21 genes form the most 3’ or most J-proximal family, whereas Vκ02 is 
a family at the 5’ end and could be taken as the J-distal family (Fig. 1-5). 
About 25 kb 3’ of the Cκ gene segment a recombining sequence (RS; Muller et al., 1990) 
without coding function can be found (Daitch et al., 1992). This RS could rearrange with a Vκ 
gene segment leading to the deletion of the intervening segments. This results in inactivation 
of the complete κ locus on this chromosome because further rearrangements are excluded this 
way (Durdik et al., 1984; Moore et al., 1985). Initially it was supposed that this 
recombination plays a role in the regulation of the λ light chain locus, but later examinations 
L1 Ln
RS
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argued against it (Dunda and Corcos, 1997; Engel et al., 1999). Involvement in receptor-
editing was postulated instead (Nemazee, 2000). 
 
Fig. 1-5: Map of the murine Vκ gene locus. The complexity and the relative chromosomal position 
of the different Vκ gene families are shown. Each bar represents a single Vκ gene segment. Two genes 
of the Vκ04/05 family are not included in this map, because the exact localization was not determined 
so far. 
 
1.4.3. The λ light chain locus 
In contrast to both the heavy and the κ light chain locus the J and C segments of the λ locus 
are arranged in pairs (Fig. 1-6). Three of the four JλCλ clusters are functional. Only three Vλ 
genes are present in the λ locus of laboratory mouse strains tested so far. One of these Vλ 
genes (Vλ1) is located between the two JλCλ clusters thus most likely excluding 
rearrangements with the upstream JλCλ cluster. The Vλ gene segments are flanked by 23mer-
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spaced RSS and the Jλ segments by 12mer-spaced RSS in agreement with the 12/23 rule. The 
organization of the λ locus seems to be the result of two sequential gene duplication events 
(Blomberg and Tonegawa, 1982; Selsing et al., 1982). The second Vλ downstream of Vλ1 was 
obviously lost after this event. 
 
 
Fig. 1-6: The murine λ light chain locus. The gene segments are displayed in germline configuration 
(not to scale). Shown are the enhancers Eλ2-4 and Eλ3-1. Promoters are indicated by arrows, pseudo-
genes by the Greek letter Ψ. 
 
1.4.4. The recombination activating genes Rag1 and Rag2 
The gene products of the recombination activating genes Rag1 and Rag2, the proteins Rag1 
and Rag2, play an essential role in the recombination process. This was demonstrated in mice 
in which Rag1 (Mombaerts et al., 1992) or Rag2 (Shinkai et al., 1992) was inactivated by 
homologous recombination. These mice can not rearrange their antigen-receptor genes, thus 
leading to a lack of all B and T lymphocytes. 
The recombination activating genes Rag1 and Rag2 are located in mice on chromosome 2 in a 
tail-to-tail configuration separated by a 7 kb intergenic region (Fig. 1-7; Bertrand et al., 1998). 
Rag1 is composed of two exons, while Rag2 consists of three, whereby the entire coding 
sequence (CDS) in both cases is restricted to the last exon. The Rag2 mRNA, 2.1 kb in length, 
encodes a polypeptide of 527 amino acids with a molecular size of 58 kD (Oettinger et al., 
1990) whereas the Rag1 mRNA is 6.6 kb in length and encodes a polypeptide of 1040 amino 
acids with a molecular size of 119 kD (Schatz et al., 1989). Both genes show no homology to 
each other, but in all species examined so far, the genomic organization of the Rag locus was 
conserved, with the two genes tightly linked and convergently transcribed (Schatz et al., 
1992). This observation led to the hypothesis that the Rag genes were derived from an 
ancestral transposon that integrated into an early vertebrate genome (Oettinger et al., 1990; 
Thompson, 1995). With one exception, the coding region of each gene is contained within a 
single exon (Hansen and Kaattari, 1995). 
L2 L1LX
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Fig. 1-7: The murine Rag locus. Shown are the exons of Rag1 and Rag2. Both exons 1 and Rag2-
exon 2 are not to scale, they are only about 70 nucleotides long. Hatched regions represent the coding 
sequence. Promoters and transcriptional orientation are indicated by arrows. 
 
Rag gene expression is restricted to the lymphocyte lineages, although low levels of Rag1 
transcripts have been reported in non-lymphoid tissues (Chun et al., 1991; Hayakawa et al., 
1996). Usually expression is found in developing B and T lymphocytes and ceases upon 
maturation. In addition, it was claimed that the Rag locus could be reactivated in mouse 
germinal center B cells (Han et al., 1996; Hikida et al., 1996; Papavasiliou et al., 1997; 
Hikida and Ohmori, 1998). However, additional studies with transgenic or knock-in Rag 
reporter constructs indicated that Rag expression can not be re-induced in most mature B 
lineage cells and the vast majority of Rag expressing cells represent B cell progenitors or 
precursors (Yu et al., 1999b; Monroe et al., 1999b). 
The mechanisms responsible for the lymphoid- and developmental stage-specific regulation 
of the Rag genes are poorly understood. Only the murine Rag2 promoter shows tissue 
specificity (Monroe et al., 1999a; Lauring and Schlissel, 1999), while ubiquitous basal 
activity is found for both the murine and the human Rag1 as well as for the human Rag2 
promoter (Fuller and Storb, 1997; Kurioka et al., 1996; Zarrin et al., 1997). Additional 
sequences 5’ of the Rag2 gene appear to regulate both Rag1 and Rag2, an organization that 
has been suggested to support the notion that the two genes were placed into the genome via a 
primordial transposon (Yu et al., 1999a). Recently, a B-cell specific and evolutionarily 
conserved transcriptional enhancer in the Rag locus, called Erag, could be identified (Hsu et 
al., 2003). 
 
1.4.5. Rearrangement and expression of immunoglobulin genes 
The recombination process itself is very similar for the heavy chain and both light chains. It 
differs only in the number of rearranged gene segments. While the light chain loci have only 
Rag1-Exon 1
Rag1-Exon 2
Rag2-Exon 3 Rag2-Exon 1
Rag2-Exon 2
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V and J gene segments to be recombined, the VH and JH gene segments of the heavy chain are 
rearranged with an intermediate DH element (summarized in Grawunder et al., 1998). 
Rearrangement starts at the heavy chain locus with the joining of one DH segment to one JH 
segment leading to the deletion of the intervening DNA. Subsequently a VH gene segment 
rearranges to DJH. After generation of a functional heavy chain, the recombination of Vκ and 
Jκ at the κ locus takes place. A peculiarity of the κ locus is that some of the Vκ gene segments 
have an opposite transcriptional orientation to that of the Jκ gene segments. When the RSS in 
such cases are combined, the intervening DNA is not lost from the chromosome but is 
retained in an inverted orientation. Similar to the heavy chain locus the rearrangement of VκJκ 
does not always lead to a functional κ chain. In this case rearrangement at the second allele 
takes place. Only if the recombination on both κ alleles was not functional, the λ locus will be 
rearranged using the same rules described for the heavy or the κ light chain, respectively. 
 
1.4.6. Proteins involved in V(D)J recombination 
V(D)J recombination is initiated by Rag1 binding to the nonamer element of the RSS, 
followed by recruitment of Rag2 and interaction with the heptamer. Then, the Rag proteins 
introduce single-strand nicks precisely between the RSS and the coding segment. This is 
followed by Rag catalysis of a trans-esterification reaction in which the 3’ OH of the coding 
strand invades the complementary DNA strand to form closed hairpin coding ends and blunt 
5’ phosphorylated signal ends (van Gent et al., 1996). The four Rag-liberated DNA ends 
remain associated with Rag in a stable postcleavage synaptic complex (Fugmann et al., 2000). 
Subsequently, the signal and coding ends are differentially processed and joined. The ends of 
the heptamer sequences are joined precisely in a head-to-head fashion to form the signal joint 
in a circular fragment of DNA, which is subsequently lost when the cell proliferates (Lewis et 
al., 1985; Lieber et al., 1988). The joining of the V, (D) and J gene segments, the so-called 
coding joint, is not precisely defined, and consequently generates extensive variability at the 
CDR3 of a heavy chain (see 1.4.7.). The joining phase of the V(D)J recombination reaction is 
carried out primarily by ubiquitously expressed non-homologous DNA end-joining (NHEJ) 
proteins, although the Rag proteins appear to be important for the joining phase of the 
reaction in the context of the postcleavage synaptic complex (Yarnell et al., 2001). These 
NHEJ proteins are usually associated with general DNA double-strand break repair - like in 
the case of radiation-damaged DNA. Three such NHEJ proteins are subunits of the DNA-
dependent protein kinase (DNA-PK), which consists of the Ku70 and Ku80 DNA-binding 
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subunits and a large catalytic subunit (DNA-PKcs) related to PI-3 kinases (Khanna and 
Jackson, 2001). Activation of DNA-PKcs requires binding of the Ku70/Ku80 complex to 
double-strand breaks. The role of DNA-PKcs first became apparent in the ionization radiation 
sensitive scid (severe combined immunodeficiency) mice, which lack B and T cell 
development due to a block of V(D)J recombination by a mutation of DNA-PKcs (Bosma and 
Carroll, 1991). Targeted disruption of this protein kinase leads to defects very similar to those 
caused by the naturally occurring scid mutation (Gao et al., 1998a; Taccioli et al., 1998). 
Similarly, defects in the Ku proteins interfere with V(D)J recombination (Nussenzweig et al., 
1996; Zhu et al., 1996; Gu et al., 1997; Ouyang et al., 1997). However, while DNA-PKcs-
deficient cells are severely impaired only for coding joining, Ku-deficient cells are severely 
impaired in both coding and signal joining. The precise role of DNA-PKcs is still unknown, 
as its in vivo substrates are not identified till now. However, its function in NHEJ was 
suggested to involve end-processing, including hairpin opening, as indicated by the unusually 
large number of P nucleotides in DNA-PKcs-deficient cells (Lewis, 1994). In addition, in 
vitro studies have demonstrated that DNA-PKcs forms a complex with Artemis and 
phosphorylates it (Moshous et al., 2001). This leads to the activation of an endonuclease 
activity that can cleave Rag-generated hairpins (Ma et al., 2002). The analysis of Artemis-
deficient mice demonstrated that this endonuclease activity is necessary to cleave coding end 
hairpins (Rooney et al., 2002) and might also contribute to the loss of nucleotides in coding 
joints (Ma et al., 2002; Schlissel, 2002b). 
Two other important factors for V(D)J recombination are XRCC4, isolated on the basis of its 
absolute requirement for NHEJ and V(D)J recombination (Li et al., 1995), and DNA ligase 
IV, implicated by its ability to form a complex with XRCC4 (Critchlow et al., 1997; 
Grawunder et al., 1997). Mice with one of these genes disrupted die late in fetal development 
due to primary defects in the nervous system (Gao et al., 1998b; Frank et al., 1998; Barnes et 
al., 1998). However, transient transfection assays with targeted ES cells (Gao et al., 1998b) or 
embryonic fibroblasts (Frank et al., 1998) demonstrated the requirement of XRCC4 and DNA 
ligase IV for V(D)J recombination. 
 
1.4.7. Generation of junctional diversity 
Diversity of the antibody repertoire is achieved by several means: first by the random 
combination of separate V, (D) and J gene segments to a complete V region and second by the 
association of different heavy and light chain V regions to form the antigen-binding site. 
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Further diversification is due to junctional diversity. This is caused by the addition or deletion 
of nucleotides at the ends of coding sequences (Fig. 1-8). 
 
 
Fig. 1-8: Generation of junctional diversity. Schematically shown is the joining of a D and a J gene 
segment. Loss and gain of nucleotides can happen between every joined gene segment. 
 
The coding end hairpins generated during the V(D)J recombination process are often opened 
asymmetrically. This activity has been proposed to be carried out by the Rag proteins and/or 
the nuclease Mre11 (Fugmann et al., 2000; Paull, 2001), although the Artemis protein 
described before appears to be the prime physiological candidate now (Ma et al., 2002). The 
asymmetric opening of the hairpin results in a single-stranded tail consisting of a few 
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nucleotides of the coding sequence plus the complementary nucleotides from the opposite 
DNA strand. DNA repair enzymes fill up the missing complementary nucleotides to complete 
the double strands again. Subsequent joining of the newly generated coding ends leads to 
short palindromic sequences at the joint, called P nucleotides (Lewis, 1994; Lafaille et al., 
1989; McCormack et al., 1989). 
The single-stranded tail can also be a target for exonucleases whose activity leads to a loss of 
nucleotides (Kenter and Tredup, 1991), a process called “nibbling”. In addition endonuclease 
action inside the coding end has also been suggested for this activity (Lewis et al., 1985; 
Besmer et al., 1998). Although several exonucleases are known in mammalian cells, the 
specific enzyme responsible for the nibbling has not been definitely identified. 
A third modification is the insertion of non-templated nucleotides, the N nucleotides, into the 
coding joints. The enzyme terminal deoxynucleotidyl transferase (TdT) catalyses the addition 
of nucleotides to the 3’ ends of the coding ends (Landau et al., 1987). After the addition of up 
to 20 nucleotides, the two single-stranded stretches form base pairs over a short region. Repair 
enzymes trim off any non-matching bases, synthesize complementary bases to fill in the 
remaining single-stranded DNA and ligate them, resulting in the formation of an intact coding 
joint. 
Mice with a targeted disruption of the TdT gene clearly demonstrate that TdT is responsible 
for the N nucleotide insertions. They have virtually no N nucleotides (Gilfillan et al., 1993; 
Komori et al., 1993). In contrast, TdT transgenic mice have increased numbers of N 
nucleotide insertions (Landau et al., 1987; Bentolila et al., 1997; Benedict and Kearney, 
1999). 
Two different splice variants of the TdT enzyme exist differing by a 60 bp insertion (Lo et al., 
1991; Doyen et al., 1993). Both the short isoform (TdTS) and the long isoform (TdTL) of 
TdT were shown to mediate modifications of the coding joints in the V(D)J recombination 
process (Thai et al., 2002; Benedict et al., 2001). TdTS could be demonstrated to catalyze N 
nucleotide additions, while TdTL was found to have 3’→5’ exonuclease activity on single-
stranded DNA (Thai et al., 2002). 
The random number of inserted or deleted nucleotides by the generation of junctional 
diversity, leads very often to a frame-shift in the reading frame. Abortion of the translation 
due to stop-codons downstream is the result (summarized in Lewis, 1994). However, if the 
rearrangement on one allele is not functional, recombination at the second allele takes place. 
In the case of a functional joining the cell can be rescued from apoptosis as described before. 
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1.5. Regulatory elements of the transcription 
The rearrangement of the immunoglobulin genes generates not only the variable regions of 
both the heavy and the light chain. The recombination process also brings regulatory cis 
elements, like promoters and enhancers, into functional proximity. Transcription of the Ig 
gene loci is regulated on several levels. On the one hand, interactions between cis-acting 
elements like promoters and enhancers and trans-activating, DNA-binding factors take place, 
influencing the capacity of the RNA polymerase II to initiate the RNA synthesis. Furthermore 
the chromatin structure, the nuclear matrix and other cis-acting elements like matrix 
attachment regions (MAR), locus control regions and silencers play a role (summarized in 
Max, 1999). 
 
1.5.1. Enhancers of the immunoglobulin gene loci 
A strong transcriptional enhancer of the heavy chain locus is localized in the large intron 
between the JH gene segments and the Cµ gene (Eµ; Fig. 1-2). Targeted elimination of this 
enhancer led to an impairment of the V(D)J recombination of the corresponding allele (Serwe 
and Sablitzky, 1993; Chen et al., 1993b). An additional enhancer was found about 16 kb 3’ of 
the Cα region (3’EH; Fig. 1-2). This enhancer has no influence on the recombination process. 
However, it plays a role for class switch recombination in later stages of B cell development 
(Cogne et al., 1994). 
For the κ locus two enhancers are known. One of them is located in the large intron between 
the Jκ gene segments and the Cκ segment (iEκ), the other is positioned 9 kb 3’ of the Cκ 
segment (3’Eκ; Fig. 1-4). In vitro studies using cell lines have shown that iEκ is necessary for 
the demethylation and germline transcription of the κ light chain locus (Lichtenstein et al., 
1994; Klug et al., 1994). Experiments with embryonic stem cells, in which iEκ was replaced 
by a neomycin resistance cassette or by a recombinant loxP site, resulted only in an impaired 
rearrangement at the corresponding locus but not in a total block (Xu et al., 1996). 
The intron enhancer iEκ has a binding site for the transcription factor NF-κB. This factor 
plays a key role in many immunological activation processes and stress responses (Lenardo 
and Baltimore, 1989). Mutations of the κB motif strongly reduced the enhancer activity 
pointing at a critical role of this enhancer function (Lenardo et al., 1987). 
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The second enhancer, 3’Eκ, displays a sevenfold increased enhancer activity compared to iEκ. 
It was demonstrated, that this enhancer alone is sufficient for the transcription of 
immunoglobulin genes in B cells (Meyer et al., 1990). Deletion of 3’Eκ led to a reduction of κ 
expressing B lymphocytes (Gorman et al., 1996). 
In the λ light chain locus two enhancers have been identified till now. The Eλ2-4 enhancer is 
located 15.5 kb 3’ of the Cλ4 gene segment, whereas the Eλ1-3 enhancer is positioned 35 kb 
3’ of the Cλ1 gene segment (Fig. 1-6; Hagman et al., 1990). Both enhancers display binding 
motifs for transcription factors found also in the κ enhancer 3’Eκ, whereas a binding motif for 
NF-κB was not found (summarized in Max, 1999). 
 
1.5.2. Promoters of the immunoglobulin gene loci 
Each V gene segment of the heavy and the light chain gene loci has on its 5’ site a promoter, 
which ensures the transcription of the rearranged chain. Before rearrangement already weak 
transcription is mediated by these promoters (Fig. 1-2; Fig. 1-4 and Fig. 1-6). Due to the 
recombination they are placed into functional proximity to the enhancers resulting in 
enhanced transcription. 
Additional promoters were described mediating transcription of still unrecombined JC 
clusters. The gene locus is hereby transcribed in its germline configuration, therefore the 
promoters are named germline promoters and the transcripts are called germline transcripts 
respectively. Presumably, these germline transcripts do not encode proteins because of many 
start and stop codons within the transcripts. Similarly promoters driving transcription of 
rearranged DJ elements at the heavy chain locus are known. 
Two promoters 5’ of the first Jκ gene segment were described for the κ locus (Fig. 1-4; Van 
Ness et al., 1981; Martin and Van Ness, 1990). At the λ locus, promoter activity for a region 
upstream of Jλ2 has been demonstrated (Engel et al., 2001). In case of the heavy chain, the 
intron enhancer Eµ displays additional promoter activity. A sequence motif, called octamer 
motif, of this region plays a role that is more important for the promoter than for enhancer 
activity (Su and Kadesch, 1990). This promoter lacks a TATA box, important for a precise 
initiation point of the transcription (Su and Kadesch, 1990). Besides, additional promoters 5’ 
of some heavy chain D gene segments were described (Reth and Alt, 1984). A bifunctional 
cis element, which displays both promoter and enhancer activity similar to Eµ, was identified 
for the most 3’ D segment, DQ52 (Kottmann et al., 1992; Kottmann et al., 1994). 
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1.6. Regulation of V(D)J recombination 
Rearrangement of receptor gene segments takes place only in well-defined stages of B and T 
cell development (Schatz et al., 1992). Although both cell types use the same recombination 
machinery, B lymphocytes recombine exclusively immunoglobulin genes, while T 
lymphocytes rearrange only gene segments of the T cell receptor to completion (Willerford et 
al., 1996). Only sporadically DJ recombination at the immunoglobulin gene locus was found 
in T cells, and although for both B and T lymphocytes two alleles exist for each locus, only 
one functional antigen receptor is generated (Rajewsky, 1996). This enormous specificity 
together with the fact that only a single recombinase is needed led to the suggestion that the 
accessibility of the gene loci and of the corresponding gene segments, respectively, must be 
strictly regulated for the recombination machinery (Yancopoulos and Alt, 1985; Yancopoulos 
et al., 1986; Alt et al., 1987). It was assumed therefore that the gene loci are first not 
accessible and become accessible to the recombination machinery only after some kind of 
modification. Changes in chromatin structure, demethylation of DNA and germline 
transcription might play a role because they were found to correlate with the appearance of 
recombinase activity. 
It is accepted that DNA methylation influences the chromatin structure and leads to changes 
in gene expression (Ng and Bird, 1999). For both, the heavy chain and the κ light chain, it 
was demonstrated that early in B cell ontogeny the loci are hypermethylated (Mather and 
Perry, 1983; Storb and Arp, 1983). Parallel to induction of recombinase activity, these loci 
become hypomethylated and transcriptional active (Kelley et al., 1988; Goodhardt et al., 
1993). In an in vitro experiment using B cell lines, demethylation of the κ locus alone did not 
lead to activation of the rearrangement, suggesting that demethylation is not the cause of 
changes in accessibility. However, in one of such cell lines germline transcription was 
induced (Cherry et al., 2000). 
More recent studies point out that the decisive step that makes the gene locus accessible to the 
recombination machinery, are changes of the nucleosomal structure (Kwon et al., 1998; 
Cherry and Baltimore, 1999; Golding et al., 1999). In this event the histone acetylation might 
play an important role. Several groups could demonstrate that histone acetylation stimulates 
V(D)J recombination (McMurry and Krangel, 2000; McBlane and Boyes, 2000; Kwon et al., 
2000). Histone acetylation is also involved in the transcriptional control of genes, e.g. the 
lymphoid transcription of the murine CD21 gene is positively regulated by histone acetylation 
(Zabel et al., 1999). 
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1.6.1. The role of germline transcription for the recombination process 
Weak transcription of the gene segments of the still unrearranged gene locus is a sign for the 
activation of the particular locus for the recombination process. This germline transcription 
shows probably the accessibility of the corresponding gene locus to the recombination 
machinery, because for both, the heavy chain locus (Yancopoulos and Alt, 1985) and the κ 
light chain locus (Schlissel and Baltimore, 1989; Lennon and Perry, 1990), a correlation 
between germline transcription and rearrangement was found. Similar results have been found 
for the gene loci coding for the T cell receptor (Fondell and Marcu, 1992; Goldman et al., 
1993; Holman et al., 1993). Equivalent findings exist also for the human κ locus (Martin et 
al., 1991). 
Changes in the chromatin structure seem to result in accessibility of the gene locus to the 
recombination machinery. The question is whether these changes are the outcome of the 
germline transcription or, if the chromatin structure is influenced by other factors, germline 
transcripts are just an indicator for the altered accessibility. Up to now this question has not 
been answered. However germline transcription seems to play an important role in the 
recombination process as was shown by targeted deletion of regulatory elements essential for 
this transcription (see above). 
 
1.6.2. Germline transcripts 
Germline transcripts of the variable gene segments were found for both the heavy and the 
light chains (Schlissel and Baltimore, 1989; Blackwell et al., 1986; Picard and Schaffner, 
1984; Picard and Schaffner, 1985; Yancopoulos and Alt, 1985). For the µ heavy chain and 
both light chains transcripts are also known, which include the C gene segments (Alt et al., 
1982; Kemp et al., 1980; Nelson et al., 1983; Nelson et al., 1984; Nelson et al., 1985; Engel 
et al., 1999). Two alternative transcripts were described for the heavy chain locus. One 
transcript initiates in the Eµ enhancer and contains a non-translatable exon, which is spliced to 
the Cµ region (Iµ0; Lennon and Perry, 1985). This non-translatable exon is located in the 
intron between the J gene segments and the Cµ gene. Normally this exon will be deleted by 
splicing in the primary RNA transcript of a rearranged heavy chain. A second transcript 
initiates 5’ of the D segment DQ52 and is, in its processed form, also spliced to the Cµ region 
(µ0; Alessandrini and Desiderio, 1991). 
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For the κ light chain locus two transcripts have been described, which include the Cκ region. 
One germline transcript starts 3.5 kb 5’ of the first J segment and leads to a primary transcript 
8.4 kb in length (Perry et al., 1980; Van Ness et al., 1981), resulting in a 1.1 kb processed 
transcript (Martin and Van Ness, 1990). The second germline transcript initiates 50 to 100 bp 
5’ of the J segments (Leclercq et al., 1989; Martin and Van Ness, 1990) and leads to a 0.8 kb 
processed transcript (Martin and Van Ness, 1990). 
For the three functional JλCλ clusters of the λ locus germline transcripts were reported. They 
initiate 5’ of the J segments and are spliced to the respective C region. Splice products of 0.6 
kb in length are the result (Engel et al., 1999; Engel et al., 2001). 
 
1.6.3. Role of germline transcription in vivo 
Initially it was demonstrated for the α locus of the TCR, that deletion of the T early alpha 
(TEA) transcript, starting 5’ of the J segments, resulted in altered J gene usage. J segments of 
the 5’ part of the Jα cluster were no longer used in rearrangements, while J segments of the 
3’ part were utilized instead. This led to the suggestion, that additional transcripts could exist 
besides transcripts of the rearranged locus (Villey et al., 1996). Subsequently a transcript of 
the β locus of the TCR was found, that initiates 5’ of the Dβ1 segment. It is comparable to the 
µ0 transcript of the immunoglobulin heavy chain locus. Deletion of the corresponding 
promoter prevents the germline transcription and results in an impaired rearrangement of the 
Dβ1 segment. In the first place, this is caused by diminished cleavage of the RSS through the 
Rag proteins (Whitehurst et al., 1999). 
For the κ light chain locus it has been shown, that deletion of a 4 kb fragment located 5’ of the 
first J gene segment led to an impaired rearrangement both in vitro and in vivo (Cocea et al., 
1999). This fragment includes the promoter for the 1.1 kb germline transcript. 
Due to several stop codons in the transcript, as mentioned above, most likely no translation 
product derived from such transcripts might exist. However, the germline transcript itself 
could play a role for the recombination process. In case of class switch recombination at the 
immunoglobulin heavy chain locus, transcription of the corresponding C segments could be 
observed similar to germline transcription preceding rearrangement. Studies at the IgG1 locus 
have shown, that modifications of the locus, preventing the processing of the germline or 
switch transcript, led to a block in the class switch recombination. In this case it was 
postulated that the switch transcript itself is directly involved in the class switch 
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recombination (Hein et al., 1998). In vitro experiments have now shown, that the switch 
transcript forms a RNA-DNA hybrid with the template strand. This results in the exposure of 
a region of single-stranded DNA on the non-template strand that may be as long as 1 kb 
(Shinkura et al., 2003; Yu et al., 2003). This structure is called an R loop and presumably 
makes the switch region (S) accessible to activation-induced cytidine deaminase (AID) (see 
1.8.). A similar role for the rearrangement could be played by the germline transcripts. 
 
1.7. Cellular stages of the B cell development 
B lymphocytes are generated from pluripotent, self-renewing hematopoietic stem cells (HSC) 
by a complex differentiation process, in liver during mid-to-late fetal development and in the 
bone marrow after birth. Such HSCs are Thy-1.1loSca-1hic-kithi and do not express surface 
markers characteristic for different blood cell lineages. In the appropriate environment, these 
lineage marker (CD3, CD4, CD8, CD45R/B220, CD11b/Mac-1, Ly-6G/Gr-1, Ter119) 
negative cells (Lin-) can give rise to cells of the erythroid, megakaryocytic, myeloid and 
lymphoid lineage (summarized in Morrison et al., 1995). An early step in the differentiation 
process is the division into an interleukin-7 receptor α chain negative (IL-7Rα)- common 
myeloid progenitor (CMP; Akashi et al., 2000b), which is able to generate all myeloid cell 
types (erythrocytes, megakaryocytes, granulocytes and macrophages), and into an IL-7Rα+ 
common lymphoid progenitor (CLP; Kondo et al., 1997), that can give rise to all lymphocytes 
(B, T and natural killer (NK) cells). This model of adult hematopoiesis with the early 
separation between the myeloid and the lymphoid lineage although widely accepted is 
challenged by observations of progenitors with macrophage-B, macrophage-T or B-T 
potential (Montecino-Rodriguez et al., 2001; Allman et al., 2003). 
 
1.7.1. Commitment of hematopoietic stem cells to the B lineage 
Immediately following the CLP stage, a restriction of some cells to the B lineage can be 
observed which is characterized by the expression of CD45R/B220 (Allman et al., 1999; Li et 
al., 1996; Ogawa et al., 2000). This molecule is also expressed on some non-B lineage cell 
types (including a subpopulation of NK cells) in the murine bone marrow, but in the context 
with other cell markers, it is possible to employ B220 to determine the earliest known 
progenitor cells committed to the B lineage. These pre-pro-B cells are 
B220+CD43+CD24/HSAlo (Hardy et al., 1991). They do not yet express the B cell marker 
1. Introduction  22 
CD19, while all later stages in B cell development do (Li et al., 1996; Rolink et al., 1996). B 
cell progenitors of this fraction also express the complement component C1q like receptor 
C1qRp, a transmembrane protein that is recognized by the monoclonal antibodies 493 and 
AA4.1 (Petrenko et al., 1999; Norsworthy et al., 1999; see also Rolink et al., 2002). In 
addition, commitment to the B lineage is characterized by the expression of genes that are 
involved in assembly and expression of the BCR complex. Thus, the signal transducing 
molecules Igα and Igβ and genes encoding the surrogate light (SL) chain, like VpreB1, 
VpreB2 and λ5, are expressed (Li et al., 1996). Furthermore, germline transcripts of the heavy 
chain locus (µ0) can be detected (Allman et al., 1999). 
The commitment to the B lineage appears to be mediated by the activity of several 
transcription factors (summarized in Schebesta et al., 2002a; Johnson and Calame, 2003). One 
particular important role plays the PU.1 (Spi-1) protein, a member of the ets family of 
transcription factors. The analysis of PU.1 knockout mice demonstrated the critical role that 
PU.1 is playing in B cell development. Mice lacking PU.1 fail to generate mature myeloid or 
B lineage cells and accumulate variable numbers of T cells (Scott et al., 1994; McKercher et 
al., 1996). Elegant complementation experiments in which different levels of PU.1 were 
expressed using retroviral mediated gene transfer showed that high levels of PU.1 resulted in 
the differentiation of precursors into myeloid lineage cells, lower levels favor generation of B 
lineage cells (DeKoter and Singh, 2000). Partial restoration of B cell development following 
ectopic expression of IL-7Rα in PU.1-/- progenitors identifies IL-7Rα as a critical B cell 
target of PU.1 (DeKoter et al., 2002). At the molecular level, low PU.1 concentrations 
activate the IL7-Rα gene, in contrast to high PU.1 levels, which prevent IL7-Rα expression 
(DeKoter et al., 2002). 
The commitment of a progenitor to the B lineage not only needs activation of a B cell specific 
program but also requires inhibition of programs driving alternative cell fates. A B cell 
specific member of the Pax family, Pax5, acts as a transcriptional activator on targets known 
to be critical in establishing B cell identity, including Cd19, mb-1 (Igα) and Blnk/SLP-65 
(Nutt et al., 1998; Schebesta et al., 2002b). In addition, Pax5 is also required to repress 
alternative cell fates. It has been shown that Pax-/- B220+ ‘pro-B cells’ of the bone marrow can 
differentiate into T cells, macrophages, dendritic cells, NK cells and even osteoclasts (Rolink 
et al., 1999a; Nutt et al., 1999a). Furthermore it was demonstrated that Pax5 determines the B 
versus T cell fate by repression of Notch1, which is critical for T lineage commitment and 
development, without influencing myeloid and NK cell ontogeny (Souabni et al., 2002; Cotta 
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et al., 2003). Pax5 is induced in response to IL-7 (DeKoter et al., 2002) and there is evidence 
that the transcription factors E2A and EBF control Pax5 expression (Greenbaum and Zhuang, 
2002). Thus B cell commitment is established by a synergy and antagonism of regulatory 
mechanisms. 
 
1.7.2. B cell development in the bone marrow 
Using cell surface molecules and intracellular markers, different developmental stages can be 
distinguished during the development from B cell precursors to mature B lymphocytes in the 
bone marrow. Two nomenclatures are commonly used (Hardy et al., 1991; Rolink et al., 
1999b). The system employed by Rolink and Melchers (Rolink et al., 1999b) includes besides 
particular markers the rearrangement status of heavy and light chains and in addition the cell 
size. It also implicates that large cells are dividing cells whereas small cells are resting cells. 
This nomenclature will be used in the present work (Fig. 1-9). 
The earliest B cell precursors in this system are the large (progenitor) pro-B and the 
(precursor) pre-B-I cells. They are characterized by the expression of B220 and CD19, cell 
surface markers found also on all later B cell stages. Plasma cells, which do not express B220, 
are the only exception. In addition, all B cell stages from the pro-B cells up to the immature B 
cells express C1qRp, which is recognized by the monoclonal antibody 493 (Rolink et al., 
1998). 
Pro-B and pre-B-I cells express on their surface the receptor phosphotyrosine kinase c-kit 
(Ogawa et al., 1991). Moreover, they are positive for the IL-7 receptor (Sudo et al., 1993). 
Pro-B and pre-B-I cells differ in the status of rearrangement of the heavy chain, i.e. pro-B 
cells have the locus still completely in germline configuration while pre-B-I cells show 
already – often on both alleles – DJH recombination. Components of the recombination 
machinery like Rag1, Rag2 and TdT are detectable in these cells (Grawunder et al., 1995a). In 
mice with a targeted inactivation of either the Rag1 or Rag2 gene and in scid mice, a complete 
block in the B cell development was observed at this stage indicating the requirement of 
rearrangement for further developmental progression (Melchers and Rolink, 1999). 
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Fig. 1-9: Cellular stages of B cell development in the bone marrow. The status of the Ig gene 
rearrangement and characteristic surface and intracellular markers are shown. H: heavy chain locus, L: 
light chain locus, N.R.: not rearranged, +: detectable, -: not detectable, protein: detectable only on 
protein level, SL: surrogate light chain, cyto-µ: cytoplasmic µ chain, Iµ0: germline transcripts of the 
heavy chain locus, κ0: germline transcripts of the κ light chain locus, λ0: germline transcripts of the λ 
light chain locus. 
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Pro- and pre-B-I cells can be grown very efficiently in tissue culture on stromal cells in the 
presence of IL-7 or IL-3 (Rolink et al., 1991; Winkler et al., 1995). Removal of one of these 
components induces differentiation up to surface IgM positive (sIgM+) immature B cells 
(Rolink et al., 1991). This differentiation happens also in B cells from Rag deficient mice, 
although these mice can not rearrange their immunoglobulin genes, and leads to the activation 
of germline transcription at both light chain loci (Grawunder et al., 1995b; Engel et al., 1999). 
Due to the absence of rearrangement, these cells die within a few days, which could be 
prevented by the transgenic expression of the proto-oncogene bcl-2 (Grawunder et al., 1993; 
Rolink et al., 1993a). 
During the progression from pre-B-I cells to the next developmental stage, further 
rearrangement at the heavy chain locus takes place. Now a VH gene segment is recombined 
with the DJH resulting in a complete VHDJH transcription unit. Due to the generation of 
diversity at the coding ends (see above) the maintenance of reading frames is not guaranteed. 
Therefore, many recombination events end in non-functional VHDJH recombinations. As a 
rule the rearrangement starts initially only at one allele. If no functional rearrangement is 
achieved, the recombination process proceeds at the alternative allele. Only a functional 
rearrangement results in progression of development into large pre-B-II cells. Although two 
heavy chain loci exist, the majority of the B lymphocytes only express one functional heavy 
chain. This phenomenon is called allelic exclusion. The molecular mechanisms for the 
regulation of allelic exclusion are still unclear (Schlissel, 2002a). 
In large type I pre-B-II cells the expression of c-kit and TdT is downregulated. The α chain of 
the IL-2 receptor, the surface marker CD25, is expressed instead (Rolink et al., 1994). Thus, 
CD25 serves as marker for the whole pre-B-II compartment. The functional VHDJH 
transcription unit is expressed as cytoplasmic µ chain and is displayed at the cell surface in 
association with the SL chain and the Ig accessory proteins Igα and Igβ as pre-BCR. The SL 
chain consists of the two proteins λ5 and VpreB1 or VpreB2 (Martensson et al., 2002). The 
importance of the presentation of the pre-BCR on the cell surface for the further 
developmental transition, has been shown in mice lacking VpreB1 (Martensson et al., 1999), 
VpreB1 and VpreB2 (Mundt et al., 2001), λ5 (Rolink et al., 1993b; Kitamura et al., 1992) or 
all components of the SL chain together (Shimizu et al., 2002). All these mice exhibit a 
severe, although incomplete block in the development at the pre-B-I stage. Similar results 
were obtained from mice lacking the transmembrane portion of the µ heavy chain (µMT; 
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Kitamura et al., 1991) or Igβ (Gong and Nussenzweig, 1996), which show an almost 
complete block after the DJH rearranged pre-B-I stage. 
Subsequent to surface expression of the pre-BCR the members of the recombination 
machinery, Rag1 and Rag2, are rapidly downregulated (Grawunder et al., 1995a). It was 
suggested that this should avoid VDJ recombination at the second allele, thus ensuring allelic 
exclusion. Although allelic exclusion takes place in pre-BCR bearing cells, the contribution of 
the pre-BCR itself is controversial (summarized in Martensson et al., 2002). Direct evidence 
for the role of the pre-BCR in mediating heavy chain allelic exclusion has come from λ5-/- 
(Loffert et al., 1996) and µMT mice (Kitamura and Rajewsky, 1992), which are ‘allelic 
included’ i.e. both heavy chain alleles are often functional rearranged. In contrast, another 
study describes the presence of a small fraction of pre-B-II cells with two functional 
rearranged heavy chain alleles in λ5-/- but also in normal mice (ten Boekel et al., 1998). In 
these cases, only one µ heavy chain pairs with the SL chain whereas the other can not. Hence, 
allelic exclusion might be regulated by pairing properties of the µ heavy chain with the SL 
chain. This would suggest that the λ5 defect does not abolish allelic exclusion which was 
confirmed at the mature stage of B cells (ten Boekel et al., 1998). However, it remains unclear 
which other complex if not the normal pre-BCR, composed of a µ heavy chain and λ5 and 
VpreB, could signal allelic exclusion, since the heavy chain locus in VpreB1, VpreB2 and λ5 
triple deficient mice does not appear to be allelically ‘included’ (Shimizu et al., 2002). 
Large proliferating type II pre-B-II cells represent the developmental stage following large 
type I pre-B-II cells. Such cells have lost the expression of the SL chain and re-express Rag1 
and Rag2 at the mRNA level (Grawunder et al., 1995a). Although the light chain loci of these 
cells are still in germline configuration (ten Boekel et al., 1995), germline transcripts of the κ 
light chain locus become detectable, a sign for the activation of the locus for recombination 
(Grawunder et al., 1995b; Engel et al., 1999). 
Cells of the consecutive developmental stage, the small pre-B-II cells, have left the cell cycle. 
The IL-7 receptor is no longer expressed. The surface marker CD40 becomes detectable for 
the first time although a function of this molecule at this stage of development is not known 
(Rolink and Melchers, 1996). Rag1 and Rag2 expression becomes detectable now not only at 
the mRNA but also the protein level (Grawunder et al., 1995a). In addition, germline 
transcripts of the λ locus appear (Engel et al., 1999). A large fraction of such small pre-B-II 
cells have already rearranged light chain loci (ten Boekel et al., 1995). Allelic exclusion exists 
also for the four light chain loci similar to the heavy chain locus. Furthermore isotype 
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exclusion takes place i.e. either the κ or the λ locus is functional rearranged, and functional 
light chain can be detected as cytoplasmic protein, but not yet on the cell surface (Engel et al., 
1998). Already at this stage of development the ratio of 10 : 1 between κ and λ expressing 
cells characteristic for the mouse could be observed (ten Boekel et al., 1995). 
This ratio of 10 : 1 between κ and λ expressing cells could be explained by a sequential 
activation of the light chain loci. The κ locus was shown to be activated for rearrangement in 
large pre-B-II cells, whereas λ activation became only detectable at the consecutive 
developmental stage of the small pre-B-II cells (Engel et al., 1999). In this study, it was 
concluded that pre-B-II cells have only a limited life span during which they have to rearrange 
the light chains. Either they are rescued by the expression of a functional light chain or they 
die by apoptosis. Therefore the κ : λ ratio seems to be in part a result of the sequential 
activation of the light chain loci and the limited time available for rearrangement (Engel et al., 
1999). 
Small pre-B-II cells that have undergone a productive light chain rearrangement can 
differentiate into sIgM+ immature B cells. These cells express their rearranged heavy and light 
chains on the cell surface as BCR. The BCR is, similar to the pre-BCR, complexed with the 
signal transduction molecules Igα and Igβ. Mice with a targeted disruption of the κ intron 
enhancer iEκ (Takeda et al., 1993) or a deleted JCκ region (Chen et al., 1993a) show an 
impaired transition from the small pre-B-II cells to the immature compartment, displayed by 
drastically decreased numbers of immature B cells. Thus, the inability to produce a κ light 
chain protein greatly effects the transition from small pre-B-II cells to immature B cells. The 
low efficiency of λ light chain rearrangement (Ramsden and Wu, 1991) and the late activation 
of the λ locus for rearrangement together with the postulated limited life span appear to be a 
likely explanation for this defect. 
Presumably, negative selection of auto-reactive B cells takes place at this developmental 
stage. It has been shown that in vitro stimulation of immature B cells with antibodies specific 
for sIgM induces apoptosis in these cells (Rolink et al., 1998). In vivo, anti-hen egg lysozyme 
(HEL) specific immature B cells in mice transgenic for HEL show a developmental arrest in 
the bone marrow at this stage. These cells downregulate the expression of B220 and sIgM 
(Hartley et al., 1993). 
Auto-reactive B cells can be rescued from apoptosis by a process called receptor editing. 
Hereby, further rearrangements mainly at the light chain loci lead to the deletion of the anti-
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self specificity, which otherwise would lead to apoptosis, and replacement by a new receptor. 
This enables the cell to complete the maturation process (summarized in Nussenzweig, 1998; 
Melchers et al., 1995). 
After surviving negative selection, the immature B cells leave the bone marrow and migrate 
into the spleen, where the final maturation takes place (Loder et al., 1999). Intermediate 
stages in the spleen are defined as transitional 1 and 2 B cells and characterized by surface 
expression levels of CD21 and CD23 (Loder et al., 1999). 
Such developmental stages are well defined for bone marrow derived cells only. For fetal 
liver derived B lymphocytes the intermediate developmental stages and places of 
differentiation are less well defined. 
 
1.8. Antigen-dependent diversification of immunoglobulins in 
mature B cells 
The majority of the newly formed naïve B lymphocytes dies within the first 3 to 4 days, while 
only 5 to 10 % of them transit into the pool of relatively long-lived mature B cells (Forster 
and Rajewsky, 1990). These cells recirculate through the secondary lymphoid organs, like 
spleen, lymph nodes and Peyer’s patches and have a life span of 3 to 8 weeks. If they 
encounter the antigen during this time via their BCR, the cells are activated, which normally 
also requires help from T cells. Three different processes affecting the structure of the Ig 
molecule can take place subsequent to activation. First, such activated B cells could 
differentiate after proliferative expansion into antibody secreting plasma cells (summarized in 
Baumgarth, 2000). The secretion of the formerly membrane-bound Ig molecule is achieved by 
alternative processing of the primary heavy chain transcript. The secreted form differs from 
the membrane-bound form by the addition of a short secretory domain and the absence of the 
C-terminal transmembrane domain and the short cytoplasmic. 
The second diversification takes place during expansion phase. At the beginning of an 
antibody response IgM antibodies display a low affinity for antigen. Later, and within the 
scope of a secondary response after renewed antigen encounter, high-affinity antibodies are 
found. These antibodies are produced by B cell clones after so called affinity maturation. 
During this process mutations (mainly base substitutions, rarely deletions or insertions) are 
introduced into the V regions of the rearranged gene loci, commonly referred to as somatic 
hypermutation (summarized in Li et al., 2004). Clones producing high-affinity antibodies are 
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selected and preferentially expanded during the germinal center reaction (Wolniak et al., 
2004). The mechanism underlying this process has recently elucidated and involves the 
activation-induced cytidine deaminase (AID) together with other DNA repair enzymes 
(Besmer et al., 2004). 
The third process affecting the Ig structure is the class switch recombination (CSR). In this 
reaction the CH gene segment is replaced by another C segment (Cγ1, Cγ2a, Cγ2b, Cγ3, Cε or Cα) 
changing the antibody class, whereas the antigen specificity of the B cell remains the same 
(Fig. 1-10). After the differentiation into plasma cells now the antibodies secreted by them 
possess a different effector function. 
 
 
Fig. 1-10: Mechanism of class switch recombination. Shown is a VHDJH rearranged heavy chain, 
where the switch from IgM to IgG1 takes place. The DNA between the recombined switch regions is 
excised, including the Cµ, Cδ and Cγ3 segments. The different C regions are displayed as single exons. 
S: switch region. 
 
The CSR takes place by looping out and deleting DNA sequences located between two 
repetitive DNA sequences, the so called switch regions, that are located 5’ of each C region 
except of Cδ. The selection of the C segment and consequently the isotype of the secreted 
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antibody are driven by cytokines, that are provided by T cells. Such regulation of CSR was 
shown by in vitro experiments. For instance, IL-4 causes the switch to γ1 and ε, whereas 
interferon-γ leads to γ2a and TGF-β to α (summarized in Snapper and Finkelmann, 1999). 
AID that was shown to be crucial for somatic hypermutation is surprisingly also essential for 
CSR (Muramatsu et al., 2000; Revy et al., 2000). But it is still unclear, how AID links these 
two processes that did not appear to be mechanistically associated before (Longacre and 
Storb, 2000; Li et al., 2004). 
Finally, after antigen encounter, B cells could leave the cell cycle and differentiate into long-
lived memory cells (Maruyama et al., 2000). This process does not affect the Ig structure, but 
it enables the body to react faster in the case of renewed antigen i.e. pathogen encounter. 
 
1.9. Mature B cell subpopulations and their functional properties 
The above properties and mechanisms are mainly attributed to a B cell population 
denominated B2 cells. However, there are additional B cell populations or subpopulations. 
Based on cell surface markers and anatomical localization the mature B cell compartment can 
be divided into B1 and B2 cells that display different functional characteristics (Kantor et al., 
1992; Kantor et al., 1995b). The B2 cell population itself is heterogeneous and can further be 
subdivided into follicular (FO) and marginal zone (MZ) B cells. FO B cells recirculate 
through the peripheral lymphoid organs and locate in the B cell follicles of spleen and lymph 
nodes. They represent the major splenic B cell population. FO B cells are characterized by the 
cell surface expression of intermediate levels of CD21 (CD21int), low levels of IgM (IgMlo), 
high levels of IgD (IgDhi) and additional expression of CD19, B220 and CD23 
(CD19+B220+CD23+). 
MZ B cells are defined as CD19+B220+CD23lo/-CD21hiIgMhiIgDlo cells in the spleen, where 
they are located as a mostly non-recirculating population in the marginal zone (Gray et al., 
1982; Oliver et al., 1997). The marginal zone is a distinct anatomical compartment that in 
mice is only found in the spleen and surrounds the B cell follicles and the periarteriolar T cell 
areas. 
Originally, B1 cells were identified by their moderate expression of CD5 (Ly-1), a 
glycoprotein normally expressed on T cells. They are the predominating B cell population in 
peritoneal and pleural cavities. B1 cells can also be distinguished from B2 cells, which are 
found in such cavities as well, by the expression level of additional surface markers. They are 
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CD19hiB220loIgMhiIgDloCD43+ and express the macrophage marker Mac-1 (CD11b/CD18). 
After the initial discovery of the CD5 expressing B1 cells, a population of peritoneal CD5- B 
cells was identified whose surface phenotype was in other respects identical to that of B1 
cells. By consensus, peritoneal B1 cells were then subdivided into the CD5+ B1a cells and the 
CD5- B1b “sisterpopulation“. 
B1a cells could also be found in the spleen, where they do not express Mac-1. Although they 
represent only a minor population of the splenic B cell compartment, their absolute number is 
similar to the number of B1a cells found in the peritoneum (Kantor et al., 1992). Due to their 
low frequency, B1a cells from the spleen have not been studied to a large extent so far. 
The phenotypically and spatially separated mature B cell subsets are also characterized by 
different functional properties. FO B cells participate in T cell dependent (TD) antibody 
responses (Martin and Kearney, 2000a). Hereby FO B cells are able to differentiate into 
antibody secreting plasma cells after antigen encounter and T cell help. Furthermore, they can 
increase the specificity of their receptors by somatic hypermutation and change their 
functional properties by switching their Ig class. FO B cells could also leave the cell cycle and 
differentiate into long-lived memory cells, which enables the body to react faster and more 
efficient in the case of a re-infection by the same pathogen. 
MZ B cells contribute substantially to the T cell independent (TI) immune response, but they 
are also able to respond to TD antigens (Martin and Kearney, 2000a; Martin et al., 2001). TI 
antigens can be classified into two types, which activate B cells by different mechanisms. 
Antigens of the first type, the TI-1 antigens, contain an intrinsic activity that can directly 
induce the proliferation of B cells. One example are the lipopolysaccharides of gram-negative 
bacteria. High concentrations of these molecules cause proliferation and differentiation of B 
cells, regardless of their antigen specificity. This is known as polyclonal activation. On the 
other hand, TI-2 antigens are molecules with highly repetitive structures, probably acting by 
extensively crosslinking the surface immunoglobulins of specific B cells. This is not 
sufficient to drive responding B cells into antibody production because additional signals 
supplied by non-cognate interactions with T cells, NK cells, and perhaps other cells are 
necessary (summarized in Vos et al., 2000). 
In TD immune responses MZ B cells capture, process and present antigen, and deliver co-
stimulatory signals to T cells faster and more efficiently than FO B cells (Martin and Kearney, 
2002). They have also the capacity to rapidly differentiate into plasma cells. Since FO B cells 
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participate also in TD immune responses, the main difference seems to be the time frame of 
involvement of MZ versus FO B cells (Martin and Kearney, 2002). 
The current model for the function of MZ B cells is based on the specialized location near to 
the marginal sinus. Here they are exposed to blood-borne antigens, possibly carried by 
dendritic cells (Balazs et al., 2002), and could interact with various other cell types of the MZ 
including dendritic cells and macrophages. It was hypothesized that MZ B cells, as excellent 
antigen-presenting cells, could participate, together with dendritic cells, in early stages of T 
cell activation (Martin and Kearney, 2002). The functional characteristics together with the 
anatomical localization have led to the suggestion that MZ B cells represent a “first line of 
defense” against blood-borne antigens (Martin and Kearney, 2000a; Martin and Kearney, 
2002). 
Since the initial discovery of (CD5+) B1 cells 20 years ago, great efforts, especially in the past 
few years, have been carried out to clarify their origins and functions. Their precise role in the 
immune system however is still unclear, especially for the B1b subset (Herzenberg, 2000). 
Although, there are shared functional characteristics between B1a and MZ B cells, both 
populations exhibit also essential differences (Martin and Kearney, 2001; Kretschmer et al., 
2003a). Similar to the MZ B cells, they display a pre-activated phenotype. Both MZ and B1 
cells are early participants in TI immune responses and give rise to the early wave of plasma 
cells in these responses (Martin et al., 2001). B1a cells are known to have a limited capacity 
to switch to other Ig classes after antigen stimulation and therefore mainly express IgM 
(Tarlinton et al., 1995). They are also believed to be the primary source of natural IgM. 
Natural IgM, which is produced in the absence of exogenous antigenic stimulation (Coutinho 
et al., 1995; Casali and Schettino, 1996), is often poly-reactive, weakly auto-reactive, and 
reacts with many common pathogen-associated carbohydrate antigens. Due to its polymeric 
structure, secreted IgM has the ability to bind multimeric antigen and to efficiently activate 
the classical complement cascade. In addition, polymeric IgM can be transported via the poly-
Ig receptor onto mucosal surfaces to provide protection from pathogenic invasion 
(Brandtzaeg, 1989; Gerhard et al., 1997). These properties and the fact that IgM is the first 
class of Ig produced during an infection, have led to the suggestion that B1a cells also act as a 
“first line of defense” against mucosal and systemic pathogens. For instance, antibodies 
produced by B1a cells have been shown to play an important role in protection against 
infection by Streptococcus pneumoniae (Briles et al., 1981; Yother et al., 1982). A non-
redundant role for B1a derived IgM has also been shown in the protective response to 
influenza virus infection (Baumgarth et al., 2000). In addition, an important function of 
1. Introduction  33 
natural antibodies for immune defense against certain pathogens has been demonstrated in 
mice deficient in antibody production by reconstitution with naïve serum (Ochsenbein et al., 
1999). 
Still controversial is the contribution of B1a cells to the IgA producing cells in the gut. 
Transfer of total peritoneal B cells (Kroese et al., 1989; Fagarasan et al., 2000) or sorted B1 
cells (Macpherson et al., 2000) into recipients resulted in the appearance of donor-derived 
IgA plasma cells in the gut. After demonstration of in situ class switch in the lamina propria 
(Fagarasan et al., 2001), this possibility has been suggested for B1 cells, since they are rarely 
found in germinal centers (Stall et al., 1996), where the class switch in B cells normally takes 
place. 
As B1 cells often produce auto-reactive antibodies, although of low affinity, it has been 
suggested that they might contribute to the anti-self antibody production in autoimmune 
diseases. Indeed, there are examples, in both human and mouse, of an association between 
autoimmune disease and B1 cells. In NZB/NZW mice cells with a B1 phenotype accumulate 
in the MZ prior to the appearance of clinical signs of systemic lupus erythematosus (SLE; 
Wither et al., 2000). Nevertheless, B1 cells are not usually associated with autoimmune 
diseases. In MRL/lpr mice, another murine model of SLE, it was demonstrated that B2 and 
not B1 cells are necessary for disease pathogenesis (Reap et al., 1993). A novel concept, 
therefore, implicates that these auto-reactive antibodies represent a distinct immune-
recognition strategy, targeting conserved self-structures which are induced or exposed only in 
conditions of stress or tissue damage (Bendelac et al., 2001). 
The B1a and the MZ B cell compartments have been found to be enriched for certain B cell 
specificities (Herzenberg et al., 2000; Martin and Kearney, 2000a; Kretschmer et al., 2002). It 
has been suggested that this restriction together with the pre-activated phenotype should allow 
a rapid response against a limited number of conserved antigens. B1a together with MZ B 
cells are therefore part of a “natural memory” response and generate effectors rapidly in the 
first stages of an immune response. In contrast, the FO B cells provide a diverse pool of 
specificities from which B cells are recruited at later stages of the immune response, whereby 
high affinity memory is generated (Martin and Kearney, 2000a; Martin and Kearney, 2001; 
Martin and Kearney, 2002). 
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1.10. Origins of the mature B cell subpopulations 
B lymphocytes are generated from HSCs in liver during mid-to-late fetal development and in 
the bone marrow (BM) after birth. The first appearance of the mature B cell subpopulations is 
consistent with these different anatomical locations and developmental periods. FO and MZ B 
cells are detectable for the first time after birth and are therefore the outcome of B cell 
development in the BM, whereas maturation into B1 cells takes place already in the fetal liver 
(FL; Akashi et al., 2000a; Busslinger et al., 2000). It was suggested that the generation of B1 
cells is completed shortly after birth and their contribution to the mature B cell compartment 
throughout life is achieved by their capacity of self-renewal (Hayakawa et al., 1985; 
Hayakawa et al., 1986). 
Reconstitution experiments gave rise to the proposition that B1 cells are developmentally 
distinct from the B2 cell population that is found in peripheral lymphoid organs, i.e. B1 and 
B2 cells derive from distinct progenitors. Adoptive transfers of embryonic splanchnopleura 
(Godin et al., 1993) or fetal omentum (Solvason et al., 1991) have shown that these sites 
contain progenitors exclusively for B1 cells and not for B2 cells. In contrast, fetal liver (day 
13 and 14) contains progenitors for both of such cells (Kantor et al., 1992; Solvason et al., 
1991). A proposed explanation for this co-existence of both progenitors is as follows: the fetal 
omentum is contiguous with the liver capsule. Therefore, as fetal omentum contains B1 but 
not B2 progenitors, it is possible that some or all of the B1 progenitors detected in fetal liver 
are located in the liver capsule or in co-isolated omental tissue. The B2 progenitors, in 
contrast, might be found in the fetal liver, but not in the omentum (Herzenberg, 2000). 
Reconstitution with adult bone marrow demonstrated that progenitors for B2 cells are 
abundant at this site and readily reconstitute the full adult B2 population. In contrast, the adult 
bone marrow failed to reconstitute the B1 compartment (Kantor et al., 1992; Kantor and 
Herzenberg, 1993; Kantor et al., 1995b). A difference between B1a and B1b cells could be 
observed. While B1a cells were very poorly reconstituted from progenitors in adult bone 
marrow, B1b cells are sometimes reconstituted to half their normal frequency (Kantor et al., 
1992; Kantor et al., 1995b). Since B1b typically represent 5 to 10 % of the overall B1 
population, this B1b reconstitution is numerically not very significant (Herzenberg, 2000). 
The functional existence of B1 progenitors independent of progenitors for B2 cells was taken 
as evidence for the existence of separate B cell lineages. Thus, the present data are most 
consistent with the idea that B1a and B2 cells (and perhaps also B1b cells) represent distinct 
developmental branches of the B lineage (Herzenberg, 2000). Further evidence for this 
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‘lineage model’ came from mice in which the neonatal B cells were depleted for 6 weeks by 
treatment with anti-IgM antibodies. The recovery of B2 cells begins as soon as the antibody 
treatment disappears and finally the B2 compartment reconstitutes completely. In contrast, B1 
recovery fails entirely or is significantly disrupted, depending on whether the antibody 
treatment removed all B1 cells or only part of the (allotype-marked) B1 cells (Hamilton and 
Kearney, 1994; Lalor et al., 1989a; Lalor et al., 1989b). 
However, there is also accumulating evidence that the differences between B1 and B2 cells 
are solely derived from differences in the specificity of their receptors (Cong et al., 1991; 
Berland and Wortis, 2002). The basic premise of this ‘induced differentiation model’ is that 
B1 and B2 cells arise from the same progenitor but express Ig receptors whose antigen-
binding specificity determines whether the newly formed B cells are triggered to differentiate 
into B1 or B2 cells. In this model, the fetal/neonatal repertoire is skewed toward the 
expression of immunoglobulins that bind frequently encountered TI-2 antigens resulting in 
the appearance of B1 cells. The adult repertoire rarely generates these specificities (due to, for 
instance, TdT expression) and therefore generates only few B1 cells (Berland and Wortis, 
2002). 
Evidence for this model came from the analysis of Ig heavy chain transgenic mouse models. 
Mice expressing a B1a derived BCR as transgene show an increase of the B1a population, 
while, conversely, in mice carrying B2 derived transgenes, the transgene expressing B cells 
are almost exclusively of the B2 phenotype (Table 1-1; summarized in Berland and Wortis, 
2002). 
 
Table 1-1: Effect of Ig transgene expression on B cell development (Berland and Wortis, 2002). 
Transgene Specificity Source Phenotypea References 
3-83 H-2KkDk (MHC class I) Adult spleen B2 (Nemazee and Burki, 1989) 
HyHEL-10 Hen egg lysozyme Adult spleen B2 (Goodnow et al., 1988) 
VH81X Unknown Fetal liver MZ (Martin and Kearney, 2000b) 
M167 Phosphoryl choline Adult spleen MZ (Martin and Kearney, 2000b) 
VH12/Vκ4 Phosphatidyl choline CD5
+ lymphoma B1a (Arnold et al., 1994) 
VH11/Vκ9 Phosphatidyl choline B1 cell B1a (Chumley et al., 2000) 
SM6C10 Thy-1 B1 cell B1a (Hayakawa et al., 1999; 
Hayakawa et al., 2003) 
4C8 Mouse red blood cells NZB spleen B1 (Okamoto et al., 1992) 
2-12H sM snRNP MRL/lpr mouse B1a (Qian et al., 2001) 
a Predominant phenotype of B cells expressing the transgene 
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Similarly, the receptor specificity may play also a role in the decision between FO and MZ B 
cells. The light chain repertoire in heavy chain transgenic mice that selects B cells into the 
MZ compartment was found to be highly restricted (Martin and Kearney, 2000b). Although 
these data can be interpreted in the way that the receptor specificity is sufficient to determine 
the phenotype, so far it has not been shown that the B1 cells in the mice described above 
originated from adult BM rather than from fetal sources. 
 
Table 1-2: Genetic alterations that affect B1 cell numbers (Berland and Wortis, 2002). 
Alterations that decrease B1 cell numbers References 
Mutation of positive regulators of BCR signaling:  
Btk-/- or point mutation (xid) of btk (Khan et al., 1995; Hendriks et al., 1996) 
PKCβ-/- (Leitges et al., 1996) 
PLCγ-/- (Wang et al., 2000; Hashimoto et al., 2000) 
Deletion of P85α of PI-3 kinase (Fruman et al., 1999; Suzuki et al., 1999) 
CD19-/- (Engel et al., 1995; Rickert et al., 1995) 
SLP65-/- (Pappu et al., 1999; Jumaa et al., 1999) 
CD21/35-/- (Ahearn et al., 1996; but see Molina et al., 
1996) 
Vav-1-/-, Vav-2-/- and Vav-1-/-/Vav-2-/- (Tarakhovsky et al., 1995; Doody et al., 
2001; Tedford et al., 2001) 
Mutation of B cell transcription factors:  
Oct 2-/- (Humbert and Corcoran, 1997) 
Aiolos-/- (Wang et al., 1998) 
NFATc-/- (Berland and Wortis, 2002) 
Alterations that increase B1 cell numbers  
Mutation of negative regulators of BCR signaling:  
Loss of function of SHP-1 (motheaten, motheatenv) (Sidman et al., 1986) 
SHP-1-/- (Schmidt et al., 1998) 
CD22-/- (Sato et al., 1996a; O'Keefe et al., 1996; but 
see Nitschke et al., 1997; Otipoby et al., 
1996) 
Lyn-/- (Chan et al., 1997) 
CD72-/- (Pan et al., 1999) 
Overexpression of positive regulators of BCR signaling:  
CD19 transgenic (Sato et al., 1996b) 
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Thus, the phenotypes of the transgenic mice where B1 cells are enriched could be explained 
by different selection processes taking place in B1 and B2 progenitors (Herzenberg, 2000). 
B1 cells in such mice could be derived from FL like in normal mice and the adult bone 
marrow might contribute only little to B cell ontogeny. Further support for different selection 
processes came from SM6C10 mice (Table 1-1), that express a heavy chain transgene derived 
from a naturally occurring auto-antibody specificity. In these mice, it has been shown that the 
presence of the particular B1a specificity depends on the interaction with the self-antigen 
(Hayakawa et al., 1999), whereas B cells with such auto-reactive specificity are negatively 
selected during adult BM development (Hayakawa et al., 2003). 
The critical influence of BCR receptor signaling for B1 cell development was shown in 
different gene targeted and transgenic mice (summarized in Berland and Wortis, 2002). 
Mutations that disrupt or attenuate BCR receptor signaling, result in a substantial loss of the 
B1 cell subpopulation. On the other hand, inactivation of negative regulators of the BCR 
receptor complex or transgenes that enhance BCR signaling result in an expanded B1 
compartment (Table 1-2). Consistently, in transgenic mice in which B cells display a high 
BCR receptor density, mainly B1 cells are found (Engel et al., 1998; Lam and Rajewsky, 
1999; Watanabe et al., 1999). 
 
1.11. Differences in lymphopoiesis between fetal liver and bone 
marrow 
Comparison of lymphopoiesis in fetal liver and bone marrow reveals many similarities 
between both processes. The above described basic concept of B cell development, with its 
correlation between cell surface and intracellular markers and the status of Ig gene 
rearrangement, is applicable to both hematopoietic sites. However, many differences in 
lymphopoiesis between fetal and adult life have been described (Douagi et al., 2002; Kincade 
et al., 2002; Hardy, 2003). 
An early step in the BM differentiation process is the division into CLP and CMP. An 
equivalent population to the CLP with regard to cell markers was found in FL. However, this 
precursor still has the capacity to generate dendritic cells and macrophages, in addition to T, 
B and NK cells (Mebius et al., 2001). Also, a tripotent precursor, which gives rise to T cells, 
B cells and macrophages, has been described (Lacaud et al., 1998). Like in the bone marrow, 
a rare population was isolated from fetal liver which has the ability to differentiate into B cells 
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and macrophages but not into other myeloid cells (Cumano et al., 1992). Further evidence for 
a link between lymphoid and myeloid development came from the finding of bi-potential 
precursors giving rise to either T/myeloid or B/myeloid progeny (Ohmura et al., 1999; 
Kawamoto et al., 2000). Interestingly, no bi-potential T/B progenitors have been found in the 
FL up to now, although such a progenitor has been demonstrated at the clonal level in adult 
BM (Kondo et al., 1997). 
The inability or difficulty to detect some intermediate precursor stages in the BM, like the 
B/macrophage progenitor, could possibly be due to a different progress of hematopoiesis in 
FL and BM (Douagi et al., 2002). Fetal hematopoiesis is initiated by a synchronous 
differentiation of a pool of multipotent cells. Thus, it leads to an enrichment of intermediate 
precursors derived from the first waves of stem cell differentiation at certain time points 
(Strasser et al., 1989). In contrast, ongoing hematopoiesis in the bone marrow results in a 
relatively low frequency of intermediate precursors, as compared to committed and mature 
cell types. Thus, the failure to detect such cells might be rather of technical nature than of a 
systemic difference. 
Distinct waves of differentiation can also be seen in T lymphopoiesis in the mouse (Itohara et 
al., 1989; Havran and Boismenu, 1994). Interestingly, these waves result in T cells populating 
different anatomical sites in the adult mouse. The first T cells that appear during fetal 
development are γ:δ T cells using Vγ5 (also known as Vγ3 in other systems) for their γ chain 
rearrangement. All cells of this wave express the same rearranged γ chain without N 
nucleotide insertion and the same δ chain displaying, therefore, the same specificity. These 
γ:δ T cells populate the epidermis of the skin. Before birth generation of this subset declines 
and is replaced by cells expressing the next proximal Vγ gene, Vγ6. This subset reaches its 
maximum around birth and generation declines afterwards. Such T cells migrate to the 
reproductive epithelium. Later in ontogeny T cells are produced continuously and no longer in 
waves. After birth α:β T cells become the predominating thymocyte population, although 
some γ:δ T cells are still generated. However, these γ:δ T cells now exhibit more receptor 
diversity. 
In fetal thymic organ culture (FTOC) it was shown, that Vγ5 expressing γ:δ T cells could only 
be generated from fetal liver HSCs, but not from HSCs isolated from adult BM. The fetal 
thymic environment was shown to be necessary for this differentiation process (Ikuta et al., 
1990). 
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The analysis of Pax5-/- mice also demonstrated differences between hematopoietic 
development in fetal liver and adult bone marrow (Nutt et al., 1997). In the bone marrow, B 
cell development proceeds until the pre-B-I stage, where DJH at the heavy chain locus is 
already rearranged. This is in contrast to the fetal liver, where no B lineage committed cells 
(i.e. B220+ cells) are detectable, suggesting a different and critical function for the Pax5 
transcription factor during fetal hematopoiesis. 
Furthermore, the earliest B lineage committed cells, the B220+CD43+CD24/HSAloBP-1- pre-
pro-B cells in the bone marrow, could be further subdivided into two subsets based on cell 
surface expression of CD4 (Allman et al., 1999). Such CD4 expressing pre-pro-B cells do not 
exist in the FL (Lu et al., 2002). Although the CD4+ pre-pro-B cells of the BM fail to develop 
into B cells in vitro (Wineman et al., 1992; Kouro et al., 2001), commitment to the B lineage 
was concluded from the detection of heavy chain germline transcripts and expression of 
certain B lineage associated genes (Li et al., 1996; Lu et al., 2002). Nevertheless, further 
studies on this subset demonstrated its capacity to generate dendritic cells leading to the 
suggestion that there is a common pathway for dendritic cell and early B cell development 
(Izon et al., 2001). 
IL-7 was shown to be a crucial factor for the development of murine B lymphocytes. The 
identification of its receptor complex revealed that it is composed of a private α chain, IL-
7Rα (Goodwin et al., 1990), and the common γ chain (γc), shared with other cytokine 
receptor complexes (Noguchi et al., 1993). Mice lacking either IL-7 or the IL-7 receptor α 
chain show a severe reduction in the numbers of peripheral B cells due to a block in B cell 
development at the pre-pro-B cell stage (IL-7Rα-/-; Peschon et al., 1994) or at the pre-B-I 
stage (IL-7-/-; Freeden-Jeffry et al., 1995). Interestingly, for IL-7-/- mice it was demonstrated 
that B cell development takes place during fetal and perinatal life resulting in the 
establishment of the B1 and the MZ B cell compartment (Carvalho et al., 2001). This suggests 
a pathway of early B lymphopoiesis that is IL-7 independent and underscores different 
developmental properties of FL and BM derived B cells. 
A possible factor which can compensate the lack of IL-7 is thymic stromal-derived 
lymphopoietin (TSLP), which also uses the IL-7Rα chain for its receptor complex (Park et 
al., 2000; Sims et al., 2000; Pandey et al., 2000). Only fetal-derived pro-B cells are able to 
respond to TSLP, although the receptor seems to be present also on the adult BM counterpart, 
as concluded from mRNA expression data (Vosshenrich et al., 2003). 
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A similar situation exists with respect to T lymphopoiesis. IL-7Rα-/- mice show a profound 
defect in thymopoiesis in the adult thymus (Crompton et al., 1998). Although total thymocyte 
numbers are reduced in embryos of IL-7Rα-/- mice, all the major thymocyte subpopulations, 
including mature single positive cells, are generated. This suggests that adult and fetal thymic 
progenitors have different requirements for the IL-7 receptor and presumably for the cytokine 
itself. 
Additional support for a distinct fetal origin of B1 and MZ B cells was provided by the 
analysis of conditional Rag2-/- mice, where deletion of the Rag2 gene at birth results in the 
generation of mice whose B cells are limited to these two subsets (Hao and Rajewsky, 2001). 
Another difference between fetal and adult B cell development concerns the pre-BCR 
expression. This receptor is expressed after successful VDJ recombination of the heavy chain 
and seems to be important for further B cell development. Introduction of a heavy chain by 
transfection into a pro-B cell line results in a strong downregulation of TdT, which normally 
decreases sharply at the pre-B-I to pre-B-II transition (Hardy et al., 2000). In the same study, 
two heavy chains derived from B1 cells have been identified that fail to induce 
downregulation of TdT. Both heavy chains, VH81X and VH11, usually found in B1 
specificities, are known to associate poorly with the SL chain (Keyna et al., 1995; Wasserman 
et al., 1998). 
Further evidence for differences in pre-BCR signaling between FL and adult BM came from 
experiments in which the effect of pre-BCR assembly on the proliferation of early B lineage 
cells was studied (Wasserman et al., 1998; Hardy et al., 2000). While the pre-BCR complex 
on isolated bone marrow cells leads to proliferation, the same pre-BCR induces an exit from 
cycle in fetal liver. In contrast, the VH11 transgene that fails to assemble efficiently with the 
SL chain has minimal effects on the ongoing fetal liver proliferation, allowing a continued 
increase in cell numbers. This difference in pre-BCR receptor signaling between FL and adult 
could explain the differential VH usage between the B1 and B2 repertoires (Yancopoulos et 
al., 1984; Marshall et al., 1996; Carmack et al., 1990; Hardy et al., 1989). VH81X and VH11 
heavy chains are lost in the BM due to the inefficient association with the SL chain, while 
survival and further maturation are favored in fetal liver. 
Several molecules were found to be differentially expressed during fetal and adult B cell 
development. One known example is the expression of MHC class II molecules, which are 
expressed on all mature B cells and are required for antigen presentation to CD4+ T-helper 
cells. While MHC class II is already present on pre-B cells from the adult BM and thus 
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precedes the surface Ig expression, pre-B cells of the FL lack the expression of such 
molecules. In neonates MHC class II molecules become apparent at about the same time as 
IgD and CD5 are expressed on the B cells (Lam and Stall, 1994; Hayakawa et al., 1994). A 
myosin light chain gene provides another example of late-onset expression. This internal 
protein is absent in precursors from the FL, in contrast to BM derived precursors (Oltz et al., 
1992). 
Another prominent difference between fetal and adult B cell development is that fetal B cell 
precursors express little or no TdT during VDJ recombination of the heavy chain (Li et al., 
1993). Consequently, heavy chains from B cells generated in the BM usually contain 
N nucleotides at the VHD and DJH junctions, while in junctions generated during fetal 
development N nucleotide addition is low or absent (Li et al., 1993; Gilfillan et al., 1993). 
Light chains generally show no N nucleotide diversification. Although there is no strict 
correlation between TdT expression and TdT activity (Cherrier et al., 2002), the lack of N 
nucleotide diversification at the heavy chain junctions is usually taken as indicator whether a 
B cell has originated from fetal sources or not. Early studies have shown, that receptors 
expressed by B1 cells only rarely have N nucleotide insertions, whereas receptors expressed 
by B2 cells nearly always have such insertions (Gu et al., 1990; Carlsson and Holmberg, 
1990; Feeney, 1990). But recent data using more sensitive methods reveal that the N 
nucleotide differences between B1 and B2 cells were greatly overestimated. Roughly 5% of 
B2 cells and 30 % of B1 cells express sequences with no N nucleotide insertion at either the 
VHD or DJH junction, while the majority of cells in both lineages express Ig with N nucleotide 
insertion in at least one junction (Kantor et al., 1997; Kantor et al., 1995a; Kretschmer et al., 
2002; Kretschmer et al., 2003b). 
As a further consequence of the lack of TdT expression, homology-directed recombination 
can take place (Fig. 1-11). In lymphocytes isolated from fetal liver or from TdT-/- mice, VHD 
and DJH junctions in which short stretches of nucleotides could have derived from either 
germline segment, were observed (Feeney, 1992). 
Although the exact mechanism is not clear, it was demonstrated that short stretches of 
homology present on juxtaposed segments can strongly influence the outcome of 
rearrangement in the absence of cellular selection (Gerstein and Lieber, 1993; Chukwuocha et 
al., 1995; Feeney et al., 1994). 
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Fig. 1-11: Homology-directed recombination. As an example the homology-directed recombination 
between a DFL16.1 and a JH1 gene segment is shown (modified from Gerstein and Lieber, 1993). 
 
Interestingly, based on their germline sequences, homology-directed recombination will favor 
in frame, productive rearrangements of VH7183 and Q52 genes, but out-of-frame, non-
productive rearrangements of the large J558 gene family (Chukwuocha et al., 1995). This 
provides an explanation for the finding that B1 cells often express heavy chains encoded by 
Q52 and VH7183 gene families, while B2 cells mainly express Ig encoded by the J558 VH 
family. 
Although the absence of TdT during fetal development limits CDR3 diversity, this lack on the 
other hand is important for the generation of certain specificities. Forced expression of TdT 
during fetal life in a transgenic mouse eliminated the well-characterized T15 anti-
phosphorylcholine (PC) B cell subset that is protective against pneumococcal infection. These 
animals became susceptible to such infections (Benedict and Kearney, 1999). 
 
1.12. Aim of my work 
As described many differences in lymphopoiesis are known between fetal and adult life up to 
now. In the case of B cell development the two subpopulations B1 and B2 seem to be the 
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result. The fetal liver was suggested as origin for B1 cells, while B2 cells originate mainly 
from the bone marrow. One could assume, that B cell progenitors from both organs display 
essential differences, and several molecules are already known to be differentially expressed. 
Substantial additional information should come from gene expression analysis. Therefore in 
this work genes differentially expressed between progenitor B cells of the fetal liver and the 
adult bone marrow should be investigated. This should provide further evidence for distinct 
progenitors and function. 
The model of two distinct progenitors is not generally excepted, although the analysis of  
IL-7-/- mice (Carvalho et al., 2001) and conditional Rag2-/- mice (Hao and Rajewsky, 2001) 
clearly demonstrated that the generation of B1 cells and MZ B cells takes place during fetal 
and perinatal life in an IL-7 independent manner. However, there was also contrasting 
evidence provided that the differences between B1 and B2 cells are derived solely from 
differences in the specificity of their receptors (Cong et al., 1991; Berland and Wortis, 2002). 
Consequently, it was suggested that the adult bone marrow could also give rise to B1a cells. 
Most of the data leading to the two different models were derived from transgenic mice or 
adoptive transfer experiments. To definitively answer the question, whether the adult bone 
marrow could also generate B1a cells, and whether B1 and B2 cells are derived from different 
progenitors or not, it appeared necessary to generate a mouse in which this question could be 
investigated under more physiological conditions. Analogous to the conditional Rag2 knock-
out mouse, a conditional Rag1 knock-in mouse should be generated, in which B cell 
development could be induced at a desired time point. 
Another aspect of the B cell development – differential expression of germline transcripts – 
should be included in this work. Germline transcription can be taken as diagnostic marker for 
the accessibility of a particular cluster of Ig gene segments to the recombination machinery. 
Characterization of germline transcripts of the murine Ig loci has so far been mainly focused 
on transcripts derived from the constant region cluster. Germline transcripts of V regions have 
not been studied to the same extent. Interestingly, transcription of germline VH gene segments 
seems to be differentially regulated depending on the stage of B cell development. This has 
been shown in B cell lines of different developmental stages as well as in fetal liver derived B 
cells (Haines and Brodeur, 1998; Lennon and Perry, 1990). Differential regulation appears to 
depend on the distance between the DJC cluster and a particular VH gene segment. This is 
supported by the fact that B cells with rearrangements at VH regions proximal to the DJC 
cluster dominate fetal liver (Perlmutter et al., 1985). 
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In former work, germline transcripts of both the κ and the λ light chain loci have been 
isolated. The obtained sequences should now be characterized and used for further 
investigation. It should be determined whether members of the Vκ cluster are activated 
differentially, depending on their distance from the JC cluster, or whether the whole cluster of 
Vκ segments is activated in toto. In addition, it should be investigated whether V and JC 
clusters of both light chain loci are regulated in a coordinate way or independently.
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2. Material 
2.1. Bacterial strains 
2.1.1. TOP10 
The Escherichia coli (E. coli) strain TOP10 (Invitrogen) was taken for the general cloning of 
the targeting vector. Initially chemically competent bacteria were used; later cloning steps 
with larger constructs were performed with electrocompetent bacteria (kind gift of Wiebke 
Hansen, GBF Braunschweig). 
Genotype: 
F- mcrA ∆(mrr-hsdRMS-mcrBC) φ80lacZ∆M15 ∆lacX74 deoR recA1 araD139 ∆(ara-
leu)7697 galU galK rpsL (StrR) endA1 nupG 
 
2.1.2. INV110 
During the cloning of the targeting vector, ClaI sites were found methylated by the dam 
methylase and were therefore not cleavable by the corresponding enzyme. INV110 
(Invitrogen) is a dam and dcm methylase-deficient E. coli strain and allows production of 
DNA that is unmethylated at the specific methylation sites. The presence of the dam 
deficiency affects INV110 in a number of ways. These bacteria have a higher mutation rate 
(greater than 250-fold) and a higher recombination frequency when compared to dam+ E. coli 
strains. Therefore INV110 were only used for single transformation steps where they were 
absolutely required. Picking of colonies and isolation of DNA was done within one day after 
transformation. For the transformation chemically competent bacteria were used. 
Genotype: 
F’ {tra∆36 proAB lacIq lacZ∆M15} rpsL (StrR) thr leu endA thi-1 lacY galK galT ara tonA 
tsx dam dcm supE44 ∆(lac-proAB) ∆(mcrC-mrr)102::Tn10 (TetR) 
 
2.1.3. 294-Cre 
The E. coli strain 294-Cre has been constructed by integrating the Cre recombinase gene into 
the lacZ locus of the strain MM294 (Buchholz et al., 1996a). The expression of the Cre 
recombinase is under the control of the temperature-sensitive cI857 repressor. Such bacteria 
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can be used as test for the recombination competence of constructs that are designed for the 
use in Cre-mediated genomic manipulations. For this test chemically competent bacteria were 
used (kind gift of Anne Fleige, GBF Braunschweig). 
Genotype: 
F- λ- supE44 endA1 thi-1 hsdR17 lacZ::cI857-Cre 
 
2.2. Cells 
2.2.1. Embryonic feeder (EF) cells 
Embryonic stem (ES) cells were cultured on a layer of mitotically inactive feeder cells 
derived from embryonic fibroblasts. These EF cells have to be G418-resistant and, therefore, 
were prepared from mice harboring the neomycin resistance gene. In this work IL-4 
transgenic mice (Muller et al., 1991) were used and EF cells were prepared from day 13 
embryos. These primary feeder cells were frozen in aliquots after a first expansion and were 
termed EF0. 
 
2.2.2. Embryonic stem cells 
For the generation of gene targeted mice Bruce-4 ES cells (Kontgen et al., 1993) derived from 
C57BL/6 mice and BALB/c ES cells (Noben-Trauth et al., 1996) derived from BALB/c mice 
were used. 
 
2.3. The BAC (bacterial artificial chromosome) clone 
For the cloning of the targeting vector a piece of genomic DNA was needed containing the 
Rag1 locus. Therefore the BAC clone RP23-111E15 (GenBank #AC084753), comprising the 
appropriate region, was ordered from the library RPCI-23 Mouse BAC II. This library has 
been created by Kazutoyo Osoegawa, Minako Tateno and Pieter de Jong at the Roswell Park 
Cancer Institute, Buffalo, New York. For the generation of the library kidney and/or brain 
genomic DNA from female 6 to 12 weeks old C57BL/6J mice was used, partially digested 
and cloned into the vector pBACe3.6 (BAC). As host the E. coli strain DH10B was used. 
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pBluescript II SK +
2961 bp
AmpR
lacZ'
MCS
f1 ori
ColE1 ori
lac-Promoter
BamHI (720)
ClaI (685)
KpnI (658)
NotI (739)
SacI (760)
SalI (675)
SpeI (726)
Xho I (669)
pBlu2SK-neo
4480 bp
NeoR
TK-Promoter
FRT
FRT
f1 ori
ColE1 ori
AmpR
lac-Promoter TK-PolyA
Cla I (2204)
Kpn I (658)
Not I (2258)
Sal I (2194)Spe I (2245)
Xho I (669)
2.4. Vectors used for the construction of the targeting construct 
 
 
 
 
 
 
 
 
 
Fig. 2-1: The pBluescript® II SK + phagemid (Stratagene). pBluescript® II SK + is a phagemid 
derived from pUC19. The ColE1 plasmid origin of replication is used in the absence of helper phage. 
The Ampicillin-resistance gene (AmpR) was utilized for antibiotic selection of the vector. The 
multiple cloning site (MCS, 658 – 760 bp) was replaced by a modified one. The modified vector was 
then the basis for the cloning of the targeting vector. 
 
 
 
 
 
 
 
 
 
 
Fig. 2-2: The neomycin resistance cassette of pBlu2SK-neo. The FRT flanked neomycin resistance 
cassette was cloned XhoI/SalI into the vector pBluescript® II SK + afterwards termed pBlu2SK-neo 
(kind gift of Werner Müller, GBF Braunschweig). The neomycin resistance gene (NeoR) is controlled 
by the herpes simplex virus (HSV) thymidine kinase (TK) promoter and contained also the TK polyA 
signal. 
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pGEM-DTA
4645 bp
DTA
PGK-Promoter
SV40-PolyA
BamHI (1129)
ClaI (1671)
AatII (21)
SalI (1721)
Xho I (78)
KpnI (68)
KpnI (1688)
NotI (44)
NotI (1708)
Sac I (362)
Sac I (1740)
Spe I (1402)
Spe I (1695)
 
 
 
 
 
 
 
 
 
 
Fig. 2-3: The DTA (diphtheria toxin A) cassette of pGEM-DTA. The DTA cassette was PCR 
amplified out of the vector pROSA26-1 (see http://www.fhcrc.org/labs/soriano) and cloned into the 
vector pGEM-T Easy (Promega) afterwards termed pGEM-DTA (kind gift of Thorsten Buch, 
University of Cologne). The diphtheria toxin subunit is controlled by the PGK-promoter and contains 
the SV40-PolyA signal. Restrictions sites used for the excision of the cassette are marked in blue. 
 
2.5. Mice 
The injection of recombinant ES cells into blastocysts was carried out in Braunschweig 
(Experimental immunology, GBF Braunschweig) or in Cologne (Center for Mouse Genetics, 
University of Cologne). Also subsequent breeding was carried out in Braunschweig or 
Cologne. BALB/c and C57BL/6 wild-type mice were obtained from Harlan Winkelmann 
GmbH (Braunschweig), Charles River (Cologne) or from internal breeding. CD1 mice 
(Braunschweig), F1 mice (F1 generation of BALB/c x C57BL/6) and CB20 mice (both 
Cologne) were derived from internal breeding. 
Donor embryos for blastocyst injection were obtained from untreated CB20 or hormone-
stimulated C57BL/6 mice at day 3.5 and used in a way that allowed chimerism to be detected 
by coat-color (i.e. CB20 for C57BL/6 ES cells and C57BL/6 for BALB/c ES cells). Pseudo-
pregnant F1 or CD1 mice were used as foster mothers. 
For the isolation of adult bone marrow cells, female BALB/c mice of an age of 7 weeks were 
taken. BALB/c fetuses of day 17 of gestation were obtained by timed pregnancies, the day of 
appearance of a vaginal plug being taken as day 0. 
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2.6. Antibodies 
The following antibodies were used for the isolation of B cell precursors by cell sorting: the 
monoclonal antibody against CD19 (1D3, PharMingen) coupled with APC and an antibody 
against c-kit (ACK-4). The antibody against c-kit was protein G purified from concentrated 
hybridoma supernatants and coupled to biotin following standard protocols. The biotinylated 
antibody was revealed by streptavidin-R-PE (Southern Biotechnology Associates). 
 
2.7. Oligonucleotides 
Synthetic oligonucleotides required for cloning were purchased from MWG (HPSF 
purification). Oligonucleotides for polymerase chain reaction (PCR) and sequencing were 
obtained from Invitrogen (standard purification) and were controlled with the program 
OLIGO® (Version 4.04-s, National Biosciences) for duplex formation and hairpin structures. 
 
2.7.1. Oligonucleotides used for cloning 
Annealed oligonucleotides were used for the introduction of short stretches of DNA into the 
targeting vector. The oligonucleotides are shown here in the annealed double-stranded form. 
Black and pink nucleotides represent the sequence of the oligonucleotides, while blue 
nucleotides only serve to elucidate the restriction sites. Pink nucleotides do not reconstitute a 
given recognition motif which leads to the destruction of the restriction site after integration 
of the annealed oligonucleotides into compatible sites. 
 
NeoR cassette mod1 (KpnI-NheI-10 bp-NheI-XhoI) 
 
NheI-site-for 5'-GGTACC^GCTAGC^ACGCTTACCA^GCTAGC^CTCGAG-3' 
NheI-site-rev 3'-CCATGG^CGATCG^TGCGAATGGT^CGATCG^GAGCTC-5' 
 
NeoR cassette mod2 (SalI-2 bp-SpeI-XhoI-NheI-NotI) 
 
SpeI-site-for 5'-GTCGAC^AT^ACTAGT^CTCGAG^GCTAGC^GCGGCCGC-3' 
SpeI-site-rev 3'-CAGCTG^TA^TGATCA^GAGCTC^CGATCG^CGCCGGCG-5' 
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new MCS (SacI-NotI-BamHI-AatII-KpnI) 
 
MCS-for 5'-GAGCTC^GCGGCCGC^GGATCC^GACGTC^TGTACC-3' 
MCS-rev 3'-CTCGAG^CGCCGGCG^CCTAGG^CTGCAG^ACATGG-5' 
 
loxinv (KpnI-LoxP-NdeI-ClaI-2 bp-KpnI-SpeI-PxoL-ClaI) 
 
LoxP-i-for 5'-GGTACT^ATAACTTCGTATAGCATACATTATACGAAGTTAT^CATATG 
LoxP-i-rev 3'-CCATGA^TATTGAAGCATATCGTATGTAATATGCTTCAATA^GTATAC 
 
^ATCGAT^AT^GGTACC^ACTAGT^ATAACTTCGTATAATGTATGCTATACGAAGTTAT 
^TAGCTA^TA^CCATGG^TGATCA^TATTGAAGCATATTACATACGATATGCTTCAATA 
 
^ACCGAT-3' 
^TGGCTA-5' 
 
2.7.2. Oligonucleotides used for PCR 
 
HYB-1-FOR:  5’-AGG GTC GAT AAA AGT AAG CAA CAC AGA-3’ 
HYB-1-REV:  5’-TCC CAT GAG ATC ACA GAA AGA AAA AGA-3’ 
 
HYB-3-FOR:  5’-CCC TTG GTT TGC ACT GAC TTT-3’ 
HYB-3-REV:  5’-TTC CGG GAG ATT GGT TGT T-3’ 
 
HYB-5-FB:  5’-GGT GAA CCG GGA GAA AGT GA-3’ 
HYB-5-REV:  5’-TCA TAA TTT TAA TCA CAG GTT TTG-3’ 
 
NEO-FOR:   5’-ACT GGG CAC AAC AGA CAA TCG GCT-3’ 
NEO-REV:  5’-TAT TCG GCA AGC AGG CAT GCG CAT-3’ 
 
RAG1-FOR-1: 5’-GAC AAA GCA GTT CAC CAA GCC AG-3’ 
RAG1-REV-1: 5’-GCG TGG TTG AGC ACA GTT TTT AGT T-3’ 
 
RAG1-FOR-2: 5’-CCC ACA GTC AGG TCT ACT TCC CAA-3’ 
RAG1-REV-2: 5’-GAC AGC CTT CAC ATC TCC ACC TTC T-3’ 
 
RAG1-S3:   5’-AGC TAT CAC TGG GAG GCA GAT TTT-3’ 
RAG1-REV-3: 5’-CGT ATC CAG TGC CCC TGA AGA-3’ 
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2.7.3. Oligonucleotides used for semi-quantitative RT-PCR 
 
β-actin:  bActfor; 
bActrev:    both Engel et al., 1999 
GAPDH: GAPDH for:   5’-ATC TTC TTG TGC AGT GCC AGC-3’ 
GAPDH rev:   5’-ACT CCA CGA CAT ACT CAG CAC C-3’ 
Vλ1/2:  VL1+2FORLEA: 5’-TGA ATT ATG GCC TGG A(CT)T TCA C-3’ 
Vλ1rev:     5’-GCC ACC TGT TAA GAA GAT GGT AGT TA-3’ 
Vλx:   Vx-for:     5’-CAT TAT GGC CTG GAC TCC TC-3’ 
Vx-rev:     5’-TCT TCA GGC TGG ATG TTG G-3’ 
λ10:   Stλ1for2; 
Cλ1R3:     both Engel et al., 1999 
Vκ02:  Vκ2-L-for:    5‘-ATG ATG AGT CCT G(CT)C CAG TTC CTG-3‘ 
Vκ02-FR3REV-1: 5’-CTC CCA AAT C(CT)T CAG CCT CCA CTC T-3’ 
Vκ21:  Vκ21L-1:    5‘-CTG CTA TGG GTG CTG CTG CTC TG-3‘ 
Vκ21-FR3REV-1: 5’-GGA TGG ATG TTG AGG (CG)TG AAG TCT G-3’ 
κ00.8:  0.8 K0FOR; 
K0REV:    both Grawunder et al., 1995b 
κ01.1:  1.1 K0FOR:  5’-CAT GTG AAG TGA AAT GGC TGT AGC CTA ATG-3’ 
(Grawunder et al., 1995b) 
K0REV:    see above 
 
2.7.4. Oligonucleotides used for sequencing 
 
NEO-R0:    5’-TGT GTT TCC CTC TCA ATC AAG TCT TAG-3’ 
NEO-R1:    5’-ACG AGG AAG CGG TCA GCC CAT T-3’ 
NEO-R2:    5’-ATC ATC CTG ATC GAC AAG ACC G-3’ 
NEO-R3:    5’-CGG ACA GGT CGG TCT TGA CAA A-3’ 
NEO-R4:    5’-ACC TGC GTG CAA TCC ATC TTG TTC-3’ 
 
RAG1-FOR-0:  5’-AGG GCA TCA ATC AGT TAT TTC CAA A-3’ 
RAG1-FOR-1:  see above 
RAG1-FOR-2:  see above 
RAG1-S1:    5’-GAT ATG CGA ACA CAT TCT GGC TGA T-3’ 
RAG1-S2:    5’-GCC TCG CCA GCA TCT CCT GTC-3’ 
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RAG1-S3:    see above 
RAG1-S3.5:   5’-TGG AAT TAT TGA TGG GCT GTC TGG-3’ 
RAG1-S4:    5’-AGT GGT GGT AAA GGA GTC TTG CGA-3’ 
RAG1-S5:    5’-TCT TCA GGG GCA CTG GAT ACG-3’ 
RAG1-S6:    5’-CAT AGA TGC GCT TCA CTG TGA CA-3’ 
RAG1-S7:    5’-GAA ACC CGT GTG GCG CTC TT-3’ 
RAG1-S8:    5’-ACC TCC AGA AGT TTA TGA ATG CTC AT-3’ 
RAG1-SLOX:  5’-GAA GAA ATA AAC AAC CAA TCT CCC G-3’ 
RAG1-SLOX-2:  5’-CTC TGT GCA TCC CTG GTC CCC T-3’ 
RAG1-REV-3:  see above 
 
M13 Forward (-20): 5’-GTA AAA CGA CGG CCA G-3’ (Invitrogen) 
M13 Reverse:   5’-CAG GAA ACA GCT ATG AC-3’ (Invitrogen) 
 
2.8. Culture media 
2.8.1. Culture media for bacteria 
LB medium 
1% (w/v) Bacto™ Tryptone (BD) 
1% (w/v) Bacto™ Yeast Extract (BD) 
0.5% (w/v) NaCl 
diluted in H2O and autoclaved. 
 
LB plates with ampicillin 
For the generation of agar plates 1.5% (w/v) of Bacto™ Agar (BD) was added to the LB 
medium before autoclaving. After autoclaving the medium and cooling down to 50°C, the 
ampicillin stock solution was diluted in the medium 1:1000 resulting in an end concentration 
of 50 µg/ml. 25 ml of this medium were used per plate. The plates were stored at 4°C after 
solidification. 
 
Ampicillin stock solution 
5% (w/v) Ampicillin (sodium salt, SIGMA) dissolved in 70% ethanol and stored at –20°C. 
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2.8.2. Culture media for cells 
EF cell medium 
500 ml Dulbecco’s MEM with Glutamax-1 (Gibco/Invitrogen) 
60 ml Fetal bovine serum (Biochrom KG) 
6 ml  Sodium pyruvate MEM 100MM (Gibco/Invitrogen) 
6 ml  Penicillin-Streptomycin (Gibco/Invitrogen) 
were mixed and stored at 4°C. 
 
ES cell medium 
500 ml Dulbecco’s mod eagle medium (Gibco/Invitrogen) 
75 ml Foetal bovine serum (performance tested, Gibco/Invitrogen) 
6 ml  Sodium pyruvate MEM 100MM (Gibco/Invitrogen) 
6 ml  Penicillin-Streptomycin (Gibco/Invitrogen) 
6 ml  L-Glutamine 200MM (Gibco/Invitrogen) 
6 ml  MEM non-essential amino acids (Gibco/Invitrogen) 
1.2 ml LIF (supernatant of the cell line CHO 8/24 720 LIF D(.1)) 
0.6 ml 0.1 M 2-Mercaptoethanol 
were mixed and stored at 4°C. 
 
0.1 M 2-Mercaptoethanol 
50 µl 2-Mercaptoethanol (SIGMA) dissolved in 7 ml PBS (see 3.2.2.), filter sterilized and 
stored as 0.6 ml aliquots at –20°C. 
 
2.9. RNA from R2-bfl cells 
The Rag2 deficient, bcl-2-transgenic pro-B cell line R2-bfl was grown on the stromal cell line 
ST-2 in the presence of recombinant IL-7 as described previously (Grawunder et al., 1995b). 
Differentiation was induced by removal of IL-7 and different cultures of cells were cultivated 
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for additional one to five days. Total RNA was isolated from the cells using Trizol reagent 
(Gibco) according to the manufacturer's protocol (kind gift of Dr. Holger Engel). 
 
2.10. Cloned germline transcripts 
Amplification products of germline transcripts from both light chain loci were obtained by 
3’-RACE (rapid amplification of cDNA ends; Dr. Holger Engel, unpublished and Sandra 
Düber, diploma thesis, TU Braunschweig 2001) using total RNA from R2-bfl cells 
differentiated for four days in the absence of IL-7 and the SMART RACE cDNA 
Amplification Kit (Clontech). The following V gene family specific primers were used for the 
3'-RACE: 
Vκ01L-1:  5’-CCT GTT AGG CTG TTG GTG CTG ATG-3’ 
Vκ2-L-for:  see above 
Vκ04/05L-2: 5’-GGA TTT TCA GGT GCA GAT TTT CAG C-3’ 
Vκ08L-1:  5’-GCA AGA TGG ATT CAC AGG CCC AG-3’ 
Vκ08L-2:  5’-CAA GAT GGA ATC ACA GAC TCA GG-3’ 
Vκ09/10L-1: 5’-CAG GAC TCA GCA TGG ACA TGA GGG-3’ 
Vκ09/10L-2: 5’-GCT CAG TTC CTT GGT CTC CTG TTG-3’ 
Vκ12/13L-1: 5’-GTT GCT GCT GCT GTG GCT TAC A-3’ 
Vκ19/28L-1: 5’-GGG CAT CAA GAT GGA (AG)TC ACA GA(CT) TC-3’ 
Vκ21L-1:  see above 
Vκ22L-1:  5’-GGA GCA GGA TGG AGT TTC AGA CC-3’ 
Vκ24/25L-2: 5’-GAT GCT TGT GCT CTG GAT TCC TG-3’ 
Vκ38cL-1:  5’-CGT CTA TTC AGT TCC TGG GGC TC-3’ 
VκDVL-1:  5’-GCC TCA GAA AGA AAA TCG TGA ACC-3’ 
Vλ1forLea: 5’-TGA ATT ATG GCC TGG ATT TCA-3’ 
Vλ2forRACE: 5’-CTT GGT TTG TGA ATT ATG GCC TGG AC-3’ 
VxforLeader:  5’-TGC ATT ATG GCC TGG ACT CCT CTC-3’. 
 
In some cases a nested-PCR was performed using the following Vκ gene family specific 
primers derived from the first framework region: 
Vκ01FR-1:  5’-TGA TGA CCC AAA CTC CAC TCT CC-3’ 
Vκ08FR-1:  5’-GGA GA(AG) AAG GT(CT) ACT ATG AGC TG-3’ 
Vκ21FR-1:  5’-ACA CAG TCT CCT GCT TCC TTA GC-3’ 
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As reverse primer a nested universal primer supplied with the SMART RACE kit was used. 
PCR products of the expected size were cloned using the TOPO TA cloning kit (Invitrogen). 
Several clones were picked and sequenced. Sequences were analyzed using Sequencher 
software (Gene Codes Corporation) and database comparison with published sequences using 
advanced BLAST search and IgBlast (National Center for Biotechnology Information, 
http://www.ncbi.nlm.nih.gov/BLAST/).
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3. Methods 
3.1. Molecular biological methods 
3.1.1. Isolation of plasmid DNA 
The isolation of plasmid DNA for analytical and preparative purposes was performed with the 
“GFX Micro Plasmid Prep Kit” (Amersham Biosciences). The isolation of plasmid DNA for 
transfections was carried out with the “QIAGEN® Plasmid Maxi Kit” (QIAGEN). Both 
purifications were done according to the manufacturer’s protocols. 
 
3.1.2. Isolation of BAC DNA 
The BAC DNA was isolated using the “NucleoBond®PC500 kit” (Macherey-Nagel) 
according to the manufacturer’s protocol. To avoid shearing of the BAC DNA, the bacterial 
lysate was filtrated and not centrifuged for clarification. 
 
3.1.3. Cleavage of DNA with restriction enzymes 
Restriction endonucleases recognize short specific DNA sequences, mostly 4 to 8 nucleotides 
long, and cleave the DNA in this region. Cleavage of DNA with restriction enzymes was used 
for the cloning of the targeting vector and for the linearization of the targeting construct 
before transfection. Generally, this cleavage was performed in 20 µl volume, but sometimes 
the volume was scaled up. The reaction was carried out using optimal buffer and temperature 
conditions for each enzyme according to the manufacturer’s protocol. For the digestion of 
genomic DNA for Southern blot 1 mM spermidine, 1 mM DTT and 50 µg/ml RNaseA were 
added to the mix. 
 
3.1.4. Dephosphorylation of DNA 
If vector DNA is cleaved with only one restriction enzyme, two compatible ends are 
generated, that can re-ligate. To minimize this option it is possible to dephosphorylate the 
vector. For this hydrolysis of 5’-phosphate residues calf intestine alkaline phosphatase (CIAP, 
MBI Fermentas) was used according to the manufacturer’s protocol. 
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3.1.5. Phenol/chloroform extraction 
Clean DNA of high quality was needed for the transfection of ES cells. To remove enzyme 
and salts after the restriction digestion for linearization, extraction with phenol/chloroform 
was performed. 
An equal volume of phenol/chloroform (1:1) was added to the DNA. After vortexing for 1 
minute, the phases were separated by centrifugation for 10 minutes (10.000 x g, RT). The 
upper phase was transferred to a new tube and an equal volume of chloroform was added. 
After vortexing for 1 minute, the phases were separated again by centrifugation for 10 
minutes (10.000 x g, RT). This chloroform extraction step was repeated. Then the DNA was 
precipitated by the addition of 1/10 volume of 3 M sodium acetate (pH 5.2) and 2 volumes of 
absolute ethanol. After 30 minutes of centrifugation (10.000 x g, RT), the supernatant was 
removed. The tube was filled completely with 70% of ethanol and stored over night at 4°C. 
This last step should sterilize the DNA. 
 
3.1.6. Annealing of oligonucleotides 
The two oligonucleotides that should anneal were diluted with water to an end concentration 
of 100 pmol/µl. 10 µl of each oligonucleotide were mixed in a tube and heated for 5 minutes 
to 95°C. Then the tube was placed in a cup of water at 60°C and tube and water were allowed 
to cool down to room temperature. 1 µl of the mix was taken later for the ligation. 
 
3.1.7. Gel electrophoresis in agarose gels 
DNA is negatively loaded in aqueous solutions due to the ionization of the phosphate 
residues. If an electric field is present, it is possible to separate DNA fragments corresponding 
to their size in a gel matrix. 
In this study gels were used at 0.8 and 2% concentration of agarose (SeaKem® LE Agarose, 
Cambrex). The size of the DNA fragments was estimated by comparison with DNA markers. 
The gels were running in 1x TAE puffer mostly at 160 V. DNA fragments were stained with 
ethidium bromide and visualized using UV light. Documentation was performed using the 
Herolab GmbH software. 
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50x TAE:   242 g Tris 
      57.1 ml Acetic acid 
      100 ml 0.5 M EDTA (pH 8.0) 
      filled up with H20 to 1 liter and autoclaved. 
DNA marker:  SmartLadder SF, 100bp-1kb (Eurogentec) 
      GeneRuler™ 1kb DNA Ladder, 250bp-10kb (MBI Fermentas) 
      Mixture of HindIII digested λ DNA and BsuRI digested ΦX174 DNA, 
      72bp-23kb (MBI Fermentas) 
 
3.1.8. Gel extraction 
The extraction of DNA fragments from agarose gels for the later ligation was performed with 
the “QIAquick Gel Extraction Kit” from QIAGEN according to the manufacturer’s protocol. 
With this kit fragments from 70 bp to 10 kb can be processed. If the DNA fragment was 
required in a higher concentration the “MinElute™ Gel Extraction Kit” from QIAGEN was 
used. Here it is possible to elute the DNA in a smaller volume of buffer (10 µl). With this kit 
only fragments in the range from 70 bp to 4 kb can be processed. 
 
3.1.9. Ligation of DNA 
DNA fragments and linearized vectors with cohesive or blunt termini can be joined by the use 
of ligases. The used T4 DNA ligase (MBI Fermentas) catalyses the formation of a 
phosphodiester bond between juxtaposed 5’-phosphate and 3’-hydroxyl termini in double-
stranded DNA. Vector DNA and the DNA fragment were optimally used in a molecular ratio 
of 1:10, to minimize the chance of vector re-ligation. The ligation was performed according to 
the manufacturer’s protocol. For cloning steps with cohesive ends and large amounts of DNA 
fragment, the reaction was incubated 1 hour at room temperature. More difficult cloning steps 
(blunt end ligation or a low amount of DNA fragment) were incubated at 16°C over night. 
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3.1.10. Transformation of bacteria 
Different methods of transformation were carried out to introduce plasmid DNA into bacteria. 
 
3.1.10.1. Transformation of chemically competent E. coli (Invitrogen) 
The competent bacteria were thawed on ice, mixed with 10 µl of the ligation reaction or with 
1 µl of plasmid DNA by gently tapping and were incubated for 30 minutes on ice. After a 
subsequent incubation for 30 to 45 seconds at 42°C, the bacteria were placed back on ice. 
250 µl of SOC medium (supplied with the bacteria) were added to the bacteria and the 
suspension was shaken for one hour at 37°C. Afterwards the bacteria were plated on LB 
plates containing ampicillin (50 µg/ml) and the plates were incubated at 37°C over night. 
On the next day, single colonies were picked and cultivated in LB medium containing 
ampicillin (100 µg/ml). The liquid cultures were shaken at 180 rpm and 37°C for 6 to 8 hours. 
Afterwards the clones were analyzed by plasmid isolation and restriction digestion. 
In case of the 294-Cre bacteria the cultivation of the liquid cultures was carried out over night 
at 27°C. 
 
3.1.10.2. Electroporation of E. coli 
The electrocompetent bacteria were thawed on ice, mixed with 2 µl of ligation reaction by 
gently tapping and incubated for 1 minute on ice. The suspension was transferred into a 
cuvette and electroporation was carried out (parameters 2.5 kV, 25 µF, 200Ω) with a Gene 
Pulser (Biorad). Immediately 500 µl of SOC medium was added to the cuvette. The 
suspension was transferred to a tube and was shaken for 1 hour at 37°C before plating on LB 
plates containing ampicillin (50 µg/ml). The plates were incubated at 37°C over night. 
Picking of colonies was performed as described above. 
 
3.1.11. Long-term storage of bacteria 
For the long-term storage of bacteria 700 µl of a fresh bacterial culture were mixed with 300 
µl of 50% glycerine and stored at –80°C. 
 
50% glycerin:  50% (v/v) glycerin in H20, filter sterilized and stored at 4°C. 
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3.1.12. Determination of nucleic acid concentrations 
The nucleic acid concentration was determined after a suitable dilution of the DNA or RNA 
probe in TE (see 3.1.17.1.) through measurement of the extinction at 260 nm. (OD260=1 
correspond for DNA to a concentration of 50 µg/ml, for RNA to a concentration of 40 µg/ml, 
respectively.) The photometer (BioPhotometer, Eppendorf) was normalized with TE before. 
 
3.1.13. DNA sequencing 
The sequencing of DNA was carried out with the “ABI PRISM™ Big Dye™ Terminator 
Cycle Sequencing Ready Reaction Kit” (PE Biosystems), based on the chain-termination 
method of Sanger (Sanger et al., 1977). This kit contains a mixture of ddNTPs coupled with 
different fluorescent dyes for the termination, dNTPs for the extension, AmpliTaq® DNA 
Polymerase FS and reaction buffer. The mixture was ready to use (premix). The reaction was 
performed in 200 µl reaction tubes (0.2 ml Micro-Strips & Caps, Abgene® House). 
 
Reaction mix:    2 µl   Premix 
1.6 pmol Primer 
60-360 ng PCR product 
       or 0.6-1.2 µg Plasmid DNA 
H20 ad 11 µl 
 
The following program was used on the thermocyler (PCR Express, Hybaid): 94°C for 60 s, 
25 cycles at 94°C for 60 s, 52°C for 20s, and 60°C for 4 min. 
 
After the reaction, the DNA was precipitated to remove primers, salts and non-incorporated 
nucleotides. Therefore 10 µl water, 20 µl 2 mM MgCl2 and 60 ml absolute ethanol were 
added to the reaction and mixed by inverting the tubes ten times. After 15 minutes incubation 
at room temperature, the precipitate was spun down (45 min, 1420 x g, RT) and the 
supernatant was removed by a subsequent centrifugation with inverted open tubes (1 min, 188 
x g). Afterwards the DNA was washed with 100 µl of 70% ethanol. The ethanol was removed 
after a further centrifugation step (45 min, 1420 x g, RT) as described above. Residual ethanol 
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was evaporated on a thermocycler by incubation at 65°C for 1 to 2 minutes. The probes were 
stored at –20°C until they were loaded on the sequence gel and analyzed with an automatic 
DNA sequencer (ABI PRISM 377, PE Applied Biosystems). 
The obtained sequences were evaluated and compared with known sequences using the 
program Sequencher™ (Version 3.1.1, Gene Codes Corporation). Sometimes a database 
comparison was performed using Advanced BLAST search and IgBLAST (National Center 
for Biotechnology Information, http://www.ncbi.nlm.nih.gov/BLAST/). 
 
3.1.14. Polymerase chain reaction (PCR) 
The polymerase chain reaction allows the selective amplification of DNA sequences of low 
abundance, present in a heterogeneous mixture. During the reaction the region flanked by the 
primers is exponentially amplified. 
 
Reaction mix:  0.5 µl Primer 1 (10 pmol/µl) 
      0.5 µl Primer 2 (10 pmol/µl) 
      2 µl  10x PCR buffer (Perkin Elmer) 
      2 µl  Nucleotide mix (2 mM each nucleotide) 
      13.9 µl H2O 
      0.1 µl AmpliTaq Gold™ (5U/µl) 
      1 µl  Template DNA 
 
The reaction was carried out in 200 µl reaction tubes (0.2 ml Micro-Strips & Caps, Abgene® 
House). Following programs were used on the thermocyler (PCR Express, Hybaid): 
 
Program Denaturation Annealing Extension Cycles 
HYB/H 94°C 20s 55°C 30s 72°C 30s 30 
HYB/L 94°C 20s 50°C 30s 72°C 30s 30 
NEO 94°C 20s 58°C 30s 72°C 30s 30 
RAG 94°C 30s 60°C 60s 72°C 60s 30 
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Each program was started by a 10 minutes activation step at 95°C for the hotstart polymerase 
and finished by 7 minutes final extension at 72°C. 
 
3.1.15. DNase treatment 
RNA preparations could contain also contaminating genomic DNA. This potentially 
contaminating DNA was therefore removed on “RNeasy Mini Kit” spin column (QIAGEN) 
using the RNase-free DNase set (QIAGEN) according to the manufacturer’s protocol. 
 
3.1.16. Semi-quantitative reverse transcriptase PCR (RT-PCR) 
A special form of the PCR is the RT-PCR. cDNA is used here as template. This cDNA had to 
be generated from mRNA by reverse transcription. Semi-quantitative RT-PCR allows 
measuring the relative differences in transcript levels between different samples. The simplest 
way of performing such analysis is to determine the amounts of PCR product during the 
exponential phase of the PCR but before the plateau phase. Therefore serial dilutions of the 
cDNA are tested in the PCR. The amount of cDNA and efficiency of reaction were controlled 
using primers specific for housekeeping genes. 
For the preparation of cDNA, 1 µg of total RNA was reverse transcribed using Superscript II 
(Gibco/Invitrogen) and oligo d(T)12-18 primer (Amersham Biosciences) according to the 
protocol supplied with the reverse transcriptase. As RNase inhibitor RNasin ribonuclease 
inhibitor (Promega) was used. The cDNA was diluted to 100 µl, which was termed the 
undiluted sample, and further serially diluted four-fold. 1 µl of these dilutions were taken as 
template for PCR. The PCR reaction was performed in a 20 µl volume as described above. 
Following programs were used on the thermocyler (PCR Express, Hybaid): 
 
Program Denaturation Annealing Extension Cycles 
β-actin 94°C 20s 55°C 30s 72°C 30s 24 
GAPDH 94°C 20s 58°C 30s 72°C 30s 26 
Lambda 94°C 20s 52°C 30s 72°C 30s 32 
V-Kappa 94°C 20s 62°C 30s 72°C 30s 32 
C-Kappa 94°C 20s 65°C 30s 72°C 30s 32 
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Each program was started by a 10 minutes activation step at 95°C for the hotstart polymerase 
and finished by 7 minutes final extension at 72°C. 
 
3.1.17. Preparation of genomic DNA 
3.1.17.1. Preparation of genomic DNA from tail biopsies 
The piece of the mouse tail (about 1 cm) was placed in a tube with 720 µl of tail buffer and 
30 µl of proteinase K. The tube was placed into a thermomixer and shook over night at 54°C. 
The next morning hairs and bones were spun down (10 min, full speed, RT) and the 
supernatant was transferred into a new tube containing 600 µl 2-propanol. It was mixed gently 
but thoroughly by inverting several times until a flocculent precipitate appeared. After five 
minutes of centrifugation (10.000 x g), the supernatant was removed and the pellet was 
washed with 500 µl 70% ethanol. After an additional centrifugation the supernatant was 
removed again and the pellet was dried at room temperature. After drying, 100 µl of TE 10/1 
was added and the DNA was dissolved by shaking for 3 to 12 hours at 54°C with a 
thermomixer. Afterwards the tubes were vortexed for 5 s and the DNA was stored at 4°C. 
 
Tail buffer (Laird): 100 mM Tris HCl (pH 8.5) 
       5 mM EDTA (pH 8.0) 
       200 mM NaCl 
       0.2% SDS 
Proteinase K:   Proteinase K (SIGMA) in H20 (10 mg/ml) stored at –20°C. 
TE 10/1:    10 mM Tris (pH 7.6) 
       1 mM EDTA 
 
3.1.17.2. Preparation of genomic DNA from ES cells 
It is possible to prepare the DNA of ES cells directly in the 96 well plates and do the cleavage 
with restriction enzymes afterwards in the same plates. The plates with the confluent ES cells 
were washed twice with PBS or the already washed and frozen plates were allowed to warm 
up to room temperature. To each well 50 µl of lysis buffer was added. The plates were 
wrapped with parafilm and transferred into a pre-warmed, humidified chamber of 56°C. The 
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lysis was performed over night. The next day the humidified chamber was allowed to cool at 
room temperature for 1 hour. Then 100 µl of absolute ethanol was added to each well of the 
plate and DNA precipitate became visible. After one hour the ethanol was removed by 
inverting the plate and carefully draining the wells on paper towels. The DNA should remain 
attached to the plastic. Then the plates were washed three times with 100 µl of 70% ethanol, 
carefully draining the wells after each washing step. Afterwards the wells were dried at room 
temperature and were ready for the restriction digestion. 
 
Lysis puffer:   10 mM Tris HCl (pH 7.5) 
10 mM NaCl 
10 mM EDTA 
0.5% Sarcosyl 
0.4 mg/ml Proteinase K (added fresh each time) 
 
3.1.18. Southern blot 
In a Southern blot DNA restriction fragments are separated in an agarose gel and transferred 
(blotted) to a membrane. Hybridization of a radioactive labeled DNA probe to the 
immobilized target sequence allows the detection of these hybrids due to the radioactivity. 
Southern blot analysis is a very sensitive method routinely used in the analysis of gene 
structure. 
 
3.1.18.1. Alkaline transfer 
One method for the capillary transfer of DNA to membranes is the alkaline transfer. In 
contrast to the original protocol of Southern (Southern, 1975), only one solution is used for 
denaturation and transfer of the DNA. 
The DNA restriction fragments were separated in an agarose gel at low voltage in the 
presence of ethidium bromide. Then a picture under UV light was taken including a 
fluorescent ruler. The size ladder was marked by punching little holes into the gel with a 
yellow tip. Then the gel was agitated in 0.25 N HCl for approximately 10 minutes for 
depurination. Afterwards the DNA was denatured by soaking the gel in 0.4 N NaOH for 
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30 minutes. The positively charged nylon membrane (Gene Screen Plus Hybridization 
Transfer Membrane, NEN™Life Science Products) was cut to exactly the same size as the 
gel. It was pre-wetted in distilled water for a few seconds and equilibrated for 15 minutes in 
0.4 N NaOH. Afterwards a downwards capillary blot according to Fig. 3-1 was set up using 
0.4 N NaOH as transfer solution. 
 
 
 
 
 
Fig. 3-1: Set-up of a downwards capillary blot. 
 
After blotting over night, the slots of the gel and the size ladder were marked on the 
membrane. Afterwards the membrane was washed with excess 2x SSC for 1-2 minutes. The 
DNA was fixed on the membrane by drying the membrane 1-2 hours at 80°C. 
 
20x SSC stock: 3 M NaCl 
      0.3 M Tri-sodiumcitrate 
      pH 7.2, filtered. 
 
3.1.18.2. Labeling of the probe 
The DNA probe was labeled using the “Ladderman™Labelling Kit” (TaKaRa) according to 
the manufacturer’s protocol. With this kit the probe was labeled with [α-32P] dCTP using 
random nonamers. After labeling, non-incorporated nucleotides were removed using 
ProbeQuant™ G-50 Micro Columns (Amersham Biosciences). After that 35 µl of sonicated 
salmon sperm DNA (10 mg/ml) were added to the probe and the mix was heated at 95°C for 5 
minutes. Thereafter the probe was ready for hybridization. 
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3.1.18.3. Hybridization and detection 
Hybridization was performed using QuikHyb® Hybridization Solution (Stratagene). This 
solution reduces the time required for hybridization from customary 12-24 hours down to 1-2 
hours. 
Prior to prehybridization the membrane was briefly dipped in deionized water to remove 
excess salt from the membrane. Then the membrane was prehybridized for at least 30 minutes 
at 65°C in a glass bottle in a rotating hybridization oven using the QuikHyb® Hybridization 
Solution. Afterwards the labeled probe was added to the solution and it was hybridized for at 
least one hour. 
After hybridization the membrane was washed twice shortly with 2x SSC/0.1% (w/v) SDS at 
room temperature. Then the membrane was washed twice with 0.1x SSC/0.1% (w/v) SDS at 
58°C for 15 minutes. Afterwards the membrane was wrapped in a plastic wrap and placed on 
a Kodak BIOMAX MS film with an intensifying screen at –80°C. Exposure was performed 
over night. The film was developed the next morning using an automatic developer machine 
(Curix 60, Agfa). 
 
3.1.19. Generation of cRNA and microarray hybridization 
High-density oligonucleotide arrays allow the parallel analysis of expressed mRNA of a large 
number of genes (Lockhart et al., 1996; Lipshutz et al., 1999). With the Affymetrix GeneChip 
MG-U74Av2 used for hybridization ~12.000 genes and expressed sequence tags (ESTs) can 
be tested. 
Total RNA from 105 sorted CD19+c-kit+ pre-B cells was isolated using the “RNeasy Kit” 
(QIAGEN). Quality and integrity of the total RNA was controlled by running all samples on 
an Agilent Technologies 2100 Bioanalyzer (Agilent Technologies). For RNA amplification 
(Fig. 3-2) the first round was done according to the protocol provided by Affymetrix without 
biotinylated nucleotides using the Promega P1300 RiboMax Kit (Promega) for T7 
amplification. For the second round of amplification the precipitated and purified RNA was 
converted to cDNA primed with random hexamers (Pharmacia). Second strand synthesis and 
probe amplification were done as in the first round with two exceptions: An incubation with 
RNase H preceded the first strand synthesis to digest the aRNA, and the T7T23V 
oligonucleotide for initiation of the second strand synthesis was used. 
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Fig. 3-2: RNA amplification for gene chip 
analysis from a limited amount of starting 
material. (a) The in vitro transcription of 
double-stranded cDNA in the presence of 
biotinylated rNTPs – the conventional procedure 
for labeling of mRNA for Affymetrix 
microarray hybridization – results already in an 
increase of cRNA relative to the starting 
material. (b) Starting from as few as 5 x 104 
cells, RNA amplification by two subsequent 
rounds of cDNA synthesis and in vitro 
transcription usually results in 60-120 µg cRNA. 
Only the second round of in vitro transcription is 
performed in the presence of biotinylated 
rNTPs. (Figure from Dr. Karsten Kretschmer, 
dissertation, TU Braunschweig 2003) 
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12.5 µg biotinylated cRNA preparation was fragmented and placed in a hybridization cocktail 
containing four biotinylated hybridization controls (BioB, BioC, BioD, and Cre) as 
recommended by the manufacturer. Samples were hybridized to an identical lot of Affymetrix 
MG-U74Av2 chips for 16 hours. After hybridization, GeneChips were washed, stained with 
streptavidine-PE and read using an Affymetrix GeneChip fluidic station scanner. Scanned raw 
data images were processed with Affymetrix GeneChip software. For normalization all array 
experiments were scaled to a target intensity of 150, otherwise using the default values of the 
Microarray suite (Affymetrix). The 16 pairs of oligonucleotides (probe pairs) representing 
every gene or EST in a probe set, with one sequence being complementary to the target 
sequence and the other having a 1 bp mismatch in a central position were used as an internal 
control for hybridization specificity. The relative abundance is reported as the averaged 
difference of the fluorescence intensity values between the perfectly matched and the 
mismatched oligonucleotides, resulting in the so-called ‘Average-Difference’ value (Lockhart 
et al., 1996; Wodicka et al., 1997). 
Probability of differential expression was calculated with unpaired t-test statistics (Data 
Mining Tool, Affymetrix). Genes were considered differentially expressed if the t-test results 
in a confidence level of at least 99%, and if they changed at least twofold with a difference in 
mean average difference value of at least 100. 
 
3.2. Cell culture 
3.2.1. Culture conditions 
Embryonic feeder (EF) cells and embryonic stem (ES) cells were cultivated in their 
appropriate culture medium at 37°C and 7.5% CO2 in a humidified atmosphere. 
 
3.2.2. Culture of embryonic feeder cells 
To maintain their pluripotency, ES cells are usually cultured either on gelatinized plastic 
plates in the presence of leukemia-inhibitory factor (LIF) or on a layer of mitotically inactive 
feeder cells derived from embryonic fibroblasts. In this work the ES cells were cultured both 
on mitomycin C-treated primary EF cells and in the presence of LIF. 
Preparation and culture of EF cells obviously needs to be done in advance of any ES cell 
work and it should be planned, how many feeder cells are required for the experiments. It is 
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possible to passage and expand EF cells 3 to 4 times, until they will age and lose their 
capacity to divide. The distinct passages were numbered starting with EF1 after the first 
thawing of the primary feeders. Normally only feeder cells until EF3 were used, and only for 
short culture periods. For homologous recombination experiments solely EF1 and EF2 were 
used. 
A tube of primary feeder cells was thawed and distributed to two or three 15 cm plates. Once 
being confluent, they were split into three plates and further expanded. When required, 
confluent plates were treated with mitomycin C (mmc) to inhibit proliferation. After this 
inactivation, the EF cells were distributed after counting to the required plates (Table 3-1). 
These plates were gelatinized in the case of a long-time cultivation (e.g. the selection for 
homologous recombinants). For gelatinization the fresh plates were covered with the gelatin 
solution for at least 5 minutes at 37°C. Directly before adding medium, the gelatin was 
removed. 
 
Gelatin:  2% solution, Type B: From Bovine Skin (SIGMA) diluted 1:20 in PBS. 
PBS:   Dulbecco’s phosphate buffered saline (PAA Laboratories GmbH) 
 
Table 3-1: Numbers of EF cells required for the different plates. 
Plate Total surface area (cm2) EF cells per plate 
15 cm 148 not applicable 
10 cm 55 3 x 106 
6 cm 21 1.2 x 106 
6 well plate 57 3 x 106 
12 well plate 45.6 2.5 x 106 
24 well plate 45.6 2.5 x 106 
48 well plate 38.4 2.1 x 106 
96 well plate 30.7 1.7 x 106 
 
3.2.3. Trypsinization 
Medium was removed from the culture and the cells were washed twice with PBS. Then 
Trypsin/EDTA was added and the plates were incubated for 5 minutes at 37°C. After 
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detaching and isolating of the cells, the reaction was stopped by the addition of medium. The 
cells were spun down (10 min, 300 x g, 4°C) and plated on new plates. 
 
Trypsin:  Trypsin-EDTA (Gibco/Invitrogen) diluted 1:10 in PBS. 
 
3.2.4. Mytomycin C (mmc) treatment 
The medium from a confluent plate of EF cells was replaced by mmc-medium. The culture 
was incubated for two to four hours at 37°C. After this incubation the cells were washed three 
times with PBS and were then trypsinized and distributed to the desired plates. 
 
mmc-medium: 2 g Mytomycin c (SIGMA) were dissolved first in 2 ml medium and then 
further diluted in 200 ml medium. After filter sterilization, 10 ml aliquots 
were stored at –20°C. 
 
3.2.5. Culture of embryonic stem (ES) cells 
The ES cells were always cultivated on a layer of mitotically inactive feeder cells. Only cells 
used for DNA preparation were cultured on gelatinized plates. 
The primary goal in handling ES cells was to preserve their pluripotency with respect to 
embryonic development. ES cells were treated as carefully as possible, thus the medium was 
changed every day. The cell density was also very important – cultures should be split 
frequently (every 2 – 3 days) such that individual colonies do not become too large (< 1000 
cells). Similarly, when trypsinizing ES cells it was important to fully resuspend the cell 
clumps (by gentle pipetting) such that no large aggregates were transferred to the new plates. 
The reason for these precautions was that large colonies easily differentiate and likely lose 
their omnipotency. Also, the surface area of the tissue culture plate covered by colonies 
should not exceed ~ 50% since ES cultures will completely differentiate into endoderm-like 
cells within a few days if the culture has ever become confluent. 
Normal culture of ES cells was performed in 10 cm plates. After a transfection the ES cells 
had to be expanded from 96 well plates. This was carried out by the use of 48 well plates, 12 
well plates and 6 well plates. 
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3.2.6. Cryo-Conservation of mammalian cells 
Cells were trypsinized and spun down. After that the cell pellet was resuspended in a small 
volume (depending on the cell number) of ice-cold freezing medium and transferred to 
cryotubes (Nunc). The cells were frozen at -80°C and later stored in liquid N2. 
 
Freezing medium: 10% Dimethylsulfoxid (DMSO, Merck) in the appropriate FCS. 
 
3.2.7. Thawing of cells 
The DMSO from the freezing medium was toxic for the cells. Therefore the thawing of the 
cells from liquid N2 was done as quickly as possible by agitating the tube in 37°C water bath. 
The tube was afterwards cleaned with alcohol before opening. The cells were immediately 
added to ~ 10 ml medium and spun down. Removal of the supernatant also removes the 
DMSO. The cells were resuspended in new medium and plated out. 
 
3.2.8. Transfection 
ES cells used for electroporation should be growing exponentially since the transfection 
efficiency and perhaps also the frequency at which homologous recombination occurs appears 
to be increased in optimally growing cells compared to dense ES cultures. For the same 
reason it was recommended to feed ES cultures with fresh medium a few hours prior to 
transfection. 
A tube with ES cells was thawed four days before transfection. After two days the cells were 
split and plated exceptionally at higher density than normal on two to three plates. Prior to 
transfection the construct must be prepared and linearized. Before the day of transfection, 
40 µg of the construct (for every 107 cells to be transfected) were linearized by restriction 
digestion followed by phenol/chloroform extraction and precipitation. The pellet should stay 
in 70% ethanol over night. 
On the day of transfection the ES cells were fed four hours before transfection with fresh 
medium. The ethanol was removed from the DNA pellet and the DNA was air dried in the 
open tube in a laminar flow hood. Afterwards, the DNA was resuspended in 400 µl of 
transfection buffer. 
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The ES cells were then trypsinized and counted. 107 cells were taken per transfection. Excess 
cells were frozen. The cells for the transfection were spun down and resuspended in 400 µl of 
transfection buffer. The cells were afterwards mixed with the diluted DNA and transferred to 
a cuvette. It was electroporated at 240 V in cuvettes with 4 mm electrode distance and 1 cm 
width, using an electroporator with 500 µF capacitance. After electroporation the cells were 
incubated 10 minutes at room temperature. The electroporated cells were then transferred into 
medium and plated onto five 10 cm plates. 
The selection was started 48 hours after transfection. ES cell medium with G418 (SIGMA, 
end concentration 300 µg/ml) was used to feed the cells. 9 to 10 days after transfection all 
non-transfected cells had died and the surviving resistant clones were ready for isolation. 
 
Transfection buffer:  RPMI 1640 w/o L-glutamine, w/o phenol red (Gibco/Invitrogen) 
 
3.2.9. Picking of ES cell colonies 
Once selection was complete, resistant clones had to be isolated. Colonies at this point should 
be fairly large in size (~4000 cells) but still maintain a discrete border or edge. Colonies may 
even have a dark ‘cap’ indicative of a high density of cells at the top of the colony. Colonies 
which had begun to differentiate (and spread out) around the edges (“fried egg”) had to be 
avoided. 
One day before picking, sufficient 96 well plates with mmc-treated EF cells were prepared. 
Four hours before picking, the ES cells were fed with fresh medium. 96 well plates (round 
bottom) with 50 µl trypsin were prepared for the picked colonies and stored at 4°C until 
picking. The picked colonies were initially transferred into these plates. After trypsinization, 
separated cells from the picked colonies were subsequently transferred into the plates with the 
EF cells. Round bottom plates were used for the trypsinization step, because it was easier to 
quantitatively remove the isolated ES cells from these plates after treatment. 
For picking the ES cells were washed once with PBS and covered then with 12 ml cold PBS. 
With a dissecting microscope in a laminar flow hood (with outward pressure) and a Gilson 
pipette, single colonies were gently dislodged from the feeder layer, withdrawn in 20 µl of 
PBS and transferred immediately to the 96 well plate with trypsin. After 30 minutes of 
picking, the plate was incubated for 3 to 5 minutes at 37°C for the separation of the cells. The 
trypsinization was then stopped by the addition of 80 µl of medium. Cells were further 
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suspended by pipetting up and down and distributed into three 96 well plates that contained 
feeder cells. To dilute the trypsin, the wells were filled completely with medium. 
Two of these three plates were used for the conservation of the picked clones. The third plate 
was used for DNA preparation and analysis of the clones. The cells of all three plates were 
fed every day. On two subsequent days (e.g. day 2 and 3) a plate kept for conservation was 
frozen. 
To this end, the cells were washed twice with PBS, 50 µl of trypsin was added and the plates 
were incubated 3 to 5 minutes at 37°C. The reaction was stopped by the addition of 50 µl of 
medium, and the cells were suspended by pipetting up and down. 100 µl of ES-FCS/20% 
DMSO was added to each well and every well was overlaid with sterile mineral oil (SIGMA). 
The plates were wrapped with parafilm and stored at –80°C. 
Cells of the third plate, intended for DNA preparation, were trysinized on day 3 and 
distributed into three gelatinized 96 well plates, thus expanding now three plates for DNA 
preparation. The ES cells were grown in these plates till full confluence. Then the cells were 
washed twice with PBS, and the plates were stored at –20°C after wrapping with parafilm. 
 
3.2.10. Flp-mediated deletion of the selection marker in ES cells 
Using a FRT flanked neomycin resistance cassette in the targeting construct makes it possible 
to remove the selection marker, after homologous recombinants have been identified. To 
delete the FRT flanked sequences in vitro, the Flp recombinase is transiently expressed in ES 
cells and clones which have lost the neomycin gene by Flp-mediated, FRT-specific 
recombination were isolated on the basis of G418 sensitivity. 
For the deletion 107 homologous recombinant ES cells were transfected with 30 µg of 
supercoiled Flp-e expression vector (for general strategy, see above). After transfection only 
1000 cells per 10 cm plate were seeded, the rest was frozen for a possible subsequent plating 
and picking. After 7 days clones were picked (for general strategy, see above) and distributed 
into three 96 well plates with mmc-treated EF cells (once ½ and twice ¼ of the cells). The 
two plates with ¼ of the cells were cultured in medium without G418. In the other plate the 
ES cells were tested for G418 sensitivity with medium that contained the threefold G418 
concentration compared to normal. Three days after picking G418 sensitivity became visible 
in these plates, because such cells did not grow. The sensitive clones were then expanded 
from the plates without G418 and were later tested by Southern blot analysis for the deletion. 
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During expansion, an aliquot of these cells was again tested with medium containing G418 
for G418 sensitivity. 
 
3.2.11. Cre transduction 
The recombination competence of the loxP sites was tested in an in vitro assay with isolated 
His-TAT-NLS-Cre protein (Peitz et al., 2002), that can be used to treat cells directly. In this 
assay homologous recombinant ES cells were plated on 6 well plates without EF cells (2 x 105 
cells per well). After 5 hours the medium was removed and replaced by the Cre containing 
medium with different Cre concentrations (2 µM, 1 µM, 0.5 µM, 0.25 µM, 0.125 µM) for 16 
hours. Afterwards the Cre medium was removed and the cells were cultured in normal 
medium. Four days later the DNA was isolated from the cells and tested by Southern blot 
analysis. 
 
Cre containing medium: The 180 µM Cre stock was diluted in a 1:1 mixture of DMEM 
and PBS containing 0.1% pluronic F-68 (SIGMA) and sterilized 
by filtration. 
 
3.2.12. Preparation of ES cells for injection 
Five days before injection a tube with recombinant ES cells was thawed. After two days the 
cells were split and 1/4, 1/8, 1/16, 1/32 and 1/64 of the cells were plated on fresh EF cells. 
Three days later the cells from the appropriate plate with the optimal appearance were 
prepared for the injection. 
The cells were trypsinized and spun down. After resuspension in 10 ml medium they were 
plated on a gelatinized 10 cm plate. After 30 minutes the EF cells have attached to the plastic 
while the ES cells are still in the supernatant or are loosely attached at the bottom. To separate 
the ES cells from the EF cells the supernatant was transferred to a fresh tube (tube 1). Then 
the loosely attached cells are rinsed with 10 ml fresh medium from the plate and transferred to 
another tube (tube 2). The cells are then spun down, resuspended in 500 µl of injection 
medium and used afterwards for injection. 
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Blastocyst medium: 500 ml Dulbecco’s MEM with Glutamax-1 (Gibco/Invitrogen) 
90 ml Foetal bovine serum (Gibco/Invitrogen) 
6 ml  Sodium pyruvate MEM 100MM (Gibco/Invitrogen) 
6 ml  NEAS (Gibco/Invitrogen) 
6 ml  Penicillin-Streptomycin (Gibco/Invitrogen) 
6 ml  L-Glutamine 200MM (Gibco/Invitrogen) 
16.7 ml HEPES (Gibco/Invitrogen) 
 
Injection medium: 50 ml Blystocyst medium 
       7.5 mg DNase (SIGMA) 
 
3.3. Immunological methods 
3.3.1. Cell sorting 
Distinct cell populations can be distinguished on the basis of their differential expression of 
cell-surface proteins. These cell-surface proteins can be detected using specific antibodies 
conjugated with fluorescent dyes and analyzed with a flow cytometer or a fluorescence-
activated cell sorter (FACS). Besides the bound fluorescence marker, also size and granularity 
of the cells can be determined. 
Single cell suspensions of bone marrow cells were obtained by flushing femur and tibia with 
FACS buffer. Alternatively, single cell suspensions from fetal livers were obtained using a 
100 µm-cell strainer (Falcon). After lysis of erythrocytes the cells were stained with the 
appropriate antibodies for 15 minutes at 4°C in the dark. After washing twice, the biotinylated 
antibody was revealed by 10 minutes incubation with Streptavidin-R-PE. After subsequent 
washing cell sorting was performed on a MOFLO cell sorter (Cytomation). A total of 100.000 
cells were sorted directly in the RLT buffer of the RNeasy kit (QIAGEN). Sorted cells were 
reanalyzed and were 95-99% pure. For the sorting experiment bone marrow of three mice and 
fetal liver of three to five fetuses were pooled. 
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1x PBS:     8 g NaCl 
       0.2 g KCl 
       1.44 g Na2HPO4 x 2 H2O 
       0.2 g KH2PO4 
       dissolved in 1 liter H2O (pH 7.0) and autoclaved. 
FACS buffer:   1x PBS 
       2% FCS 
       2 mM EDTA 
ACK lysis buffer: 150 mM NH4Cl 
       10 mM KHCO3 
       0.1 mM Na2EDTA 
       pH 7.2-7.4, filter sterilized (0.2 µm). 
4. Results  77 
4. Results 
Many aspects in B cell development, especially the precise differences in fetal liver and adult 
bone marrow, are largely unknown. In the present work, first germline transcripts of both 
immunoglobulin light chain loci were cloned and characterized, thus obtaining the 
prerequisite for subsequent experiments. In these experiments, differential expression of 
germline transcripts of V gene segments was investigated. The results were then compared 
with the appearance of JC germline transcripts during B cell development. 
Furthermore, a comparison of gene expression patterns between B cell precursors derived 
from fetal liver and adult bone marrow was performed, using microarrays. Thus, an extensive 
information about differentially expressed genes was obtained. Finally, a new mouse model 
with inducible lymphopoiesis was established that should allow to investigate the potential of 
B cell precursors that arise in neonatal and adult bone marrow. 
 
4.1. Analysis of germline transcripts of immunoglobulin light 
chain variable regions 
In order to study the appearance of transcripts of particular V region families, germline 
transcripts of V gene segments from both light chain loci had to be isolated and characterized 
first (Dr. Holger Engel, unpublished and Sandra Düber, diploma thesis, TU Braunschweig, 
2001). For this isolation and the subsequent investigation of the expression of germline 
transcripts of V and JC clusters, the synchronously differentiating pro-B cell line R2-bfl was 
used (Grawunder et al., 1995b). This line had previously been used to establish differential 
expression of JC germline transcripts of the κ and λ loci (Engel et al., 1999). R2-bfl cells 
were derived from fetal liver from Rag2 deficient mice. The mice were also transgenic for 
bcl-2, an anti-apoptotic gene, which improves the survival of cells in culture. When grown on 
bone marrow stromal cells in the presence of IL-7, R2-bfl cells can be kept in the pro-B cell 
stage. Upon removal of IL-7, these cells almost synchronously differentiate to the phenotype 
of mature B cells (Grawunder et al., 1995b). Due to the Rag2 gene deficiency, all Ig loci in 
this cell line remain in germline configuration. Hence, all Ig transcripts in such cells are 
transcripts of germline gene segments. 
The previously cloned germline transcripts of both light chain variable regions were now 
characterized with regard to their 3’-UTR. The obtained sequence information was then used 
4. Results  78 
to design primers specific for V gene segments. Subsequently the appearance of germline 
transcripts of Vκ region families and of the Vλ gene segments was determined in 
differentiating R2-bfl cells by semi-quantitative RT-PCR. Finally, the findings were 
compared to the appearance of JC germline transcripts of both light chain loci during the 
differentiation process. 
 
4.1.1. Cloning and characterization of germline transcripts from light chain 
variable regions 
To characterize germline transcripts from Vκ gene segments, in vitro differentiation of R2-bfl 
was allowed for 4 days. At that time the JC clusters of both light chain loci had been shown to 
be fully activated in these cells and consequently all V regions should be active as well. RNA 
was isolated (kind gift of Dr. Holger Engel) and used in a VL-specific 3’-RACE (rapid 
amplification of cDNA ends). Forward primers for the 3’-RACE were specific for particular 
members of Vκ families. To distinguish specific from non-specific amplification products, 
that were observed in some cases, a nested PCR was performed using primers specific for 
frame work region I of the particular Vκ family. Alternatively, Southern blot analysis was 
carried out with an oligonucleotide probe that should allow detection of all Vκ regions. 
This strategy made it possible to obtain amplification products of germline transcripts for at 
least one member of 12 of the 18 Vκ families (Fig. 4-1a and Table 4-1). All these transcripts 
belonged to functional or potentially functional V gene segments. From Fig. 4-1a and Table 
4-1 it is also apparent that the 3’-UTR of Vκ gene segments, with few exceptions, are 
extremely heterogeneous in length and in sequence. In addition, for some germline transcripts 
alternative polyadenylation sites were found. 
Germline transcripts of the three Vλ gene segments were obtained by a similar 3’-RACE. 
Forward primers for Vλ1/2 and Vλx that hybridized to the leader region were designed and 
amplification products were cloned and characterized. As shown in Fig. 4-1b and Table 4-2, 
heterogeneity in length and sequence was again found, especially when comparing Vλ1/2 and 
Vλx. Even in the case of the Vλ1 and Vλ2 gene segments, which exhibit extremely high 
sequence homology at the 3’-UTR, small differences in length were observed. In addition, 
two distinct polyadenylation sites were found for the Vλ1 germline transcripts, whereas for 
Vλ2 only a single site could be detected. 
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1 
 bb1  CACAGTGATA CAGACCCTAA CAAAAATAGT CTTACTTTGG GTATCCCAGC TGCTAAATAT GTTATTTATG TGTGAGAGAG GTTNTGAGGG 
cr1  ---------- ---------- ---------- ---------- -----A---- ---------- ------C--- -T-------- ---C------ 
91 
bb1  ACTCCAGATT ATTGGTTCCA GCTGAGGGCA AGTGCAGCCG TGCTACAGAT CACTGGTCAT TCATTTTTGG CTTCATTGCC NCAATAACAA 
cr1  -------T-- ---------- ---------- ---------T G-------C- ---------- ---------- ---------- A--------- 
181 
bb1  TGTGAACAGG TGCCCTCCCA GAAGCC 
cr1  -A-------- ---------- ------ 
 
 
1 
 bd2  CACAGTGATT CAGACCTGAA CAAAAACTTC CTTGCCTGGG GCAGCCCAGC TGACAATGTG CAATCTGAAG AGGAGCAGAA AGCATCCTGT 
91 
GTCTGTGTGA GAGGGAGGGG CTGGGGCACA TGAGTACTTG TTTGCAGCTG TGAGCTCTGG CCAGACTCAT CTGGCTTTAT GAGTATTTTG 
181 
ACTAGATCTC AAGTGACATA CATTTCTGGT CCTTCCTGTA ATAGCCATTG TGTTGCCTCT GCATCAGGAT TATTTCCCTT TACTAATCTA 
271 
GCTGGTTTTT GATGATTTTT AACTATTTTT CATTAAATAT TTGAGCTTC 
 
 
1 
ah4  CACAGTGATA CAGACTGGAA CAAAAACCCT CTAAGTCCTT AGGGTCTAGC TACTTCCTCC TAGAAATAAA CTGTGGCCAG TGGTTTGATT 
91 
GCAGAAGTTC 
 
 
1 
    8-21 CACAGTGCTT CAGTCTCCTA CACAAACCTC CTTTAGAGTT TCACCAGCTG CCTGCATAAC ACACAGCCAT GGGTCTGCAC ACTTCCTCTT 
8-28 ---------- ---C------ ---------- ---A-----C ---A--A-A- TG-A---C-- --------C- --C-A----- --------C- 
8-34 ---------- T--C--T--- ---------- ---G---CAC ---------- ---A--CC-- -----T--C- ---------- -T-----TC- 
      91 
8-21 TCTACAAGAG AGCCAGCATG CCAGAAAC A CATGGAAATT TTTCAGAGTC CAGCAAAGAT AATGAGTTCN CTGNCTCTTG TGTTTTTTCT 
8-28 ---G-CT--C –C-T-A---- -- 
8-34 -N--AG--TC --TGT--C-- AA---CT-TN - 
 181 
8-21 TTCTTTTTTC TTTTTTGGCA TGAAAATAAT TTGTATGAAA NCGC 
 
 
1 
    cw9  CACAGTGATA CAAATTATAA CATAAACC C CATGAAAGCA GAAATGAGAG GCTGGGCTGC TCCAGCTGCT CCTTCTCATG AATCACCCAC 
cp9  ----A----- T—-G-C---- --------T- ---------N - 
91 
cw9  TCTGAATTTC TCAGATGTAA CAGGTCTCTC TGAGAGTTTG GGGTGACTCA TAAGACACAA AATACACGTA TGCTGTAGTC TCCCCTCCCC 
181 
cw9  CAGCCTGAAA CCTGCTTGCT CAGGGGTGGA GCTTCCCGCT CATTCGCTNT GCCACGCCCA CTGCTGGAAC CTGCGGAGCC ACACACGTGC 
 271 
cw9  ACCTTTNTAC TGGACCAGAG ATTATTNTGC GGGAATCGGG TCCCCTCCCC CTTCCTTCAT AACTAGTGTC CCAACAATAA AATTTGAGCC 
 361 
cw9  TTGATCAGC 
 
 
1 
    12-46 CACAGTGATT CAAGCCATGA CATAAACCAT GCAGGGAAGC AGAAGTGAGA GCACAGGCTG CCCCAACTGC TACTTATGAT GTCTCCAGCT 
      91 
GCTCAGCTAC TATGAGTGTT TCTCTTTGCC AGGGCTTAAA GGTCAATGTG ATGCAATATA ATAGTCAGAG AAAATGTTCT ATATACTGAA 
      181 
   TCCCTGTTTT GTTTTCCTAG GCCTAGTATC AAAACAAGGG AATGGTTTAC ATTACTTATT NACC 
 
 
1 
    19-15 CACAGTACTT CAGCCTCCTA CATAAACCTC CTCTGAGATT CTAACCAGCT GCCTGCACCT CACATCCCTA GACCTACACA CTTCCCCT C 
19-20 ------G--- --------C- -------AA- -- ------- --C-A----- -TA------C T-T-G-T--T -----G--T- -A------T- 
91 
19-15 TGCCTGC AG CTGCTATGCC TG  T  CTN TTGCAAAGTT TGGTAGAAAA TTAATGAATA GATCCTTTGA CTTGGAATGT TTTAATGGCA 
19-20 ------AT-C ---------- --AC-AA--G A------A-A ---- 
 181 
19-15 AAAAAGAAGT AAAGAGATNA AATCTTTATT TTTTTTAATT CCC 
 
 
1 
    21-7 CACAGTGCTC CAGGGCTGAA CAAAAACCTC CTGGGGTTGC AGCTCACTGA GGCTCAGTCT CTCAGTTCTC TCTTACTCTC TAACATCTCA 
      91 
AAACAGAGCT ATAGGCTTGT TTGGAAAAAT ATCTCAAACA ATGATACAAG TCTTATGAAC AGATATGTAT GTGTGTCCCA TCCTTCATGC 
181 
   TTTCTAATTT AATTATTTCC CAACAAAATA TATGATTGTT CT 
 
 
1 
    22-33 CACAGTGCTT CAGCCTCCTA CACAAACCTT CTTGAGAGTC TCACCAGCTG CCTATACCAC ACACACCCCT GGTCTTGCAC ACTCCCACCC 
      91 
CCCAACACTT CCTGAGAGCT GGTGTGCCTG AAAAATTGAT GAGCCCAGTA AATATGATTT TTTTATGTCT CATGTCTTTT CATATGAAAA 
181 
   ACCATTGTAT AAAAATNC 
 
 
1 
    he24 CACACTGATA CAGCCCTGAA CAAAAACACC CTTGCCTCAG TTGACAAAGC TGCCTGGTAA GTTCTTTGTT TTGGGTGTAA CATGATGTTT 
      91 
CCAGCATGGG AAAGTGAATA TTTTTTTTTA AGAGATTCTT GTTTTCCTCT GAATTTCACC TAAGAAAAAT GAAGCCCTAG GAAATGAAAC 
181 
   ATTCCATGAG GGTTCATGCT TGAAGAAGAT GCAGCAACTT CTCTGCAGTA ATGATATTTC ATAAAATGCC TTATTCGATA GGAACAAGTG 
      271 
CACTCAGTTA TGATTAGTGG TAGGCAGGAC CACACCTTGG CCAAGACGAC ATCAATGTGC ATATTGGTAG CCTTATATTT TATCTTCAAT 
361 
   CTCATTTCAG GACTCGTCTA GTTCTCTGGA TGTATTTGTC CCACCTTCCA ACGTATCCAG ATTAAATAAC TTTTTTCTGA CTTTTACTTT 
   451 
CATGTAAGCT TATTGATAAC ATGTTGCTAT GCCAGGCTTG GGAAACATTT GTTGATTCCA TGTGATGCAC CAATAGAAAA TGATGTAAGA 
 
(a) 
Vκ21
Vκ19/28
Vκ22
Vκ12/13
Vκ09/10
Vκ08
Vκ04/05
Vκ02
Vκ01
Vκ24/25
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561 
 CTTTGTAAGA AATAGATGTT GAAAGAGTCA AAATAGTGGG TATCTGAGTC CTTAGAACAA ATGGAACCTA TGCATTCAGG AATTATTAAC 
 641 
TAGAATATAC ATAGAATAAA ACATATAACA AAATTAATCN 
 
 
1 
    dv36 CACAGTGATT CAACATGTCA CAAAAACCTC CAGGAGACCA CAGTGTATTT GCTTCTACCA GCTACTTCCT TTGTAGCAGC TGCAATGCTG 
      91 
GGTGCTAATT TTTAGCATTT TTATCTTCGT TGTAAATACT GAGATGCTAA AAGTAACTCC AAGTAAATGT TTGTGTTCTT GCTTCCC 
 
 
1 
    gj38c CACAGTGATA CAAATCATAA CAAAAACCAC CCAGGGAAGC AGAAGTGAGA GGCTAGGTTG CCCACAAATT CTTACCCTTT GTCTTAACCA 
      91 
TTTTGCTAAG AGATTTTTTT TTNTAAGTTG CAAAGTCTTT GGGACCTTTT AGTAAAAAGA GACCN 
 
 
 
 
 
1 
    Vλ1  CACAATGACA TGTGTAGATG GGGAAGTAGA ACAAGAACAC TCTGGTACAG TCTCATAACT ACCATCTTCT TAACAGGTGG CTACATCTCC 
Vλ2  ---------- ---------- ---------- ---------- ---------- ---------- ---------- ---------- ------G--- 
91 
Vλ1  CTAGTCTGTT CTCTTTTACT ATAGAGAAAT TTATAAAAGC TGTTGTCTCA ATCAATAAAA AGTTTTATTT C 
Vλ2  ---------- ---------- ---------- ---------- ---------G 
 
 
1 
    Vλx  CACAGTAACG GAGATAAAGG AGGAAGCAGG ACAGAAACTT TTTTTTTTCT CTTCAAAGGT CTTTTCTACC AGAATCATTG GTTTTTTTTT 
      91 
TTCTTTTTTG CTTATTAATA AAGTAGATAG TCTAGC 
 
 
Fig. 4-1: 3’-UTRs of germline transcripts of VL gene segments of both the κ (a) and the λ (b) 
locus were analyzed by 3’-RACE. Amplification products were cloned and sequenced. The displayed 
sequences start at the first nucleotide of the heptamer of the recombination signal sequence. In cases 
where more than one member of a Vκ family could be analyzed, a sequence comparison was carried 
out. In this case, identical nucleotides were indicated as dashes for the second and third gene of a 
family. Arrowheads mark the end of a 3’-UTR due to alternative polyadenylation sites. Vκ genes were 
named according to the nomenclature described previously (Kirschbaum et al., 1998; Kirschbaum et 
al., 1999; Roschenthaler et al., 1999; Roschenthaler et al., 2000; Schable et al., 1999; Thiebe et al., 
1999). 
 
4.1.2. V region transcripts of light chain loci are differentially activated 
The sequence information obtained from germline transcripts of V regions of both light chain 
loci was combined with previous information on germline transcription of JC clusters. Thus, 
it was now possible to test, by semi-quantitative RT-PCR, whether germline transcription of 
the V and JC clusters of a particular light chain locus is initiated at the same developmental 
stage. In addition, it was investigated whether all V gene segments of the Vκ cluster were 
activated at the same time, or whether differential activation could be observed. As a first 
attempt activation kinetics of the two Vκ families that are furthest apart from each other were 
established. Primers specific for members of the Vκ02 family representing the Vκ family most 
Vκdv
Vλ1/2
Vκ38c
Vλx
(b) 
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distal of the JC cluster, and for members of the most proximal Vκ family Vκ21 were 
employed. Differential activation should be revealed by a delay in the appearance of specific 
RT-PCR products for either Vκ family in differentiating R2-bfl cells. 
 
Table 4-1: Length of 3'-UTRs from germline Vκ gene transcripts. 
Vκ family Gene Length of 3'-UTR (bp) Length of introna (bp) GenBank Acc. No.b 
Vκ01 bb1 206c 382 AJ231201 
  cr1d,e 206c 377 AJ231205 
Vκ02 bd2f 319 402 AJ231196 
Vκ04/05 ah4d,e 100 176 AJ231216 
Vκ08 8-21d 164 and 223c 196 Y15982 
  8-28d 112c 204 AJ235947 
  8-34d,e 121c 202 AJ235958 
Vκ09/10 cp9d 41 124 AJ231247 
  cw9d 368 123 AJ231248 
Vκ12/13 12-46d 244 123 AJ235956 
Vκ19/28 19-15d 173, 193 and 217 177 Y15976 
  19-20d 133 292 Y15981 
Vκ21 21-7 222c 241 K02158/Y15970 
Vκ22 22-33d 198 203 AJ235965 
Vκ24/25 he24 445 and 670 358 AJ132683 
Vκdv dv36d,e 153 and 177 172 AJ235966 
Vκ38c gj38cd 155 121 AJ235935 
 
a For comparison, the length of the intron between exons 1 and 2 is indicated. 
b Accession numbers of gene sequences described in references (Kirschbaum et al., 1998; 
Kirschbaum et al., 1999; Roschenthaler et al., 1999; Roschenthaler et al., 2000; Schable et al., 
1999; Thiebe et al., 1999). 
c Generated with a FWR1 specific forward primer. 
d Transcriptional orientation opposite to the JCκ cluster. 
e No expression product, usually cDNA, derived from the germline gene could be found in the 
database. 
f The found sequence is most homologous to this gene. 
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Table 4-2: Length of 3'-UTRs from germline Vλ transcripts. 
Gene Length of 3'-UTR (bp) Length of introna (bp) GenBank Acc. No.b 
Vλ1 146 and 161 90 X58409 
Vλ2 140 93 X58423 
Vλx 126 104 D38129 
 
a For comparison, the length of the intron between exons 1 and 2 is indicated. 
b Accession numbers of gene sequences described in references (Kirschbaum et al., 1998; 
Kirschbaum et al., 1999; Roschenthaler et al., 1999; Roschenthaler et al., 2000; Schable et al., 
1999; Thiebe et al., 1999). 
 
 
 
 
 
 
 
 
 
 
Fig. 4-2: Differential activation of germline transcription at the light chain loci. The expression of 
germline transcripts of the light chain loci was analyzed in R2-bfl cells by semi-quantitative RT-PCR 
at various time points after initiation of differentiation by removal of IL-7. Total RNA was isolated 
and reverse transcribed into cDNA. The cDNA was PCR-amplified undiluted and after serial fourfold 
dilution with primer pairs specific for germline transcripts of V gene segments (Vλ1/2, Vλx, Vκ02, 
Vκ21) or JC clusters (λ10, κ00.8, κ01.1) from both light chain loci. For standardization cDNA primer 
sets specific for β-actin and GAPDH were used. The additional upper band in the case of Vλ1/2 and 
Vλx resulted from contaminating genomic DNA indicated by the size of the amplification product. 
Controls with water showed no product in any case. 
 
To this end, IL-7 was removed from R2-bfl cultures to start synchronous differentiation. Cells 
were harvested on each consecutive day, RNA was extracted from the aliquots (kind gift of 
Dr. Holger Engel) and subjected to the semi-quantitative RT-PCR, using the V and JC 
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specific primers for the κ chain gene segments as well as several primers for housekeeping 
genes to standardize the amplification. As demonstrated in Fig. 4-2, the two JCκ germline 
transcripts κ0.8 and κ1.1 were already detectable at low levels at day 0. The same was true for 
transcripts of the most proximal Vκ family Vκ21. Thus, transcripts of JCκ and Vκ21, as far as 
can be determined within this system, became apparent at the same stage of differentiation. 
Interestingly, the appearance of transcripts of the most distal Vκ family Vκ02 is delayed 
compared to transcripts of the Vκ21 family. 
RNA from the above cells was also used for detection of germline transcripts derived from 
the λ locus. JCλ transcripts were weakly detectable first at day 2 after the start of 
differentiation of R2-bfl, confirming the previous results on differential expression of JC 
germline transcripts of the two L chain loci. Interestingly, weak expression of both Vλ 
germline transcripts was apparent already after one day of differentiation. Thus, activation of 
germline transcription of Vλ and JCλ clusters is slightly asynchronous. Nevertheless, germline 
transcription of Vλ and JCλ starts later than that of JCκ and the most proximal Vκ21 family. 
However, Vλ and the most distal Vκ02 family seem to be activated roughly at the same time. 
 
4.2. Comparison of gene expression patterns between B cell 
precursors derived from fetal liver and adult bone marrow 
The B lymphopoiesis in the fetal liver is in many aspects extremely similar to the B 
lymphopoiesis in the adult bone marrow. Thus, the basic concept of B cell development, with 
its correlation between cell surface and intracellular markers and the status of Ig gene 
rearrangement, is applicable to both hematopoietic sites. However, despite these similarities, 
two different B cell subpopulations apparently arise from these two distinct anatomical 
locations as concluded from cell transfer experiments. These experiments led to the 
hypothesis of two distinct progenitors. Additional support for this idea came from further 
differences in lymphopoiesis described for fetal and adult life (Douagi et al., 2002; Kincade et 
al., 2002; Hardy, 2003). Hence, particular molecules are known to be differentially expressed 
in B cell precursors from either hematopoietic sites, like the myosin light chain (Oltz et al., 
1992), TdT (Li et al., 1993) and MHC class II molecules (Lam and Stall, 1994; Hayakawa et 
al., 1994). 
To obtain more complete information about differentially expressed molecules, gene 
expression analysis using microarrays should be employed. Thus providing further evidence 
4. Results  84 
for distinct progenitors and to identify potential marker genes. The comparison of gene 
expression was performed on pro- or pre-B-I cells from the liver of 17 days old fetuses or 
from bone marrow of 7 weeks old BALB/c mice (adult bone marrow). These cells were 
isolated on the basis of their expression of CD19 and c-kit (Fig. 4-3). 
 
Fig. 4-3: Isolation of B 
cell precursors. The pro- 
or pre-B-I cells were 
FACS purified on the basis 
of their expression of 
CD19 and c-kit from fetal 
liver day 17 or bone 
marrow of 7 weeks old 
BALB/c mice. After the 
sort the isolated cells were 
reanalyzed to determine 
the purity of the sorted 
population. 
 
This developmental stage was chosen for analysis because it represents the first cell stage that 
is committed to the B lineage. At this stage the Ig loci should be still completely in germline 
configuration or at the heavy chain locus DJH segments might be rearranged. Components of 
the recombination machinery like the Rag proteins are detectable in these cells (Grawunder et 
al., 1995a), indicative for the ongoing rearrangement process in such cells. 
Total RNA was extracted from 105 sorted cells from both anatomical sites and used for 
mRNA amplification by two subsequent rounds of cDNA synthesis and in vitro transcription. 
The samples were then hybridized to high-density oligonucleotide arrays interrogating 
approximately 12.000 transcripts (Affymetrix). Three independent replicate experiments were 
performed and the probability of differential expression was calculated with unpaired t-test 
statistics. 
Between B cell precursors from fetal liver or adult bone marrow, a total of 88 genes – 70 
known genes and 18 expressed sequence tags (ESTs) - were identified as differentially 
expressed by a factor of 2 or more with a confidence level of at least 99% (Fig. 4-4). 
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Fig. 4-4: Hierarchical cluster analysis 
of 88 differentially expressed genes 
and ESTs as detected by unpaired 
t-test statistics with 99% confidence. 
Genes or ESTs were considered 
differentially expressed if they changed 
at least twofold with a difference in 
mean average difference value of at 
least 100. Normalized genes are 
organized in rows. Green denotes an 
expression level above, red an 
expression level below the mean. The 
columns represent the replicate 
experiments from fetal liver (FL) or 
bone marrow (BM), respectively. 
 
 
 
 
By lowering the confidence level, the number of differentially expressed genes can be 
increased to 133 genes (at 95% confidence). However, this also enhances the possibility of 
false positive or false negative values. Thus, only the values that were found within the limits 
of 99% confidence were taken for first analysis (Fig. 4-5). 
In fetal liver derived precursor cells, 26 genes were up-regulated compared to bone marrow 
derived cells. Expression of 14 genes was altered at least 2-fold, 5 were at least 3-fold and 7 at 
least 5-fold regulated. Eight of these regulated genes were absent or close to background 
expression levels in the bone marrow population, six of these eight genes belonged to the 
group of at least 5-fold regulated genes. Five ESTs were up-regulated in the fetal liver. For 
two of them sequence homology with known proteins could be found in the database. 
In the bone marrow derived precursor cells, 62 genes were up-regulated compared to fetal 
liver derived cells. Expression of 19 genes was altered at least 2-fold, 13 were at least 3-fold, 
13 at least 5-fold and 17 at least 10-fold regulated. 
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Affy_id Gene Symbol Description FL SD BM SD Fold Change
93028_at H19 H19 fetal liver mRNA 760 32 42 21 18.2 
103674_f_at Eif2s3y eukaryotic translation initiation factor 2, subunit 3 198 32 17 11 9.9 
102627_at Igf2bp1 insulin-like growth factor 2, binding protein 1 245 20 25 15 9.7 
160074_at Ddc dopa decarboxylase 386 40 44 23 8.7 
95183_i_at --- EST 166 7 14 8 8.3 
98149_s_at 1110033J19Rik (similar ribosomal protein) 581 25 70 14 8.3 
95758_at Scd2 stearoyl-Coenzyme A desaturase 2 910 64 135 23 6.7 
161050_at --- EST 515 38 117 49 4.4 
162077_f_at Scd2 stearoyl-Coenzyme A desaturase 2 1187 19 275 72 4.3 
96791_at 1500005K14Rik (similar hypothetical protein) 573 12 178 35 3.2 
104592_i_at Mef2c myocyte enhancer factor 2C 164 12 55 8 3.0 
99327_at Prss19 protease, serine, 19 (neuropsin) 172 5 57 16 3.0 
97497_at Notch1 Notch gene homolog 1, (Drosophila) 521 51 181 25 2.9 
93021_at Rex3 reduced expression 3 454 17 171 23 2.7 
92646_at Mrpl23 mitochondrial ribosomal protein L23 1178 115 478 86 2.5 
101561_at Mt2 metallothionein 2 304 39 126 24 2.4 
92737_at Irf4 interferon regulatory factor 4 1103 37 461 74 2.4 
97450_s_at Aldh7a1 aldehyde dehydrogenase family 7, member A1 264 16 110 11 2.4 
92796_at Akp2 alkaline phosphatase 2, liver 278 19 117 22 2.4 
101494_at Afp alpha fetoprotein 218 17 94 10 2.3 
161889_f_at Aldo1 aldolase 1, A isoform 416 44 180 22 2.3 
104716_at Rbp1 retinol binding protein 1, cellular 274 24 122 31 2.3 
97374_at 2810025M15Rik EST 780 45 351 23 2.2 
160568_at Eno1 enolase 1, alpha non-neuron 1601 125 730 89 2.2 
98440_at Ltb4dh leukotriene B4 12-hydroxydehydrogenase 3962 375 1835 161 2.2 
96066_s_at Pkm2 pyruvate kinase, muscle 569 31 280 22 2.0 
100554_at Pdlim1 PDZ and LIM domain 1 (elfin) 103 12 211 22 -2.0 
103202_at Gbp3 guanylate nucleotide binding protein 3 148 28 303 20 -2.1 
101681_f_at --- (similar MHC class I) 213 19 439 16 -2.1 
103562_f_at --- (mouse endogenous retrovirus truncated gag protein) 109 13 228 18 -2.1 
96657_at Sat spermidine/spermine N1-acetyl transferase 170 40 374 44 -2.2 
100828_at Myla myosin light chain, alkali, cardiac atria 106 12 238 12 -2.2 
93063_at App amyloid beta (A4) precursor protein 154 30 348 30 -2.3 
103501_at Pura purine rich element binding protein A 238 22 544 40 -2.3 
160101_at Hmox1 heme oxygenase (decycling) 1 256 33 595 67 -2.3 
98284_f_at H2-T18 histocompatibility 2, T region locus 18 225 63 537 67 -2.4 
97398_at 9130022B02Rik (similar phosphoenolpyruvate carboxykinase) 192 15 464 32 -2.4 
98092_at Plac8 placenta-specific 8 315 58 759 44 -2.4 
94831_at Ctsb cathepsin B 185 39 447 59 -2.4 
96971_f_at --- (similar Ig kappa light chain) 67 19 169 8 -2.5 
93865_s_at H2-T10 histocompatibility 2, T region locus 10 210 11 543 23 -2.6 
104680_at Ramp1 receptor (calcitonin) activity modifying protein 1 206 28 535 13 -2.6 
102797_at Rsdr1-pending retinal short-chain dehydrogenase/reductase 1 84 13 220 15 -2.6 
103517_at --- EST 63 11 168 12 -2.7 
100611_at Lyzs lysozyme 62 8 181 20 -2.9 
99379_f_at H2-K histocompatibility 2, K region 185 45 583 14 -3.2 
97700_at --- (similar MHC class I) 121 23 407 44 -3.4 
97349_at 2610019M19Rik (similar FERM-domain-containing protein) 71 4 241 16 -3.4 
98000_at Ly64 lymphocyte antigen 64 64 34 241 23 -3.8 
101487_f_at Ly6e lymphocyte antigen 6 complex, locus E 1062 44 4040 390 -3.8 
99446_at Ms4a1 membrane-spanning 4-domains, subfamily A 67 28 263 19 -3.9 
102824_g_at --- (Ig gamma-2b chain C region, membrane-bound) 65 13 261 32 -4.0 
99071_at Mpeg1 macrophage expressed gene 1 68 6 271 31 -4.0 
103035_at Tap1 transporter 1, ATP-binding cassette, sub-family B 137 24 551 63 -4.0 
101876_s_at H2-T17 histocompatibility 2, T region locus 17 145 24 625 44 -4.3 
102064_at Casp1 caspase 1 34 13 163 11 -4.7 
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103240_f_at Ear2 eosinophil-associated ribonuclease 2 66 19 314 25 -4.8 
98543_at Ctss cathepsin S 258 24 1234 42 -4.8 
100944_at --- EST 28 10 145 10 -5.2 
93088_at B2m beta-2 microglobulin 1070 128 5600 291 -5.2 
102161_f_at --- (similar MHC class I) 180 16 976 92 -5.4 
101468_at Pfc properdin factor, complement 22 16 124 8 -5.5 
93320_at Cpt1a carnitine palmitoyltransferase 1, liver 179 18 1142 63 -6.4 
99378_f_at H2-Q1 histocompatibility 2, Q region locus 1 82 15 570 71 -7.0 
101195_at Mylc2pl myosin light chain 2, precursor lymphocyte-specific 26 16 199 3 -7.7 
93092_at H2-DMa histocompatibility 2, class II, locus DMa 25 3 192 23 -7.7 
93120_f_at H2-K histocompatibility 2, K region 643 41 5010 217 -7.8 
100607_at Pld3 phospholipase D3 14 2 168 14 -8.4 
160965_at Rasa4 RAS p21 protein activator 4 30 16 260 41 -8.8 
101753_s_at Lzp-s P lysozyme structural 6 1 187 10 -9.3 
97540_f_at H2-D1 histocompatibility 2, D region locus 1 624 118 6005 756 -9.6 
98438_f_at H2-Q7 histocompatibility 2, Q region locus 7 188 6 1980 225 -10.5 
92223_at C1qg complement component 1, q subcomponent, gamma 16 4 216 5 -10.8 
102904_at H2-Ea histocompatibility 2, class II antigen E alpha 14 8 220 25 -11.0 
98562_at C1qa complement component 1, q subcomponent, alpha 41 14 468 27 -11.3 
93714_f_at H2-K histocompatibility 2, K region 301 86 3779 136 -12.6 
97541_f_at H2-D1 histocompatibility 2, D region locus 1 179 17 2465 156 -13.8 
96020_at C1qb complement component 1, q subcomponent, beta 34 24 480 49 -14.2 
92558_at Vcam1 vascular cell adhesion molecule 1 77 21 1123 85 -14.7 
101886_f_at H2-D1 histocompatibility 2, D region locus 1 171 1 2552 85 -14.9 
102823_at --- (Ig gamma-2b chain C region, membrane-bound) 10 9 330 42 -16.5 
92316_f_at 2010309G21Rik (Ig lambda light chain) 26 4 424 35 -16.5 
92866_at H2-Aa histocompatibility 2, class II antigen A, alpha 9 2 356 28 -17.8 
95356_at Apoe apolipoprotein E 78 34 1458 197 -18.8 
102156_f_at --- (Ig kappa light chain) 249 33 4743 543 -19.0 
103962_at Dntt deoxynucleotidyltransferase, terminal 10 6 526 17 -26.3 
161409_f_at Dntt deoxynucleotidyltransferase, terminal 68 33 8093 460 -118.7 
103961_s_at Dntt deoxynucleotidyltransferase, terminal 9 4 6761 596 -338.0 
 
Fig. 4-5: Differentially expressed genes between B cell precursors. The unique Affymetrix probe 
set identifier (Affy_id), the gene symbol with description and the mean average difference value with 
the standard deviation (SD) of the three replicate experiments from fetal liver (FL) and adult bone 
marrow (BM) cells are shown. Only genes with a t-test confidence level of at least 99% are displayed. 
ESTs are marked by dashes or the RIKEN cDNA clone number. For complete unknown sequences 
EST is written in the description. In the case of known protein similarities the possible protein is 
displayed in brackets. For the calculation of the fold change mean average difference values below 20 
were set to 20. 
 
26 of these regulated genes were absent or near background expression levels in the fetal liver 
population. 17 of these 26 genes belonged to the group of at least 5-fold or 10-fold regulated 
genes indicating strong differences. 13 ESTs were up-regulated in the bone marrow. For 11 of 
them sequence homology with known proteins could be found in the database. 
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Some of the genes up-regulated in the fetal liver derived B cell precursors encoded 
transcription factors and molecules involved in protein biosynthesis (Mef2c, Irf4, Eif2s3y, 
1110033J19Rik and Mrpl23). Of particular interest could be Irf4, a PU.1 interaction partner. 
Other genes were associated with general metabolism or proteolysis/peptidolysis (Scd2, 
Aldh7a1, Akp2, Aldo1, Rbp1, Eno1, Pkm2 and Prss19). A gene of the group that was 5-fold 
or even more regulated, was the dopa decarboxylase (Ddc) with a 8.7-fold higher expression 
level. The corresponding protein exhibits aromatic-L-amino-acid decarboxylase activity and 
is involved in the catecholamine biosynthesis. The significance of this however is still 
unclear. 
The gene with the highest up-regulation (18.2-fold) was the H19 fetal liver mRNA. 
Expression of H19 can be seen in a wide range of embryonic tissues and is down-regulated 
shortly after birth, except in skeletal muscle. H19 together with the gene for insulin-like 
growth factor 2 (Igf2) are often held up as a paradigm of genomic imprinting. The H19 and 
Igf2 genes are thought to be regulated coordinately, both in terms of their common expression 
pattern and reciprocal imprinting, with H19 being expressed from the maternally inherited 
allele, whereas Igf2 is paternally transcribed (summarized in Arney, 2003). 
The Igf2 gene encodes a major fetal growth factor (Constancia et al., 2002). The function of 
the H19 mRNA is still unclear. This mRNA contains multiple translation termination signals 
in all three reading frames. Cellular fractionation has shown that the H19 RNA is found 
cytoplasmic but not associated with the translational machinery. Thus, it was suggested that 
the H19 RNA is not a classical mRNA, but may be an RNA molecule that displays a direct 
function (Brannan et al., 1990). Interestingly also an Igf2 mRNA binding protein (Igf2bp1) 
was found to be up-regulated in the fetal liver derived precursors. This is consistent with a 
functional expression of this group of genes. 
One further gene with a relatively low up-regulation (2.9-fold) but of particular interest can be 
found differentially expressed in these precursors, the notch gene homologue 1 (Notch1). 
Signaling through the Notch cell surface receptor is a highly conserved mechanism of cell fate 
specification widely used during embryonic development in both vertebrates and 
invertebrates. When Notch interacts with one of its ligands on the surface of an adjacent cell, 
the receptor is proteolytically processed, and nuclear translocation of the receptor’s 
intracellular domain results in transcriptional regulation of lineage-specific genes 
(Weinmaster, 2000; Egan et al., 1998; Artavanis-Tsakonas et al., 1999). Hematopoiesis is 
also regulated by Notch signaling (Milner and Bigas, 1999). Notch ligands have been 
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identified in both human (Li et al., 1998) and murine (Jones et al., 1998; Varnum-Finney et 
al., 1998) bone marrow stroma in addition to murine fetal liver (Walker et al., 2001). Notch 
receptors have been found in many blood cell types, including developing T cells (Hasserjian 
et al., 1996; Ellisen et al., 1991) and B cells (Ohishi et al., 2000; Bertrand et al., 2000). 
The list of differentially up-regulated genes in bone marrow derived precursors confirmed 
previous findings. Thus, the myosin light chain (Mylc2pl), TdT (Dntt) and transcripts of the 
MHC class II cluster (H2-DMa, H2-Ea and H2-Aa) were detectable in these cells whereas 
they were absent in the fetal liver derived ones. Interestingly, many MHC class I genes were 
found differentially expressed (H2-T18, H2-T10, H2-K, H2-T17, H2-Q1, H2-D1 and H2-Q7), 
i.e. low expression levels were found in fetal liver. Class I gene products are heterodimers 
consisting of a heavy chain that is associated non-covalently with the β2-microglobulin light 
chain. This β2-microglobulin light chain was also found to be differentially expressed (B2m). 
In addition, consistent with the above data, cathepsin S (Ctss) that is involved in maturation of 
MHC class II molecules (Hsieh et al., 2002) and the transporter 1 (Tap1) that is involved in 
MHC class I presentation (Garbi et al., 2003; Chefalo et al., 2003) were up-regulated in bone 
marrow derived precursors. 
Similar to the fetal liver, some of the genes up-regulated in the bone marrow were 
transcription factors and molecules involved in nucleotide metabolism (Pdlim1, Sat and Pura). 
Also an RNase of the RNase family A was found differentially expressed (Ear2). Other genes, 
associated with general metabolism or proteolysis/peptidolysis (9130022B02Rik, Rsdr1-
pending, Cpt1a, Pld3, Ctsb, Casp1) and two molecules involved in cell signaling (Ramp1, 
Rasa4) were up-regulated compared to the FL derived precursors. Surprisingly, also κ and λ 
light chains and an Ig gamma-2b chain were found differentially expressed (102156_f_at, 
2010309G21Rik, 102824_g_at). 
C1q is the first subcomponent of the C1 complex of the classical pathway of complement 
activation. All three chains of C1q (C1qg, C1qa, C1qb) were found to be up-regulated in the 
bone marrow derived precursors. But the function of this molecule at this developmental stage 
is not clear, since complement components are supposed to be synthesized by macrophages 
and hepatocytes (Morgan, 2000). 
The gene for amyloid beta (A4) precursor protein (App) was also found to be up-regulated in 
the bone marrow derived precursors. The fold change was only 2.3 times, but this protein 
could nevertheless be interesting. Notch1, that was found to be up-regulated in the fetal liver, 
and App are processed by the same γ-secretase. In in vitro experiments, competition for the 
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enzyme activity between both molecules was demonstrated (Lleo et al., 2003). In addition, 
activation of the Notch signaling pathway induced down-regulation of Presenilin 1 (PS1), 
which is a critical component of the γ-secretase complex. This suggests that the Notch1 
pathway exerts some control on PS1 gene regulation that may ultimately affect App 
processing (Lleo et al., 2003). 
A gene with a high up-regulation (18.8-fold) was Apoe. Apolipoprotein E (ApoE) is a 
glycosylated protein with multiple biological properties. It was originally described in the 
context of cholesterol metabolism, but effects of ApoE on innate and acquired immune 
responses have been demonstrated. Thus, ApoE has the ability to suppress lymphocyte 
proliferation in vitro (Avila et al., 1982). In addition, ApoE can stimulate cultured neutrophils 
(Terkeltaub et al., 1991). More recent data showed that ApoE deficient mice exhibit impaired 
immune responses after bacterial challenge with Listeria monocytogenes (Roselaar and 
Daugherty, 1998), and increased susceptibility to endotoxemia induced by lipopolysaccharide 
(LPS; de Bont et al., 1999). 
Another interesting differentially expressed molecule was Vcam1 (CD106). This gene 
product was almost completely absent in fetal liver derived precursors and 14.7-fold up-
regulated in the bone marrow derived cells. Vcam1 mediates adhesion of leukocytes but is 
also supposed to be a costimulatory molecule for T cells (Burkly et al., 1991). Its expression 
has been described for bone marrow stromal cells (Miyake et al., 1991), follicular dendritic 
cells (Brasel et al., 1996), stimulated endothelial cells (Rice and Bevilacqua, 1989), but also 
for splenic B1a cells (Kretschmer et al., 2003b). 
Three additional cell surface molecules were found to be up-regulated in bone marrow 
derived precursors (Ly64, Ly6E and Ms4a1). For Ly64 a possible regulatory role in the 
cellular response to IL-3 was suggested (Dougherty et al., 1989). A presumable involvement 
in adhesion to endothelial cells was also hypothesized (Tang et al., 2002). Ly6E is also known 
as stem cell antigen 2 (Sca-2) or as thymic shared antigen 1 (TSA-1) and belongs to the Ly-6 
family, a group of small cysteine-rich cell surface proteins (Classon and Coverdale, 1994). 
Ms4a1 is better known as the cell surface antigen CD20. CD20 is expressed only on B lineage 
cells but is absent from plasma cells (Tedder and Engel, 1994). It is a member of the 
CD20/FcεRIβ superfamily of leukocyte surface antigens which also includes the β subunit of 
the high-affinity receptor for IgE (FcεRIβ) and HTm4. It has been demonstrated that CD20 
can exist in a complex with MHC class I and II, and the molecules CD53, CD81 and CD82 
(Szollosi et al., 1996). No extracellular ligand for CD20 has been identified so far. Indirect 
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evidence suggests that CD20 functions as a B cell Ca2+ channel subunit (Bubien et al., 1993). 
An ion channel function would be consistent with reports that CD20 regulates cell cycle 
progression (Kanzaki et al., 1995) and exists on the cell surface as a homo-oligomer (Bubien 
et al., 1993). 
Taken together, comparison of gene expression patterns between fetal liver and bone marrow 
derived B cell precursors revealed significant differences between both populations. However, 
from these results it is not yet possible to conclude whether these populations are derived 
from different precursors or not. This would require detailed functional analysis of the 
differentially expressed genes. Therefore it was important to generate a mouse model in 
which this question could be answered more definitely in a holistic approach. 
 
4.3. Generation of mice with inducible Rag1 expression 
The origin of B1a cells, which are suggested to act as a “first line of defense” against mucosal 
and systemic pathogens, is still controversially discussed. It is unclear, whether these cells are 
only generated during fetal and perinatal life, or whether the adult bone marrow could also 
give rise to such B cells. This question should definitely be answered with a gene-targeted 
mouse that has initially a block in the development, especially during fetal development. This 
block should be abrogated later in the adult life to allow B cell ontogeny. 
Due to the extraordinary developments in modern molecular biology it is possible to turn 
genes on and off at discretion. In the mouse, this has been accomplished by using binary 
systems in which gene expression is dependent on the interaction of two components that 
results in either transcriptional transactivation or DNA recombination. The number of these 
binary systems has steadily increased, and the initially established systems, such as the 
Cre/loxP recombination and the TetR (tetracycline repressor) based transactivator system, 
have been optimized. 
 
4.3.1. The search of an appropriate target gene 
First was the question of the appropriate target gene to generate such a mouse. It has been 
demonstrated that gene defects preventing BCR expression, like defects in V(D)J 
recombination, lead to an arrest in B cell development. But some of these knock-outs were 
leaky and led to the accumulation of small numbers of B cells, for instance in mice with the 
scid mutation (Bosma and Carroll, 1991). Other gene defects concerned genes involved in 
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BCR signaling, like the knock-out of mb-1. This gene encodes Igα, that is required for the 
transport of the BCR onto the cell surface. Together with Igβ, Igα forms a heterodimer that 
mediates signal transduction from the BCR (Kim et al., 1993). Since signal strength via the 
BCR seems to have an influence on the generation of different B cell subpopulations, 
targeting of a molecule involved in signaling should be avoided. Nevertheless, the mb-1 gene 
was already used for the generation of knock-in mice using loxP sites in opposite orientation 
(Pelanda et al., 2002). In these mice the generation of different B cell subpopulations was not 
studied so far. 
A more appropriate target seemed to be one of the recombination activating genes – Rag1 and 
Rag2. Mice in which one of these genes had been inactivated by homologous recombination 
(Mombaerts et al., 1992; Shinkai et al., 1992) were not able to rearrange their antigen-
receptor genes leading to a complete lack of all B and T lymphocytes. This complete block in 
B cell development was the reason to target one of these genes for the generation of a mouse 
with inducible B cell or lymphocyte development, respectively. The remaining question was 
whether Rag1 or Rag2 should be the target. It has been demonstrated, that in addition to the 
transcriptional control of both Rag genes, the Rag2 protein levels are regulated during cell 
cycle (Lin and Desiderio, 1994). This posttranslational control is apparently mediated by 
modulation of Rag2 protein stability resulting from cell cycle-dependent phosphorylation (Lin 
and Desiderio, 1993). Furthermore, the expression of Rag2 seems to have an influence on the 
half-life of Rag1 protein (Grawunder et al., 1996). Since Rag1 seems to be less regulated than 
Rag2, and Rag2 expression obviously influences Rag1 protein levels and not vice versa, Rag1 
appeared to be the appropriate target gene. Of course targeting of Rag1 will also influence the 
T cell development. However, this was taken as a welcome side effect. Thus, both cellular 
mediators in adaptive immunity were made inducible at the same time. 
 
4.3.2. The search for the appropriate inducible system 
After the decision to target Rag1, there was still the question of the experimental system. Site-
specific DNA recombination or a TetR based transactivator system were the two alternatives 
for the project. Two members of the integrase family of site-specific recombinases, Cre from 
bacteriophage P1 (Sauer and Henderson, 1989) and Flp from Saccharomyces cerevisiae 
(O'Gorman et al., 1991), are presently used to conditionally control gene expression by site-
specific DNA recombination. Cre and Flp recombinases catalyze a conservative 
recombination event between two 34-bp recognition sites (loxP and FRT, respectively) that 
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differ in primary sequence but share secondary structure. Because these recombinases do not 
require accessory proteins or high-energy cofactors for their activity, they are suitable for use 
in the foreign milieu of a mouse cell. To this end, Flp has been modified to alter its 
temperature optimum for improved activity at 37°C – the body temperature of mice 
(Buchholz et al., 1998). 
Dependent on the location of the recognition sites and their orientation, the DNA 
recombination can delete or invert DNA fragments in cis or insert or translocate DNA 
fragments in trans. Thus, when both recognition sites are located on the same chromosome 
(cis) as direct repeats, recombinase expression leads to the deletion of the intervening DNA. If 
the recognition sites have an opposite orientation, recombinase expression inverts the 
intervening DNA (summarized in Zheng et al., 2001). The inversion of the DNA is a 
reversible process and the continuous presence of recombinase in the nucleus results in 
repeated inversions (flipping) of the loxP or FRT flanked (so called floxed or flrted, 
respectively) DNA sequence. Ceasing of the nuclear recombinase activity stops further 
recombination and stabilizes the floxed or flrted DNA into one of the two possible 
orientations with equal probability. 
Tetracycline-dependent regulatory systems were developed by Gossen and Bujard (Gossen 
and Bujard, 1992). In these systems, the effector molecule is encoded by a fusion of a gene 
segment that encodes a VP16 transactivation domain and the tetracycline repressor (TetR) 
gene from E. coli. The fusion protein specifically binds both tetracycline and the 19 bp 
operator sequences (tetO) of the tet operon in the target transgene which results in 
controllable transcription. There are two versions of this system. In the original system, the 
tetracycline-controlled transcativator (tTA) can not bind DNA when the inducer is present 
(‘tet-off’), whereas in a modified version, the ‘reverse tetA’ (rtTA) binds DNA only when the 
inducer is present (‘tet-on’; Gossen et al., 1995). The current inducer is doxycycline (Dox) 
because of its low cost, commercial availability, and because it efficiently activates rtTA and 
inactivates tTA at doses that are well below cytotoxic levels (Baron and Bujard, 2000; Gossen 
et al., 1995). A disadvantage of this system for the current project was, that TetR based 
transactivators permit expression only at a transgenic level. Thus, the target genes are not 
regulated, as they would be under physiological conditions. 
However, physiological regulation appears to be especially important for the expression of the 
Rag proteins. For instance, a negative effect of transgenic Rag expression has been shown in 
two previous studies. In the first study, Rag1 and Rag2 were constitutively expressed under 
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the control of an early thymocyte-specific promoter leading to defects in mature T cell 
differentiation antigen expression and in T cell receptor-mediated activation, as well as 
lymphocyte homing defects (Wayne et al., 1994a; Wayne et al., 1994b). In the second study, 
ubiquitous expression of both Rag genes lead to a block in early B and T lymphopoiesis, in 
addition, to growth retardation and early death of the mice (Barreto et al., 2001). Because of 
these indications of the importance that correct regulation of Rag expression is necessary, it 
was decided to realize the project by site-specific DNA recombination thereby retaining the 
full transcriptional control of the target gene. 
The correctness of this decision was confirmed in a very recent report (Shockett et al., 2004). 
In this study it was tried to obtain mice with inducible Rag expression using a tetracycline-
based auto-regulatory system for inducible gene expression (Shockett et al., 1995). Only 
partial reconstitution of lymphocyte populations was found in these mice. This study focused 
on T cell development, thus B1a cells of the peritoneum were excluded from investigation. 
However, in the transgenic mice only a low level of B cell reconstitution was observed in the 
spleen, although normal levels of serum immunoglobulin were found in these mice. This 
measurement of serum Ig levels indicated that some B cells could accumulate in the absence 
of induction. Thus, the system was not completely closed. 
Therefore, this confirmed that the best choice to realize a mouse with inducible Rag1 
expression was obviously the use of site-specific DNA recombination. The two systems that 
are currently in use to conditionally control gene expression are the Cre/loxP and the Flp/FRT 
system. The Cre/loxP recombination system is the most frequently used, as it was the first 
well-developed system. Initial attempts to develop the Flp/FRT system in transgenic mice 
resulted in either no recombination (Ludwig et al., 1996) or mosaic recombination (Dymecki, 
1996). This was due to the decreased enzyme stability at 37°C of both wild-type Flp and an 
Flp variant (Flp-F70L; Buchholz et al., 1996b). The generation of the thermostable variant 
Flp-e solved this problem (Buchholz et al., 1998). Thus, Flp-e transgenic mice mediate 
recombination efficiencies resembling those of Cre (Rodriguez et al., 2000) and can be used 
now as alternative. In contrast to the Flp/FRT system, many effector and target transgenic 
mouse lines exist already for the Cre/loxP system, to which newly generated mouse lines can 
be crossed. Thus the Flp/FRT system should be used in the generation of mice in this project 
only as supplementary system for the removal of the positive selection marker, whereas the 
gene activation was attempted by using the Cre/loxP system. 
4. Results  95 
Two ways exist for the Cre-mediated gene activation. In the first, a STOP cassette, flanked by 
loxP sites in the same orientation, is introduced between the promoter and the gene of interest. 
Such a STOP cassette can consist of polyadenylation sequences, false translation initiation 
codons and splice donor sequences, thus preventing transcription and translation of the target 
gene. A SV40 tumor antigen was shown to be rendered completely quiescent by using such a 
STOP cassette (Lakso et al., 1992). The STOP cassette can be removed by Cre-mediated 
DNA recombination leading to normal transcription of the target gene. This method is often 
used for inducible transgene expression. 
The other possibility, and the possibility used in this work, is the flanking of a target gene by 
loxP sites in opposite orientation. If the target gene is first in an inverted orientation, Cre 
expression will lead to reversion and thus restoration of the normal transcription unit. The 
continuous presence of recombinase in nuclei results in the repetitive inversion (flipping) of 
the floxed DNA sequence. Removal of nuclear recombinase, stops further recombination, 
stabilizing the floxed DNA into one of the two possible orientations with equal probability. 
Thus only 50% of the cells will show gene activation. 
Since it could not be guaranteed that the insertion of a STOP cassette completely silences a 
given gene, the inversion of Rag1, floxed in opposite orientation, was chosen as the 
appropriate system. It seemed tolerable under these circumstances that only 50% of the 
lymphocyte precursors might end up with an active Rag1 gene. Since lymphocyte ontogeny 
involves extensive proliferation, this defect should be compensated. 
 
4.3.3. Strategy for the deletion of the neomycin resistance cassette 
A positive selection marker, e.g. a neomycin resistance cassette, is routinely used to select for 
recombinant ES cell clones and is necessarily part of the initial floxed allele. However, the 
placement of the neomycin resistance gene in introns can interfere with gene expression at the 
floxed allele. This loss of target gene function was observed if the resistance gene was in the 
same orientation relative to the transcription of the floxed gene (Meyers et al., 1998; Nagy et 
al., 1998; Postic et al., 1999; Cao et al., 2001). In addition, loss of target gene function was 
also found for opposite transcriptional orientation (Wang et al., 1999; Hayhurst et al., 2001; 
Xu et al., 2001). In some additional cases, it has been determined that cryptic splice sites in 
the neomycin resistance gene interfere with normal splicing and therefore reduce mRNA 
levels of the target gene (Meyers et al., 1998; Nagy et al., 1998; Xu et al., 2001). Interference 
of target gene expression was also observed if the neomycin resistance gene has been placed 
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in 5’- or 3’-flanking or untranslated regions (Lowe et al., 2001; Matsuda et al., 2001; Rucker, 
III et al., 2000). 
A common solution to this problem, that for instance was used in the initial tissue-specific 
knock-out experiments, is to use three loxP sites, positioned such that the neomycin resistance 
cassette, as well as the essential region of the gene of interest, is floxed (Gu et al., 1994). A 
partial Cre-mediated recombination event could then remove the cassette and leave the 
essential region floxed. This partial deletion is most often achieved in vitro in ES cells by 
transiently introducing a Cre-expression cassette. 
The generation of a thermostable variant of the Flp recombinase – Flp-e – provided an 
alternative to this – sometimes inefficient – partial Cre-mediated recombination. A positive 
selection marker cassette, flanked by FRT sites, can now be removed by Flp-mediated 
recombination. This recombination has no influence on the floxed target gene and can be 
carried out both in vitro and in vivo. 
 
4.3.4. Targeting strategy 
The Rag1 gene is located on mouse chromosome 2 and consists of two exons, whereby the 
whole coding sequence resides in the second exon. The construction of the targeting vector 
was carried out by using a 9.6 kb genomic BamHI fragment containing the exon 2 of Rag1 
(Fig. 4-6). The complete vector had a short arm of homology of 1.1 kb and 3.5 kb as the long 
arm of homology. For the initial silencing of the Rag1 gene, a region, including the CDS, 3.7 
kb in size, was inverted to prevent Rag1 expression. To achieve inducible Rag1 expression, 
this region was flanked by loxP sites in opposite orientation. Thus, inactivation can be 
reversed by Cre expression. The first loxP site was located in the intron between exon 1 and 
2, whereas the second site was localized in the 3’-untranslated region (Fig. 4-6). 
Homologous recombination is a rare event in mammalian cells, and therefore a neomycin 
resistance cassette was inserted into the construct to provide the possibility to enrich 
transfectants. This cassette was flanked by FRT sites as direct repeats to render the selection 
marker removable (Fig. 4-6). However, G418 resistance per se only indicates that the cells 
have taken up and integrated the neomycin resistance gene. To be able to select for cells in 
which homologous recombination has occurred, the construct contained also a negative 
selection marker, in this case a DTA cassette (Fig. 4-6). 
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Fig. 4-6: Targeting strategy for the generation of mice with inducible Rag1 expression. A 
restriction map of the wild-type Rag1 locus is shown in (a). Indicated are only restriction sites 
important for the targeting. Probes used to verify targeting events are marked lilac and are shown with 
the expected size of the restriction fragment after SpeI digestion. The targeting vector is displayed 
linearized in (b). The BamHI fragment of the Rag1 locus is shown with the vector backbone (gray 
box). The DTA cassettes are marked red. The complete coding sequence of Rag1 is now inverted and 
flanked by loxP sites in opposite orientation (indicated by arrowheads). The FRT flanked neomycin 
resistance cassette was inserted into a unique NheI site. Two new SpeI sites were introduced through 
the cloning. The structure of the targeted Rag1 locus is displayed in (c). The localization of the NEO 
probe is shown in addition to sizes of diagnostic restriction fragments after SpeI digestion. 
 
This cassette encodes the subunit A of Diphtheria toxin, which ADP-ribosylates elongation 
factor 2 and thus prevents protein synthesis in all cells that express DTA. Target cells that 
incorporate DNA randomly usually retain the entire transgenic construct including the DTA 
cassette and are therefore eliminated. On the other hand homologous recombinants integrate 
only the sequence between the regions of homology and thus lose the DTA cassette allowing 
their survival. This results in enrichment of homologous recombinants. For the screening of 
DTADTA
(a) Wildtype locus
SpeI BamHI SpeIBamHI
Rag1-Exon 2
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HYB-1 HYB-5B
14.1 kb
(c) After homologous recombination
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(b) Targeting vector
BamHI BamHICDS SpeISpeI
NeoR
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homologous recombinants, a strategy based on Southern blot analysis was developed. This 
strategy included the introduction of two SpeI sites into the targeting vector. Digestion with 
SpeI and hybridization with the external 5’ and 3’ probes HYB-1 and HYB-5B results in the 
14.1 kb wild-type band (Fig. 4-6a). ‘External’ indicates here that the probes hybridize outside 
the region of homology found in the targeting vector. Clones which have integrated the 
construct by homologous recombination should show, in addition, to the wild-type band a 
5.2 kb or a 3.9 kb band, respectively (Fig. 4-6c). It is advisable to choose a restriction 
fragment size that is smaller than that of the wild-type allele to verify the targeting event, 
since this excludes false positive results from incompletely digested DNA. 
Fig. 4-7: Site-specific DNA recombination. The structure of the targeted Rag1 locus is displayed in 
(a). The probe used for Southern blot analysis is marked lilac and is shown together with the expected 
size of the restriction fragment after SpeI digestion. The targeted locus after inversion of the CDS (b), 
the locus after removal of the neomycin resistance cassette (c) and the previously NeoR deleted locus 
after inversion of the CDS (d) are shown, including sizes of diagnostic restriction fragments after SpeI 
digestion. 
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During establishment of a homologous recombinant it is essential to rule out the possibility 
that an additional construct has integrated as transgene. Hybridization using a probe specific 
for the neomycin resistance cassette (NEO; Fig. 4-6c) also needs to be carried out. 
In addition to the original homologous recombination, other recombination events, like the 
inversion of the floxed region or the deletion of the neomycin resistance cassette, can be 
monitored by Southern blot analysis (Fig. 4-7). To this end, an internal probe can be used. 
Digestion with SpeI and hybridization with HYB-3 should result in a 2.9 kb band after 
inversion of the CDS, in addition to the unaltered 6.6 kb fragment. The two bands are found 
due to the equal probability of both orientations after repeated inversions (Fig. 4-7b). 
The final deletion of the neomycin resistance cassette can be detected by appearance of a 
specific 5.2 kb band when hybridized with HYB-3 (Fig. 4-7c). Similarly, the inversion of the 
CDS in the locus after the removal of the neomycin resistance cassette can be verified using 
the same probe by the appearance of a 1.6 kb band (Fig. 4-7d). 
 
4.3.5. Modification of the neomycin resistance cassette 
The neomycin resistance cassette was a kind gift of Dr. Werner Müller (Experimental 
Immunology, GBF Braunschweig). An XhoI/SalI fragment containing the neomycin 
resistance gene flanked by FRT sites was cloned into the vector pBluescript II SK+. To verify 
the nature of the promoter and to ensure the functionality of the neomycin resistance gene, the 
whole fragment was sequenced. This revealed that the neomycin resistance gene was under 
the control of the herpes simplex virus (HSV) thymidine kinase (TK) promoter and contained 
also the TK polyA signal. The flanking of the resistance cassette by two FRT sites in the same 
orientation was also confirmed this way (Fig. 2-2). With the obtained sequence information it 
was now possible to modify the neomycin resistance cassette for cloning into the targeting 
vector (Fig. 4-8). 
In a first modification step an NheI site was introduced between the KpnI and the XhoI site 
using an adapter, leading to NeoR cassette mod1. In a second step, resulting in NeoR cassette 
mod2, the region between SalI and NotI was removed and replaced by SpeI, XhoI and NheI 
sites. The SpeI site was important for the screening of recombinants described above. The 
other modifications made it possible to remove the neomycin resistance cassette either by 
NheI or XhoI from pBluescript II SK+ and to use it for further cloning. 
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Fig. 4-8: Modification of the neomycin resistance cassette. In (a) is a part of the vector 
pBlu2SK-neo shown containing the FRT flanked neomycin resistance cassette together with adjacent 
restriction sites of pBluescript II SK+ important for the modification. (b) and (c) show the resistance 
cassette after the first and the last modification step, respectively. Sites marked in blue are indicative 
for the next cutting step, while sites marked in pink are newly introduced sites, which are important 
for the cloning of the targeting vector. 
 
4.3.6. Cloning of the targeting vector 
For the final cloning of the targeting vector a fragment of genomic DNA was needed that 
contained the entire Rag1 locus. Therefore a database search with the Rag1 mRNA sequence 
(GenBank #M29475) against the NCBI HTG (high throughput genomic) sequences at the 
RZDP Deutsches Ressourcenzentrum für Genomforschung (http://www.rzpd.de) was 
performed. The HTG division contains 'unfinished' DNA sequences generated by the high-
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throughput sequencing centers and was established to provide these 'unfinished' genomic 
sequence data rapidly to the scientific community. The screening recovered a clone from a 
genomic BAC (bacterial artificial chromosome) library (clone RP23-111E15, GenBank 
#AC084753), that should contain the Rag1 locus. This was confirmed by an additional search 
within a nucleotide database using Fasta nucleotide (http://www.ebi.ac.uk/fasta33/nucleotide; 
Pearson and Lipman, 1988). Subsequently, the clone was obtained from RZPD. This BAC 
clone was already sequenced in parts. Thus it was possible to align all known elements to 
assemble a map of the complete Rag locus (Fig. 4-11a). With this map a restriction fragment 
for further cloning could be selected. As the best choice a 9.6 kb BamHI fragment became 
apparent. 
The knowledge of the sequence of the Rag locus made it also possible to search for potential 
probes for the Southern blot analysis described above. For this search, repetitive DNA regions 
were identified by the program CENSOR (http://www.girinst.org/Censor_Server-
Data_Entry_Forms.html; Jurka et al., 1996) and were excluded from the probe design. 
HYB-1, HYB-5B and HYB-3 were chosen this way to function as external 5’and 3’ and as 
internal probes, respectively (Fig. 4-6; Fig. 4-7). 
After receiving the BAC clone stock from the RZPD, the identity of the fragment was 
confirmed first. This was tested by PCR with Rag1 specific primers on isolated BAC DNA. 
Both primer pairs showed a product of the expected size, thus verifying that the right genomic 
fragment constituted the BAC clone (Fig. 4-9). 
 
 
 
 
 
 
 
 
Fig. 4-9: Confirmation of the BAC clone. Isolated DNA from the ordered BAC clone (BAC1) was 
tested by PCR in different dilutions with two primer pairs specific for Rag1. As negative control 
served another independent BAC clone (BAC2). As positive control DNA from a tail biopsy of 
C57BL/6 mice was taken. The expected bands were 434 bp and 725 bp in size, respectively. 
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pBlu2new
2885 bp
AmpR
f1 ori
ColE1 ori
lac-Promoter
BamHI (666)
Aat II (664)
Not I (673)
Sac I (684)
These primers were also useful for the first cloning step in the generation of the targeting 
vector. BACs contain large fragments of genomic DNA (40-300 kb) and it is sometimes 
difficult to subclone a specific restriction fragment. With the help of a colony PCR on the 
other hand, it was possible to identify clones which had integrated the correct fragment into 
their vector backbone amongst several other colonies. 
 
SacI-NotI-BamHI-AatII-KpnI 
 
5'  GAGCTC^GCGGCCGC^GGATCC^GACGTC^TGTACC  3' 
3'  CTCGAG^CGCCGGCG^CCTAGG^CTGCAG^ACATGG  5' 
 
 
 
 
 
 
 
 
 
Fig. 4-10: Generation of pBlu2new. The multiple cloning site of the vector pBluescript II SK + was 
replaced by the annealed oligonucleotides shown in (a). Black and pink nucleotides represent the 
sequence of the oligonucleotides, while blue nucleotides only serve to elucidate the restriction sites. 
Pink nucleotides do not belong to the recognition sequence of the enzyme, which leads to the 
destruction of the restriction site after integration of the annealed oligonucleotides. The newly 
generated vector with the reduced multiple cloning site is displayed in (b). The blue BamHI site is 
indicative for the next cutting step. 
 
The 9.6 kb BamHI fragment was first cloned into the vector pBluescript II SK + and the entire 
CDS region was sequenced. The sequencing revealed one difference to the mRNA sequence 
found in the database. This nucleotide variance should lead to a predicted amino acid 
exchange of histidine to leucine at amino acid position 609. Therefore, the same region was 
amplified out of genomic DNA from a C57BL/6 mouse and sequenced. An identical 
nucleotide difference was also found here. Thus, this difference is most likely a sequencing 
(a) 
(b) 
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RAG-Locus
35028 bp
Rag1-CDS
Rag2-CDS
Rag1-Promoter
Rag2-Promoter
Rag1-Exon 1
Rag1-Exon 2
Rag2-Exon 3
Rag2-Exon 2
Rag2-Exon 1BamHI (4202)
BamHI (6613)
BamHI (9807) BamHI (19454)
BamHI (23194)
BamHI (23312)
pBlu2new-Rag
12532 bp
Rag1-Exon 2
Rag1-CDS
f1 ori
ColE1 ori
AmpR
lac-Promoter
Cla I (6808)
Aat II (664)
Kpn I (3137)
Nhe I (1815)
Not I (10320)
BamHI (666)
BamHI (10313)
error in the mRNA sequence of the database or possibly a genetic polymorphism between 
different mouse strains. Since the sequence of the Rag1 gene recovered from the BAC clone 
was also found in the genome of C56BL/6 mice, this Rag1 gene was considered functional 
and the subcloned fragment was taken for further cloning. 
The 9.6 kb BamHI fragment was then integrated into a descendant of the Bluescript vector, 
pBlu2new (Fig. 4-10b). To generate this vector, the MCS of the original pBluescript II SK + 
was removed by a SacI/KpnI digestion and replaced by a new one, which was specifically 
designed for this particular targeting (Fig. 4-10a).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4-11: Subcloning of the genomic fragment. The wild-type Rag locus is shown in (a). Promoters, 
exons and coding sequences of Rag1 and Rag2 are indicated. Restriction sites of BamHI are displayed, 
those marked in blue bound the subcloned genomic fragment. The subcloning of the BamHI fragment 
into pBlu2new leads to pBlu2new-Rag (b). Only some restriction sites are shown. Those marked in 
blue are indicative for the next cutting step. 
(a) 
(b) 
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It was important to destroy or delete some restriction sites of the old MCS, because otherwise 
they would interfere with further cloning steps. For instance, a nucleotide replacement in the 
oligonucleotides led to a destruction of the KpnI site. BamHI was introduced again for the 
insertion of the genomic fragment of DNA. While AatII or NotI were first thought as 
alternative sites for linearization of the construct, NotI was later taken for cloning of the DTA 
cassette. The insertion of the BamHI fragment into pBlu2new resulted in pBlu2new-Rag (Fig 
4-11b). Clones that had integrated the Rag1 exon in the same transcriptional orientation as the 
lac-promoter grew very poorly and the DNA yield of plasmid preparations was very low, 
possibly due to transcriptional effects that resulted in a metabolic burden for the transfectants. 
Therefore, a clone was chosen for further cloning which had inserted the Rag1 gene in the 
opposite orientation. 
Before it was possible to continue with the next cloning step, the plasmid DNA was first 
transformed into the dam- E. coli strain INV110, because the ClaI site, that was supposed to 
be used in this step, was found to be methylated by the Dam methylase and ClaI is a 
methylation sensitive enzyme. After recovery of pBlu2new-Rag from dam- bacteria, it was 
possible to remove the CDS region by a ClaI/KpnI digestion and replace it by an adapter 
leading to pBlu2new-loxinv (Fig. 4-13b). 
 
 
 
 
 
 
 
 
Fig. 4-12: The loxP flanked region. The wild-type locus containing exon 2 of the Rag1 gene is 
shown in (a). The restriction sites KpnI and ClaI used for cloning are indicated. The targeted locus is 
shown in (b). The original restriction sites KpnI and ClaI are destroyed. At these sites the loxP sites 
were introduced in opposite orientation (indicated by arrowheads). Together with the new restriction 
sites an SpeI site was inserted. The CDS is now inverted preventing thus Rag1 expression. Note that 
the SacI sites are distributed asymmetrically in the CDS and could therefore used together with a site 
outside the CDS as restriction sites for Southern blot analysis. 
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pBlu2new-loxinv
8958 bp
residual Rag1-Exon 2
loxP
loxP
f1 ori
ColE1 ori
AmpR
lac-Promoter
Cla I (3180)
Aat II (664)
Kpn I (3191)
Nhe I (1815)
Not I (6746)
Spe I (3193)
BamHI (666)
BamHI (6739)
pBlu2new-Raginv
12624 bp
residual Rag1-Exon 2
Rag1-CDS
loxP
loxP
f1 ori
ColE1 ori
AmpR
lac-Promoter
Cla I (3180)
Aat II (664)
Kpn I (6857)
Nhe I (1815)
Not I (10412)
Spe I (6859)
BamHI (666)
BamHI (10405)
    KpnI-LoxP-NdeI-ClaI-2 bp-KpnI-SpeI-PxoL-ClaI 
 
5' GGTACT^ATAACTTCGTATAGCATACATTATACGAAGTTAT^CATATG^ATCGAT^AT 
3' CCATGA^TATTGAAGCATATCGTATGTAATATGCTTCAATA^GTATAC^TAGCTA^TA 
 
^GGTACC^ACTAGT^ATAACTTCGTATAATGTATGCTATACGAAGTTAT^ACCGAT 3' 
^CCATGG^TGATCA^TATTGAAGCATATTACATACGATATGCTTCAATA^TGGCTA 5' 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4-13: Cloning steps leading to the inversion of the CDS. The coding sequence of the vector 
pBlu2new-Rag was replaced by the annealed oligonucleotides shown in (a). The orientation of the 
loxP sites becomes visible from the underlined ATG. This cloning leads to pBlu2new-loxinv (b). After 
this step the CDS is reintroduced, now in inverted orientation due to the new ClaI and KpnI sites, 
leading to pBlu2new-Raginv (c). Blue sites are indicative for the next cutting step, while the newly 
introduced SpeI site, important for the Southern strategy, is marked in pink. 
(a)
(b) 
(c) 
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pBlu2new-Raginv-neo
14175 bp
residual Rag1-Exon 2
Rag1-CDS
loxP
loxP
f1 ori
ColE1 ori
AmpR
lac-Promoter
FRT
FRT
NeoR
TK-Promoter
TK-PolyA
ClaI (4731)
AatII (664)
KpnI (8408)
NotI (11963)
SalI (1835)
NheI (1815)
NheI (3366)
SpeI (1827)
SpeI (8410)
BamHI (666)
BamHI (2031)BamHI (11956)
pBlu2new-Raginv-neo/2DTA
17503 bp
residual Rag1-Exon 2
Rag1-CDS
loxP
loxP
FRT
FRT
DTA
PGK-Promoter
SV40-PolyA
DTA
PGK-Promoter
SV40-PolyA
f1 oriColE1 ori
AmpR
lac-Promoter
NeoR
TK-Promoter
TK-PolyA
AatII (664)
Not I (11963)
NotI (13627)
NotI (15291)
Spe I (1827)
Spe I (8410)
Spe I (13321)
Spe I (13614)
Spe I (14985)
Spe I (15278)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4-14: Final introduction of positive and negative selection markers. The neomycin resistance 
cassette was cloned into the NheI site of the vector pBlu2new-Raginv resulting in pBlu2new-Raginv-
neo (a). Two DTA cassettes were then cloned into the NotI site leading to the final targeting vector 
pBlu2new-Raginv-neo/2DTA (b). The AatII site for the linearization of the vector is marked in blue, 
while the newly introduced SpeI sites, important for the Southern strategy, are marked in pink. 
 
(a) 
(b) 
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This adapter was generated using annealed oligonucleotides (Fig. 4-13a). It was designed in a 
way that its integration destroys the ClaI and KpnI sites and adds new ClaI and KpnI sites 
sites further inside (Fig. 4-13a). In addition, it contained two loxP sites in opposite orientation 
which becomes obvious from the orientation of the ATGs in the spacer region (Fig. 4-13a). It 
was important to insert these ATGs in an orientation which does not lead to translation of the 
mRNA that will be produced from the modified gene. Furthermore, an SpeI site was 
introduced with the adapter into the targeting vector important for the later screening by 
Southern blot analysis (Fig. 4-13a). 
The Dam methylase methylated again the ClaI site, that should be used in the next cloning 
step, in the new segment. Therefore, pBlu2new-loxinv was transformed into the INV110 
strain to obtain unmethylated DNA for the next cloning step. 
For this step the ClaI/KpnI fragment, containing the Rag1 CDS excised before, was cloned 
into the vector pBlu2new-loxinv resulting in pBlu2new-Raginv (Fig. 4-13c). The order of the 
sites in the adapter resulted in an inverted orientation of the CDS in the targeting vector and 
this inverted CDS was now flanked by loxP sites in opposite orientation (Fig. 4-12). 
The neomycin resistance cassette was then excised from pBlu2SK-neo with NheI and inserted 
into the NheI site of the pBlu2new-Raginv resulting in pBlu2new-Raginv-neo (Fig. 4-14a). A 
clone was chosen which had the transcriptional orientation of the neomycin resistance cassette 
opposing the normal Rag1 transcription. At this step, the whole sequence of the neomycin 
resistance cassette and the CDS together with the flanking loxP sites was controlled by 
sequencing. 
Initially it was not planed to use a negative selection marker, because some groups called the 
profit of this step in question. However, this decision was later revised and shortly before the 
transfection of the ES cells the DTA cassette of pGEM-DTA (Fig. 2-3) was cloned into the 
NotI site of the targeting vector, originally planed for linearization. A clone was inadvertently 
chosen for DNA preparation which had integrated two DTA cassettes in the same orientation 
(Fig. 4-14b). For time pressure, it was not possible to expand another clone. In addition, there 
was no argument against the use of a second DTA cassette. Thus, this vector was taken as 
targeting vector for the ES cell transfection. The high frequency of homologous recombinants, 
obtained in the transfections, might actually argue in favor of the use of two DTA cassettes. 
 
4. Results  108 
6583 bp
4911 bp
4052 bp
1371 bp
7768 bp
2909 bp
8585 bp
Co
ns
tru
ct
Clo
ne
 3
Clo
ne
1
Cl
on
e 2
4.3.7. Functional test of the loxP sites in E. coli 
Since the procedures required to establish a mouse strain from recombinant ES cells are rather 
time consuming, the functionality of some components of the construct were tested in 
alternative systems. The recombination competence of the loxP sites in the targeting construct 
was tested in a Cre expressing E. coli strain. Hereby, the vector pBlu2new-Raginv-neo/2DTA 
was transformed into the strain 294-Cre (Buchholz et al., 1996a), which had the Cre gene 
integrated into its genome. The expression of the recombinase was under the control of a 
temperature-sensitive repressor, leading to a functional enzyme when incubated at 37°C. 
The plasmid DNA from particular clones, after the transformation, was isolated and digested 
with SpeI (Fig. 4-15). The targeting vector, designated as construct in Fig. 4-15 and used as 
control, showed the expected fragments for the non-recombined vector. The next two lanes 
display two independent clones, which showed two additional bands of 2909 and 8585 bp, 
indicative for a recombination. The bands of 4911 and 6583 bp were still present, since the 
recombination of loxP sites in opposite orientation is a continuous process, whereby the 
intervening segment is flipping with respect to the rest of the molecule in the presence of a 
functional Cre recombinase. The restriction pattern of clone 3 could be explained by a 
deletion of the intervening segment instead of an inversion. It is known that high expression 
levels of Cre, as found in 294-Cre at 37°C, might alter the directionality in Cre-loxP site-
specific recombination and result in deletions instead of inversions (Aranda et al., 2001). 
 
 
 
 
 
 
 
Fig. 4-15: Site-specific DNA recombination in E. coli. The targeting vector was transformed into the 
E. coli strain 294-Cre. Plasmid-DNA was isolated from three clones (Clone 1, 2 and 3) and digested 
with SpeI. The targeting vector was digested as control (Construct). The sizes of the bands are 
indicated besides the photo. All digestions showed an expected band of 293 bp, not represented on this 
photo. 
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4.3.8. Homologous recombination in ES cells 
The planned background for the Rag1 knock-in mouse was initially BALB/c, because a 
mouse model, the L2 mouse (Engel et al., 1998), intensively studied in the group with respect 
to B1 cell development and function, was also on the BALB/c background. However, since 
the genomic DNA used for the targeting vector was derived from C57BL/6 mice, and since it 
was not clear whether potential polymorphisms between the different mouse strains could 
influence the chance of recombination, the targeting was performed both, in BALB/c and in 
C57BL/6 derived ES cell lines. Another argument for the use of C57BL/6 derived ES cells 
was that most of the Cre transgenic mouse strains, that should be used later for experiments 
with the newly established mouse strain, are mainly established on the C57BL/6 background. 
Thus a homogenous genetic background could be maintained when crossing such mouse 
strains. 
After transfection of BALB/c (BALB/c background) and Bruce-4 (C57BL/6 background) ES 
cells and subsequent selection with G418, 60 clones for BALB/c and 24 clones for Bruce-4 
were picked and frozen at the 96 well plate stage. Southern blot analysis using the 5’ probe 
HYB-1 (data not shown) revealed 4 and 2 homologous recombinants, respectively (Table 
4-3). Southern blot analysis after expansion of the clones, using the 3’ probe HYB-5B 
indicated that some of the homologous recombinants were only partial recombinants. They 
had only integrated the neomycin resistance cassette but not the second SpeI site at the second 
loxP site. Only a band of 10.5 kb was seen, in addition to the 14.1 kb wild-type band, for the 
C57BL/6 clone 6-2 (Fig. 4-16). Similar results were obtained from the three BALB/c derived 
partial recombinants (data not shown). However, the C57BL/6 clone 22-2 and the BALB/c 
clone 23 exhibited the expected 3.9 kb band for a complete integration of the floxed inverted 
CDS (Fig. 4-16 and Fig. 4-17). Therefore these two clones were homologous recombinants. 
 
Table 4-3: Efficiency of homologous recombination. 
ES cell line Genetic background 
No. of picked 
clones 
Homologous 
recombinants 
Complete 
homologous 
recombinants 
BALC/c BALB/c 60 4 1 
Bruce-4 C57BL/6 24 2 1 
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Fig. 4-16: Southern blot analysis of C57BL/6 ES cell clones. Genomic DNA from wild-type Bruce-
4 cells (C57BL/6) and clones 6-2 and 22-2 were digested with SpeI and hybridized with probe HYB-
5B to verify the targeting event and NEO to exclude additional transgene integration, respectively. 
 
 
 
 
 
 
 
 
Fig. 4-17: Southern blot analysis of BALB/c ES cell clones. Genomic DNA from wild-type BALB/c 
cells (BALB/c) and clones 22 and 23 were digested with SpeI and hybridized with probe HYB-5B to 
verify the targeting event and NEO to exclude additional transgene integration, respectively. 
 
The frequencies of these recombinants were 1 out of 24 and 1 out of 60, respectively. Such 
high frequency was not expected from the initial targeting experiments of the Rag1 locus 
(Mombaerts et al., 1992), and might be due to the presence of the second DTA cassette. 
To exclude the possibility that the clones had integrated an additional copy of the construct as 
transgene, additional hybridization with a probe specific for the neomycin resistance cassette 
(NEO) was performed. Both clones showed only a single band of the expected 6.6 kb when 
hybridized with the neo probe (Fig. 4-16 and Fig. 4-17). Thus both could be used for 
establishing the new mouse model. 
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4.3.9. Functional test of the loxP sites in vitro 
The recombination competence of the loxP sites in the context of a mammalian cell was 
tested in an in vitro assay using the C57BL/6 derived clone 22-2. In this assay a His-TAT-
NLS-Cre protein (Peitz et al., 2002) was used to transduce the cells directly. This Cre protein 
was histidine-tagged and fused to a nuclear localization signal (NLS) in addition to a peptide 
derived from the HIV TAT protein. This combination results in enhanced cellular uptake, 
transport to the nucleus and subsequent site-specific recombination. Different fusion protein 
concentrations were tested to find out an optimal amount without toxic effects that might 
emerge with high Cre concentrations for the cells. One of these concentrations gave rise to 
recombination events in vitro. The expected band of 2.9 kb was present at a Cre concentration 
of 0.25 µM indicating functionality of the loxP sites also in the mammalian system (Fig. 
4-18). 
 
Fig. 4-18: Site-specific DNA 
recombination after Cre-transduction 
in vitro. The C57BL/6 ES cell clone 22-2 
was transduced with different 
concentrations of Cre protein or media as 
control in vitro. After expansion of the 
transduced cells, genomic DNA was 
isolated, digested with SpeI and 
hybridized with probe NEO to verify the 
recombination event. 
 
4.3.10. Deletion of the neomycin resistance cassette in ES cells 
The neomycin resistance cassette could later interfere with gene function, either directly or 
due to its constitutive promoter; therefore it needed to be removed. This could be carried out 
still in the ES cells in vitro or later in the mice in vivo. For the in vitro deletion in ES cells a 
second transfection is necessary, but each transfection minimizes the chance to obtain 
germline transmission. Since a Flp-e transgenic mouse already exists (Rodriguez et al., 2000), 
which is backcrossed on the C57BL/6 background for several generations, it was decided that 
the cassette should be removed in vivo for the C57BL/6 derived clone 22-2. Since such a 
transgenic mouse does not exist with BALB/c background, the neomycin resistance cassette 
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from the BALB/c derived ES cell clone was removed in vitro. Although not necessary in 
vitro, this removal was also performed for the C57BL/6 derived ES cell clone 22-2. 
Both clones were transfected with a Flp-e expression plasmid (kind gift of Thomas 
Wunderlich, University of Cologne). This plasmid expresses the mutated form of the Flp 
recombinase that is active at 37°C. After transfection and growth for a few days, clones were 
picked and tested as triplicates for G418 sensitivity. G418 sensitive clones were expanded and 
tested by Southern blot analysis. Both C57BL/6 and BALB/c derived ES cells gave rise to 
three clones which had deleted the neomycin resistance cassette (Table 4-4). They all showed 
the expected 5.2 kb recombinant band in addition to the 14.1 kb wild-type band (Fig. 4-19). 
The BALB/c derived clone 1-F7 showed also the non-deleted 6.6 kb band indicative for a 
contaminated clone. This was also apparent in the test for G418 sensitivity, since resistant 
cells survived the selection. 
 
Table 4-4: Efficiency of in vitro deletion of the neomycin resistance cassette. 
ES cell clone Genetic background No. of picked clones G418 sensitive clones
23 BALB/c 192 3 
22-2 C57BL/6 384 3 
 
 
 
 
 
 
 
 
 
Fig. 4-19: In vitro deletion of the neomycin resistance cassette. The C57BL/6 ES cell clone 22-2 
and the BALB/c ES cell clone 23 were transfected with a Flp-e expression plasmid. Genomic DNA 
from G418 sensitive clones were digested with SpeI and hybridized with probe HYB-3 to verify the 
deletion of the neomycin resistance cassette. 
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4.3.11. Chimeric mice and their offspring 
The clone 22-2 (C57BL/6 background) and the clones 2-D2 and 2-B8 (BALB/c background, 
neomycin resistance cassette deleted) were chosen for injection into blastocysts. These 
blastocysts or donor embryos were derived for clone 22-2 from CB20 mice while those for 
2-D2 and 2-B8 were derived from C57BL/6 mice. This combination allows to distinguish 
later between donor derived and ES cell derived offspring based on the coat-color (see 
below). Injected ES cells could be pluripotent and would give rise to all tissues like skin, 
muscles and organs. If they have retained their omnipotency they could differentiate into 
germ cells, in addition, and the new allele would be hereditary. Because ES cell lines are 
usually derived from male mice, the injection of ES cells should mainly result in male 
offspring when they contribute to the germline. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4-20: Chimera derived from the C57BL/6 ES cell clone 22-2. Shown is a female chimera with 
50% chimerism (applied to the coat-color) together with its agouti offspring. 
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The blastocysts were transferred after injection into foster mice. Some of their offspring 
showed coat-color chimerism indicating successful transfer and differentiation of the ES cells 
(Table 4-5 and Fig. 4-20). 
 
Table 4-5: Overview of the different blastocyst injections. 
Chimeras No. Clone Background Blastocysts Pups 
M F 
Rangea 
1 22-2 C57BL/6 53 7 3 1 50-90% 
2 2-D2 BALB/c 76 18 4 2 25-70% 
3 2-B8 BALB/c 26 2 - - - 
4 22-2 C57BL/6 44 22 10 5 10-80% 
a Range of chimerism applied to the coat-color. 
 
These chimeric mice were then bred to wild-type mice i.e. C57BL/6 for 22-2 and BALB/c for 
2-D2. Dependent on the coat-color of the offspring it was possible to decide if germline 
transmission was obtained from the chimera or not. Thus, the combination for the clone 22-2 
with C57BL/6 mice will give rise to black animals, when the offspring is derived from the ES 
cells, while offspring between C57BL/6 and the CB20 donor will result in brown-gray 
animals due to the dominant agouti gene in the donor mice. Analogue for the clone 2-D2, the 
agouti gene of the BALB/c mice in combination with the donor derived C57BL/6 germ cells 
should lead to an agouti offspring, while white offspring will be derived from the ES cell 
derived sperm cells. 
Only a small fraction of the chimeras gave rise to a black or white offspring, respectively. 
Nevertheless, this indicated that germline transmission was obtained for both ES cell clones 
(Table 4-6). 
 
Table 4-6: Overview of the chimeras that showed coat-color germline transmission. 
Germline transmission No. Clone 
(Background) 
Chimerism Litters Pups 
Coat-color Targeted allele 
1 22-2 (C57BL/6) 80% 1 4 4 3 
2 22-2 (C57BL/6) 90% 6 53 2 - 
3 2-D2 (BALB/c) 50% 3 5(7)a 5 1 
a Two pups died short after birth. 
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Fig. 4-21: Southern blot analysis of the offspring that showed coat-color germline transmission. 
Genomic DNA from the offspring of both strains were digested with SpeI and SacI, respectively, and 
hybridized with probe HYB-5B for the detection of the targeted allele. 
 
To find out whether the targeted chromosome was transmitted to the ES cell derived 
offspring, Southern blot analysis was employed. Due to the heterozygocity of the targeted ES 
cells, only half of the offspring is expected to carry the particular allele. DNA from tail 
biopsies was digested with SpeI and SacI respectively and hybridized with the 3’ probe 
HYB-5B. For both clones, mice were found, that carried the targeted allele. These mice 
showed the expected 3.9 kb SpeI restriction fragment and the 6.3 kb SacI restriction fragment 
in addition to the wild-type band (Fig. 4-21). 
These mice were taken for breeding to establish two new mouse strains. The newly 
established mouse strains were named Indu-Rag1 from inducible Rag1 combined with the 
ending (B6) or (C) indicative for the genetic background (B6 for C57BL/6 and C for 
BALB/c). The heterozygous Indu-Rag1 mice were fertile and were able to transmit the 
targeted allele. Crossing with additional recombinant mice, with inducible Cre expression, 
this newly generated system will now allow definitive experiments to study differentiation, 
antibody repertoire establishment and selection processes during B cell development in the 
adult bone marrow. 
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5. Discussion 
In this work different aspects of B cell ontogeny were investigated. First, differential 
expression of germline transcripts from both light chain loci was measured as diagnostic 
marker for the regulation of accessibility of the particular loci for rearrangement. Second, 
gene expression patterns of B cell precursors from either fetal liver or adult bone marrow 
were compared using microarrays, thus significantly extending previous data. Third, a new 
mouse model with inducible lymphopoiesis was established, that should provide further 
insights into the different ontogeny between fetal liver and bone marrow derived B cell 
precursors. 
 
5.1. Germline transcripts of immunoglobulin light chain variable 
regions are structurally diverse and differentially expressed 
By using 3’-RACE technology it was possible to isolate germline transcripts of 17 Vκ gene 
segments that could be assigned to 12 of the 18 Vκ families. Transcripts from V regions that 
were oriented in either transcriptional direction could be recovered during these experiments 
(Table 4-1). Additionally, germline transcripts of all three Vλ gene segments were isolated 
this way. 
Only germline transcripts of functional or potentially functional Vκ gene segments were 
obtained. None of the isolated transcripts could be assigned to a pseudo-gene. This is 
probably partially due to the way the primers were designed, since the primers in most cases 
covered sequences of functional or potentially functional gene segments. In addition, the 
sample size of the germline transcripts obtained so far is still very small. Thus, together with 
the primer selection this might explain why no amplification products of pseudo-gene 
transcripts were obtained. On the other hand, it can not be ruled out that transcripts of pseudo-
genes are absent or present at extremely low levels, since many of these gene segments 
display alterations in their promoter regions (Thiebe et al., 1999; Schable et al., 1999). In 
addition, the half-life of some of these RNAs could be extremely short which might also be 
the case for some of the functional Vκ segment transcripts. Finally, some V gene segments 
might lack polyadenylation sites. Such transcripts would escape detection because cDNA 
synthesis was started from the polyA tail. Since the 3’ regions of only some of the Vκ gene 
segments are published, this possibility can not yet be excluded. Together, this might explain 
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why, for members of certain Vκ families, no amplification products were obtained despite of 
extensive trials. As germline transcripts of Ig genes are believed to have no function, the 
transcripts we observed might just be the result of the opening of particular gene segments. 
Hence, instability and low abundance of germline transcripts would have no physiological 
consequences. 
The extreme heterogeneity in size of germline V transcripts is striking. The lengths of the 
3’-UTRs were found to be between 41 and 670 nucleotides. In addition, a few transcripts were 
polyadenylated at two or even three alternative sites. 3’-UTRs within families, where a 
comparison was possible, were either extremely homologous in sequence and size (Vκ01) or 
very different in both aspects (Vκ08 and Vκ19/38). The observed extreme heterogeneity only 
adds to the notion, that germline transcripts might have no function, and the lack of selective 
constraints would allow for variability of these 3’-UTRs. On the other hand, conserved 
3’-UTRs were found in some families (Vκ01 and Vλ1/2). Such sequence conservation might 
be explained by gene conversion which is known to act on multi-gene families. This 
recombination mechanism introduces extensive changes at sites of variability but also 
conserves sequences at other sites. 
One might also expect to find similar size and sequence heterogeneity for the intron between 
the first and the second exon of a V gene segment, as such sequences might also be devoid of 
a function. However this seems not to be the case (Kirschbaum et al., 1998; Kirschbaum et 
al., 1999; Roschenthaler et al., 1999; Roschenthaler et al., 2000; Schable et al., 1999; Thiebe 
et al., 1999). Although size and sequence heterogeneity can be found when different families 
are compared, comparison within the same family showed that length and sequence remained 
highly conserved, with only a few exceptions. Since the intron is also part of the primary 
transcript of a functional immunoglobulin light chain after rearrangement, obviously selective 
constrains act on this part of the transcription unit other than the 3’-UTR of germline 
transcripts. In addition, so far unknown functions might be encoded in this stretch of DNA. 
The previous finding that JCκ is activated and rearranged before the λ locus was confirmed 
and extended (Engel et al., 1999). Already at the earliest developmental stage of R2-bfl 
differentiation which could be analyzed, germline transcripts of JCκ and Vκ21 were 
detectable. Although, the member of the most distal Vκ family Vκ02 lagged behind in its 
activation, it already is detectable at the same time as Vλ transcripts. Since rearrangements at 
the κ locus do not prevent further rearrangements at the same allele unless the most 
downstream Jκ5 is involved, a non-random sequential activation of Vκ gene segments from 
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proximal Vκ to distal Vκ regions might increase the probability that a functional heavy/light 
chain combination can be expressed by a B cell. This is consistent with previous findings of 
multiple rearrangements of the same allele at the κ locus (Yamagami et al., 1999). 
Besides this slight asynchronicity within the Vκ cluster and a similar asynchronicity between 
the Vλ and the JCλ segments, the previous finding of a sequential activation of the κ and the λ 
JC cluster was now extended to the complete loci of both light chains. The slight difference in 
expression might be explained by the different promoters and additional regulatory elements 
driving the Vλ and JCλ segments. How a differential activation within the Vκ cluster can be 
regulated remains to be determined. Some of the motifs of the Vκ promoters are highly 
conserved, while others are diverse and could influence the kinetics of activation (Bemark et 
al., 1998). In addition, recently a transcriptional coactivator has been described to influence 
Vκ transcription and usage (Casellas et al., 2002). However, additional regulatory elements 
have been determined within the λ cluster (Engel et al., 2001) and so far uncharacterized 
DNase sensitive sites exist within the λ locus, which might indicate the existence of further 
regulatory elements (Hagman et al., 1990). Similarly, unknown regulatory sites might also 
exist within the Vκ cluster. 
To interpret the findings of consecutive activation of the two light chain loci and to explain 
the phenotype of mice in which the κ locus had been inactivated (Chen et al., 1993a; Zou et 
al., 1993), a “hit and run” hypothesis for light chain rearrangement in the mouse was 
proposed (Engel et al., 1999). This hypothesis would also explain the κ/λ ratio found in this 
species (Hood et al., 1967). Developing B cells at the stage of light chain rearrangement (pre-
B-II; large and small) would have a limited life span. During this time they first activate their 
κ locus for rearrangement. Independent of the events at the κ locus, the λ locus will be 
activated at a consecutive developmental stage. Rearrangement of λ will take place unless the 
pre-B cell was already rescued to the immature B cell stage by a functional B cell receptor, 
resulting from a functional and appropriate κ rearrangement. This would also result in a 
down-regulation of the rearranging mechanism. Due to the limited life span of such pre-B 
cells, unsuccessful κ rearrangement can only partially be compensated by rearrangement at 
the λ locus, thus partially explaining the κ/λ ratio of the mouse. This predicts that extension 
of the life span of a pre-B cell would alter the κ/λ ratio. Mice transgenic for the anti-apoptotic 
gene bcl-2 indeed have an altered κ/λ ratio with a predicted increase in the frequency of λ 
bearing cells (Lang et al., 1997). Variation in the life span of pre-B-II cells could thus explain 
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the various κ/λ ratios found in species other than the mouse. The synchronous activation of 
the V and JC segments of a particular locus described here, represent an essential prerequisite 
of this hypothesis. 
 
5.2. Comparison of gene expression patterns between B cell 
precursors derived from fetal liver and adult bone marrow 
In addition to the function of germline transcripts, many other aspects of B cell development, 
like the different ontogeny in fetal liver and adult bone marrow, are largely unknown. The 
present work describes gene expression patterns of early B cell precursors (CD19+c-kit+) 
derived from fetal liver and adult bone marrow. Such precursors obviously give rise to distinct 
B cell populations (Herzenberg, 2000). With this study it was possible to obtain significant 
information about differentially expressed molecules in such precursors. 
Relatively few genes were found differentially expressed, but the validity of this gene 
expression data set was underscored by the finding that genes whose expression patterns have 
been identified earlier, were detected in a manner concordant with the previous results. Both 
TdT (Li et al., 1993) and the myosin light chain (Oltz et al., 1992) were found differentially 
expressed i.e. in bone marrow and not in fetal liver. In addition, MHC class II molecules were 
expressed solely in the bone marrow derived precursors (Lam and Stall, 1994; Hayakawa et 
al., 1994). It has been suggested, that such distinct programs of class II expression during fetal 
and adult lymphopoiesis could result in differences in susceptibility to tolerance (Hayakawa et 
al., 1994). 
The initial analysis was based on differentially expressed genes that differ by a factor of two 
or more. Although a regulation factor of two seems rather low, several examples have 
demonstrated a functional significance of mono- versus bi-allelic expression i.e. of a twofold 
difference in expression levels (Nutt et al., 1999b). 
Other genes, however, might require more significant changes in expression level to become 
functionally relevant. Therefore, not all of the identified genes may actually contribute to the 
fate of the B cell precursors. As an example, the importance of a particular expression level 
for B cell development was shown for the transcription factor PU.1. High levels of PU.1 
result in the differentiation of precursors into myeloid lineage cells, lower levels favor 
generation of B lineage cells (DeKoter and Singh, 2000). IL-7Rα was identified as critical B 
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cell target of PU.1. At the molecular level, low PU.1 concentrations activate the IL7-Rα gene 
in contrast to high PU.1 levels, which prevent IL7-Rα expression (DeKoter et al., 2002). 
One differentially expressed gene, found in the analysis of the array data, which appeared of 
particular significance, was Notch1, which showed higher expression levels in fetal liver 
compared to bone marrow derived precursors. Notch1 plays an important role in the T versus 
B lineage decision, where it is essential for the development of both thymus-dependent and 
-independent T cells (Radtke et al., 1999; Wilson et al., 2000). Bone marrow progenitors from 
Notch1-/- mice enter the thymus, but develop into B cells (Wilson et al., 2001). In contrast, the 
expression of a dominant active form of Notch1 in bone marrow precursors leads to ectopic T 
cell development in the bone marrow and simultaneously blocks B cell development (Pui et 
al., 1999). Taken together, these results suggest that Notch1 signaling must be either absent or 
negatively regulated in BM progenitor cells to allow B cell development, and that a Notch1 
signal is sufficient for T cell commitment. It has been demonstrated that the transcription 
factor Pax5 essential for B lineage commitment represses Notch1 expression at the 
transcriptional level in B cell progenitors, providing a possible mechanism to ensure B cell 
development in the BM (Souabni et al., 2002). Nevertheless, Notch receptors and ligands are 
expressed on BM progenitors and stroma as well as on FL progenitors and fetal liver. Thus, 
this differential expression could be of significance, especially since a molecule that might 
compete with Notch1, the amyloid beta (A4) precursor protein, is up-regulated in the BM. In 
addition, PU.1 has been identified as a specific direct target gene of Notch1, a transcription 
factor also involved in B cell development (Schroeder et al., 2003). 
Interestingly, an important role for another member of the Notch receptor family, Notch2, has 
been shown for the development of the MZ B cell subset. Conditional inactivation of Notch2 
in the hematopoietic compartment leads to a loss of the MZ B cells (Saito et al., 2003). 
Peritoneal B1 cells develop normally in these mice. This is in contrast to a recent report that a 
significant reduction in both MZ B cells and B1 cells was observed in Notch2 heterozygous 
mice (Witt et al., 2003). The reason for this discrepancy is currently unknown. 
Taken together, Notch1 appears to be a prime candidate for further detailed studies since it is 
a molecule that is involved in lineage decision and might thus also influence B1 versus B2 
decision. 
Surprisingly, in addition to the MHC class II molecules, also MHC class I molecules were 
found differentially expressed with low expression levels in the fetal liver derived precursors. 
It is known that tolerance against the fetus is a multi-factorial process. The trophoblast, which 
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is the outer layer of the placenta and the interface between fetal and maternal tissues, does not 
express classical MHC class I and class II molecules, thus making it resistant to recognition 
and attack of maternal T cells (Bulla et al., 2003). However, low MHC class I expression 
levels have not been described for fetal liver derived B cell precursors before. Although the 
significance of this finding is still unclear, it may have relevance for practical experiments. 
Tissues lacking MHC class I expression are attacked by NK cells (Karre, 2002). The 
trophoblast might be protected from such attack by the expression of a non-classical MHC 
class I molecule, while in reconstitution experiments with murine cells the fetal liver derived 
B cell precursors could be attacked by NK cells when transferred into recipients. This 
hypothesis can be tested experimentally. 
Unexpectedly, κ and λ light chains and an Ig gamma-2b chain were found expressed in the B 
cell precursors derived from the adult bone marrow. κ and λ lights chains are normally 
detectable at the pre-B-II stage, while Ig gamma-2b chains should only be detectable after 
antigen contact and class switch recombination. Detection of germline transcripts from the κ 
and the λ light chain loci was unlikely as explanation, because such transcripts become 
detectable in cells of developmental stages that were not included in this analysis and occur 
only at low abundance. This surprising finding might be explained by contaminating plasma 
cells in the sorted precursors. Plasma cells can be found in the bone marrow and they are 
absent in the fetal liver. Because of the high expression of genes encoding antibodies in such 
cells, already low numbers of contaminating cells could give rise to high mRNA levels. This 
possible contamination should not obscure the other data since only Ig mRNA is exceptional 
high in plasma cells. 
In summary, the combination of the previous knowledge about B cell development and the 
functional annotation of differentially expressed genes defined by the microarray experiments 
identified genes potentially involved in specific processes that take place in the particular 
murine B cell precursors. Nevertheless, it is still open, whether these differences are 
significant or not. Sometimes only one gene of a particular pathway or a signaling cascade 
was found differentially expressed. Thus, obviously further detailed investigation is 
necessary. However, these array date provide clues, which pathways are prime candidates. As 
a first confirmation quantitative measurements at the RNA and protein level are required. 
These analyses should also include the other molecules involved in the pathways indicated. 
Another obvious task will be to test the expression of the identified cell surface markers, thus 
possibly providing new markers for the isolation of such cells. Furthermore, functional 
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analysis should be performed. The availability of ApoE-/- and conditional VCAM-1-/- mice 
provide a first starting point. The conditional VCAM-1-/- mice could be crossed to CD19-Cre 
mice which results in deletion of VCAM-1 in B cells. Because of the differential expression 
of both ApoE and VCAM-1 a functional difference in the knock-out mice compared to the 
wild-type should become detectable. 
The comparison of gene expression patterns was initially performed to provide further 
evidence for or against distinct B cell progenitors. However, after the present analysis the 
question remains whether such pro- and pre-B-I cells are the precursors in which the different 
B cell traits are distinct. This cell type is the first to be committed and the microenvironment 
appears to induce the particular trait at this stage. However, the commitment might only 
partially be manifested in the differentially expressed genes at the pro-/pre-B-I stage and it 
might become more obvious at consecutive stages of B cell ontogeny. Consequently, the gene 
expression analysis should be extended to cells of these stages. 
One basic question can not be answered by this gene expression analysis, namely, whether the 
adult bone marrow is able to generate B1a cells under physiological conditions. To more 
definitely answer this question, a mouse model with inducible B cell development was 
established. 
 
5.3. Generation of mice with inducible Rag1 expression 
The use of transgenic and gene targeting technology has been a great advantage for studying 
gene function in mice. However, in many cases transgene expression or gene inactivation 
results in embryonic lethality, such that only the earliest phenotype can be explored (Lobe and 
Nagy, 1998; Marth, 1996; Rajewsky et al., 1996). A strategy to circumvent this limitation is 
the conditional control of gene expression (summarized in Lewandoski, 2001). Such control 
can be tissue-specific (spatial) and/or temporal. Thus, it is possible to silence or activate genes 
where and when desired as described above. 
In the present work, conditional gene expression of Rag1 was used to generate mice with 
inducible B cell development using ES cell technology. These newly generated mouse strains 
should, in addition to providing insights into antibody repertoire establishment and function 
of fetal liver derived B cells, definitively answer the question, whether the adult bone marrow 
also gives rise to B1a cells, and whether B1 and B2 cells are derived from different 
progenitors or not. 
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The frequency of homologous recombinants in ES cells in the present targeting experiments 
was astonishingly high. In situations in which the same genomic locus was targeted in 
multiple instances, generally a similar frequency of homologous recombination events has 
been observed. The targeting frequency from the generation of the Rag1 knock-out mice 
(Mombaerts et al., 1992) should therefore deliver a clue for the number of clones that had to 
be picked. In the study mentioned, the obtained frequencies were 1 out of 130 and 1 out of 
117 targeted clones without the use of a negative selection marker. 
After the transfection of the BALB/c and Bruce-4 ES cells only 60 clones for BALB/c and 24 
clones for Bruce-4 were obtained. The lower number of the Bruce-4 derived clones was 
presumably due to the lower amount of vector DNA taken for transfection. Four clones of the 
BALB/c ES cells and two clones of the Bruce-4 ES cells showed homologous recombination. 
Thus targeting frequencies of 1 out of 15 and 1 out of 12 were obtained. Compared to the 
construct of Mombaerts, in the present work the arms of homology of the targeting vector 
used were substantially shorter, but negative selection was included in the procedure. 
However, the use of negative selection should lead to an enrichment of targeted clones of a 
factor 2 (Werner Müller, personal communication). One might speculate, that this significant 
enrichment was due to the second DTA cassette in the targeting vector, since in another 
targeting approach with a similar vector containing only one DTA cassette, no homologous 
recombinants out of 96 clones were found with Bruce-4 ES cells and 2 partial recombinants 
out of 96 clones with BALB/c ES cells (data not shown). On the other hand, this decrease 
could also be explained by the constitution of the particular ES cell preparation for the second 
transfection. 
The targeting for the Indu-Rag1 mouse also led to partial homologous recombinants. This 
partial integration was likely caused by unfortunate features of the targeting vector, since the 
vector also contained regions of homology between the neomycin resistance cassette and the 
non-homologous part of the vector. 
Before injection of the targeted ES cell clones into blastocysts, the recombination competence 
of the loxP sites was tested in vitro. Only the Cre concentration 0.25 µM gave rise to a 
recombination event. This does not imply that the recombination needs a specific 
concentration. This method of direct treatment is very rigorous and lead to the death of many 
cells. At higher Cre concentration many cells died. Only the lower Cre concentration left the 
cells alive and mediated the DNA recombination. 
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To obtain inducible B cell development, the inverted coding sequence of the Rag1 gene was 
flanked by loxP sites in opposite orientation. Cre expression will lead to reversion and thus 
restoration of the normal transcription unit. However, continuous presence of recombinase in 
nuclei results in repeated inversions of the floxed DNA sequence. Constitutive presence of 
Cre or high expression levels might possibly cause genomic instability leading to deletions 
instead of inversions, as seen in Cre expressing E. coli (Aranda et al., 2001). 
To avoid such instability, Cre should only temporarily be expressed. To gain the temporal 
control over the recombination event, the Cre expression should be inducible. This induction 
can be obtained either at the transcriptional or posttranslational level. The Mx-Cre mice 
represent an example for induction at the transcriptional level (Kuhn et al., 1995). In these 
mice a Cre recombinase transgene is controlled by the inducible promoter of the mouse Mx1 
gene. Mx1 is part of the defense system against viral infections and is silent in healthy mice. 
The Mx1 promoter can be transiently activated to high amounts of transcription in many 
tissues upon application of interferon α (IFN-α), IFN-β or of the IFN inducer synthetic 
double-stranded RNA (polyinosinic-polycytidylic acid, pI-pC; Staeheli et al., 1986). 
Induction at the posttranslational level employs fusion proteins of Cre with mutated ligand-
binding domains of steroid receptors. In MerCreMer mice the Cre recombinase carries at both 
ends a mutated murine estrogen receptor (Mer) binding domain (Hobeika et al., unpublished). 
The expression of this MerCreMer recombinase is controlled by the mb-1 promoter that is 
specifically active in B cells. Therefore the MerCreMer mice represent, in contrast to the 
ubiquitous inducible Mx-Cre mice, an example for tissue-specific induction. Without 
induction, the MerCreMer fusion protein is in the cytoplasm in an inactive form. Induction 
with the estrogen analogue 4-hydroxytamoxifen (OHT) leads to the migration of the protein 
into the nucleus, where the DNA recombination event takes place. Both mice are available 
and will be used for further experiments. 
It is still unclear if the induction with these Cre transgenic mice will lead to continuous 
lymphopoiesis or only to a wave of lymphocyte development. If long term HSCs are targeted, 
this should lead to continuous lymphopoiesis. If later developmental stages are targeted, this 
will only lead to short term reconstitution and a wave of lymphocyte development will be the 
result. In the case of the MerCreMer mice the latter situation is expected, since mb-1 is an 
early B cell marker, indeed early but B cell specific. 
An ambiguity in the employment of the Mx-Cre mice is their potential expression of Cre 
recombinase without induction due to endogenous production of IFN in these mice 
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(‘leakiness’). Background recombination was observed in some tissues, when crossing Mx-
Cre mice to mice with floxed alleles (Kuhn et al., 1995). These mice were maintained in a 
conventional facility. Thus, mice need to be maintained under specific pathogen free (SPF) 
conditions to lower endogenous IFN production and hence reduce the background 
recombination to negligible levels. 
Recently, a new mouse strain has been described that expresses a fusion protein consisting of 
Cre recombinase and a mutated ligand-binding domain of the estrogen receptor. The coding 
region of the fusion protein was inserted into the ubiquitously expressed Rosa26 locus 
through homologous recombination to allow induction by 4-hydroxytamoxifen administration 
in all organs. No background activity based on Southern blot analysis was observed in non-
induced mice (Seibler et al., 2003). This mouse appears as an ideal partner for the Indu-Rag1 
mouse for the desired experiments. 
Another possibility for the induction of the Indu-Rag1 mice is still under investigation. 
Protein transduction is a method to introduce biologically active proteins directly into 
mammalian cells with high efficiency. Up to now, the direct introduction of Cre recombinase 
was carried out in vitro and resulted in the inversion of Rag1. 
One in vivo study reported transduction of Cre recombinase in mice, but recombination was 
not proven by Southern blot analysis (Jo et al., 2001). Nevertheless modified Cre proteins 
could make it possible to directly treat the mice in the future. The newly generated Indu-Rag1 
mice could hereby serve as an optimal test system. Already a low number of recombination 
events will lead to an accumulating number of B cells. These B cells will produce serum Ig, 
easy to measure by ELISA. The application of the Cre protein could be performed either 
intravenously or directly into the bone marrow. 
A potential problem could be that only half of the cells will express Rag1 after induction of 
Cre expression due to the nature of the recombination process. However, this should not lead 
to any problems in later experiments. Reconstitution of mice can be carried out with low 
numbers of HSCs. Such mice will still develop full immunological competence and normal 
lymphoid compartments. 
In the future, a potential solution for this flipping characteristic of inverted loxP sites might be 
the use of mutated sites that mediate unidirectional genetic inversion in mice (Oberdoerffer et 
al., 2003), thus obtaining a higher percentage of restored cells. One such loxP pair consists of 
two asymmetric, mutant loxP sites that carry a 5 bp mutation in the distal end of either the left 
(lox66) or the right (lox71) inverted repeat. Cre-mediated recombination of a lox66/lox71 pair 
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yields one loxP site with two mutated inverted repeats (lox72) and one wild-type loxP site. 
This pair showed a higher threshold for the initiation of Cre-mediated recombination than 
wild-type loxP sites and requires 2- to 3-fold higher Cre concentrations to recombine with an 
efficiency comparable to wild-type sites in vitro. Both in vitro and in vivo, no or decreased 
reverse recombination was observed with this system. 
Besides the disadvantage, that only in 50% of the cells the Rag1 gene can be activated, there 
is also the risk, that the second loxP site, placed in the 3’-UTR region could interfere with 
gene expression. The size of the genomic BamHI fragment, that ends shortly downstream the 
second exon of Rag1, and the limiting size of the targeting vector, prevented the possibility to 
flank the whole second exon with the loxP sites. In most targeting experiments, loxP sites 
were placed in introns, but sometimes have also been inserted in 5’- (Dragatsis et al., 2000; 
Sakai et al., 2001) or 3’-flanking regions (Guy et al., 2001; Brakebusch et al., 2000) without 
compromising gene expression. Thus this loxP site, most likely, should not disturb gene 
expression and function. 
Another potential problem could be that the Indu-Rag1 mice might not be completely blocked 
in B and T cell development despite the inversion of the Rag1 CDS. Although this possibility 
seems to be highly unlikely, the Indu-Rag1 mice should be compared with conventional 
Rag1-/- mice by flow cytometric analysis and measurement of serum Ig levels. After this 
confirmation it should be tested, if normal B cell development is influenced by the introduced 
loxP sites and the continuous inversion of the coding sequence during the presence of Cre in 
the nucleus. Therefore the Indu-Rag1(B6) mice should be crossed with mice that express the 
Cre recombinase constitutive under the control of the B cell specific CD19 promoter. This 
should allow B cell development in fetal liver as well as in the bone marrow. The emerging 
offspring should be compared – again by flow cytometry and measurement of serum Ig levels 
by ELSIA – with CD3 knock-out mice, that have also only B lymphocytes but no T 
lymphocytes. 
After the establishment of an appropriate system for induction – Cre transgenic mice or 
purified Cre protein – the induction of B and T cell development, respectively, should be 
carried out at various time points after birth. The resulting mature B cell subpopulations 
should be analyzed by flow cytometric analysis. These experiments should then definitely 
answer the question whether the adult bone marrow gives rise to peritoneal B1a cells or not. 
If B1a cells will be found in these mice, the antibody repertoire should be analyzed. In normal 
mice, B1a cells are especially generated in a phase, when TdT is not expressed. In addition, 
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the B1a compartments has been found to be enriched for certain B cell clones (Herzenberg et 
al., 2000; Kretschmer et al., 2002). This strong antigenic selection should work also in the 
presence of TdT in Indu-Rag1 mice. Thus, a similar bias might be observed. 
The role of B1a cells as part of a ‘first line of defense’ against mucosal and systemic 
pathogens might be investigated in case of their absence in the adult induced Indu-Rag1 mice. 
The susceptibility of these mice against different pathogens should be investigated in 
comparison to normal wild-type mice. This investigation could be performed also even if B1a 
cells are developing in the adult induced mouse. This would demonstrate whether the fetal 
liver has an essential role in B cell ontogeny. It would extend experiments where enforced 
expression of TdT during fetal life in a transgenic mouse eliminated the well-characterized 
T15 anti-phosphorylcholine B cell subset that is protective against pneumococcal infection. 
These animals were susceptible to such infection (Benedict and Kearney, 1999). Similar 
experiments could be performed with the Indu-Rag1 mice. 
By the inactivation of Rag1 both lymphocyte compartments – B as well as T cells – are 
deleted. T cells however might be required for the complete development of the particular B 
cell compartments and/or some of their functions. To avoid such problems mice could be 
reconstituted with T cells or stem cells from mice that lack B cell development e.g. Igα-/- 
mice. Thus B cell development under both conditions can be compared. 
For T cell development it was also suggested, that specific T cell subsets are only generated 
during fetal and neonatal development (Vγ5+ and Vγ6+ γ:δ T cells). This can now be 
confirmed in Indu-Rag1 mice. This new mouse model also enables to investigate potential 
functions of such subsets. 
Taken together, a new mouse model on two different genetic backgrounds was established, 
that could be used to investigate different aspects of B cell development. It should deliver new 
insights in the different ontogeny between fetal liver and bone marrow derived B cell 
precursors. In addition, it can be used to investigate similar aspects of T cell development. 
This model can be used in the future for further approaches, where inducible lymphocyte 
development is required. 
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6. Summary 
In the present work several aspects of B cell development were addressed. The first part 
focused on differential activation of variable regions of the light chain loci for the 
rearrangement process. Activation was monitored in a synchronously differentiating pro-B 
cell line by detection of germline transcripts. Several transcripts of Vκ families and all three 
transcripts of Vλ were cloned and characterized. Differential expression of Vκ germline 
transcripts from Vκ families proximal or distal to the JCκ cluster was observed. Nevertheless, 
both clusters opened roughly at the same time as the JCκ cluster. Similarly, Vλ and JCλ 
opened almost synchronously. However compared to the κ locus, activation was found at a 
later developmental stage. 
The second part concerned differences in B cell ontogeny between fetal liver and adult bone 
marrow. B cell precursors from either hematopoietic sites obviously give rise to distinct 
mature B cell subpopulations. Therefore, the gene expression patterns of early B cell 
precursors from fetal liver and adult bone marrow were compared using microarrays. This 
analysis confirmed previous findings and revealed further significant differences between 
both populations that can now be subjected to a more detailed analysis. 
So far it is not possible to conclude from these results, whether such precursors represent 
committed progenitors for the different mature B cell subpopulations. As such, a mouse 
model was established, in which the origin of mature B cell subpopulations could be analyzed 
more definitely. In this model, the B cell development was made inducible. Therefore, the 
coding sequence of the Rag1 gene was initially inverted for gene inactivation. Flanking of this 
region by loxP sites in opposite orientation renders it possible to revert this region by 
expression of Cre recombinase, thus restoring the transcription unit. This temporal control of 
Cre expression can be realized by the use of transgenic mice with inducible Cre expression 
thus allowing B cell development to be induced at discretion. Hence, the differentiation 
potential of bone marrow progenitors can be investigated after induction of B cell ontogeny in 
neonatal or adult mice. Since the Rag1 gene was used for the targeting in this new mouse 
model, T cell development was rendered inducible in addition. Therefore, this mouse strain 
could be used to answer similar questions in T cell ontogeny. 
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8. Abbreviations 
AID    activation-induced cytidine deaminase 
AmpR   ampicillin resistance gene 
aRNA   antisense RNA 
BAC    bacterial artificial chromosome 
BCR    B cell receptor 
BM    bone marrow 
bp     base pairs 
C     constant region gene segment 
CD    cluster of differentiation 
cDNA   complementary RNA 
CDR    complementarity-determining region 
CDS    coding sequence 
CIAP    calf intestine alkaline phosphatase 
CLP    common lymphoid progenitor 
CMP    common myeloid progenitor 
CSR    class switch recombination 
D     diversity gene segment 
DMSO   dimethylsulfoxid 
DNA    deoxyribonucleic acid 
DTA    diphtheria toxin A 
DTT    dithiothreitol 
E. coli   Escherichia coli 
EDTA   ethylenediaminetetraacetate 
EF    embryonic feeder 
e.g.    exempli gratia 
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ELISA   enzyme-linked immunosorbent assay 
ES    embryonic stem 
EST    expressed sequence tag 
et al.    et alii 
FACS   fluorescence-activated cell sorter 
FCS    fetal calf serum 
FL    fetal liver 
FO    follicular 
FTOC   fetal thymic organ culture 
FWR    frame work region 
H     heavy 
HEL    hen egg lysozyme 
HSC    hematopoietic stem cell 
HSV    herpes simplex virus 
i.e.    id est 
IFN    interferon 
Ig     immunoglobulin 
IL     interleukin 
J     joining gene segment 
L     leader 
L     light 
LB    Luria Bertani 
LIF    leukemia inhibitory factor 
LPS    lipopolysaccharide 
MAR    matrix attachment regions 
MCS    multiple cloning site 
MHC    major histocompatibility complex 
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mmc    mitomycin C 
mRNA   messenger RNA 
MZ    marginal zone 
N     non-templated 
NeoR   neomycin resistance gene 
NHEJ   non-homologous DNA end-joining 
NK    natural killer (cell) 
NZB/NZW  New Zealand Black/New Zealand White 
P     palindromic 
PBS    phosphate buffered saline 
PC    phosphorylcholine 
PCR    polymerase chain reaction 
pre    precursor 
pro    progenitor 
RACE   rapid amplification of cDNA ends 
Rag    recombination activating gene 
RNA    ribonucleic acid 
RS    recombining sequence 
RSS    recombination signal sequence 
RT    reverse transcription 
RT    room temperature 
S     switch 
scid    severe combined immunodeficiency 
SDS    sodiumdodecylsulphate 
sIg    surface immunoglobulin 
sIgM    surface IgM 
SL    surrogate light (chain) 
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SLE    systemic lupus erythematosus 
SPF    specific pathogen free 
TAE    Tris-acetic acid-EDTA 
TCR    T cell receptor 
TD    T cell dependent 
TdT    terminal deoxynucleotidyl transferase 
TEA    T early alpha 
TI     T cell independent 
TK    thymidine kinase 
TSLP   thymic stromal-derived lymphopoietin 
UTR    untranslated region 
UV    ultraviolet 
V     variable region gene segment 
v/v    volume per volume 
w/v    weight per volume 
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